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Background and Aims. 
Background and Aims. 
This project arose as a result of the pharmaceutical industry's interest in a new 
treatment for non-insulin dependent or type II diabetes mellitus (NIDDM). This 
therapeutical area has attracted attention from all the major companies over the last 
fifteen years, and has warranted an article in Chemistry and Industry earlier this 
year.1  
One class of compounds being investigated is based upon 5-benzyl thiazolidine-2,4-
dione. The initial observation made in this area was the discovery of Ciglitazone 1 
(Takeda) and its ability to alleviate the symptoms of NIDDM.2 There have followed 
several related compounds : BRL 49653 2 (SmithKline Beecham);3 Pioglitazone 3 
(Takeda);4 Englitazone 4 (Pfizer);5 Troglitazone 5 (Sanyko, Parke Davis, Glaxo 
Wellcome).6 
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The final step in the synthesis of all these compounds is the reduction of the 
appropriate benzylidene compound. In the case of BRL 49653 and its analogues 
vii 
Background and Aims. 
SmithKline Beecham found this to be problematic. This led to the development of a 
microbial procedure, using Rhodotorula rubra CBS 6469, to reduce the double bond 




I 	 NH 




Rhodotorula rubra CBS 6469 
IN 	BRL 49653, 2 
The initial aims of this project were two-fold. Firstly the synthesis of a range of 
compounds, based on the template shown below, was proposed to ascertain which 
structural features were required for a compound to be accepted as a substrate by the 
reductase system. In doing so it was envisaged that a range of relative reaction rates 
could be measured. 




The second aspect of the project aimed to elucidate the mechanism of reduction by 
the introduction of isotopically labelled substrates. 
Abstract. 
Abstract. 
A range of compounds designed around a template based upon (Z)-5-benzylidene 
thiazolidine-2,4-dione were synthesised by Knoevenagel condensation. These were 
screened against Rhodotorula rubra CBS 6469, a red 
yeast, using a modification of a process developed by 
R' 	 NR  
SmithKline Beecham.' This has allowed the construction ,- 	xL..J 
of a 'map' defining the structural features of the template 
which are required to afford reduction of the carbon-carbon double bond. It has been 
shown that X' and X2 must be S and 0 respectively whilst R3 can be methyl or 
benzyl. Alkyl substitution at R2 is not tolerated but a variety of substituents can be 
present at R1 . Para groups can be accomodated at R', but only methyl in the alkyl 
series, as well as the meta methoxy group. it has also been shown that replacement of 
the phenyl ring with a cyclohexyl moeity still allows reduction to take place. 
Relative reaction rates are also discussed along with the development of a process to 
afford reduction using Rhodotorula rubra CBS 6469 immobilised in calcium alginate 
beads. 
By carrying out reductions on deuterated compounds, and in deuterated medium, 
steps have been taken towards the elucidation of the mechanism of reduction. The 
following scheme is proposed as a possible mechanistic pathway. 
rjH
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There follows a list of common abbreviations used in the text of this thesis. 
Ac Acetyl 
bp Boiling point 
Chemical shift of proton (nmr) 




d.e. Diastereomeric excess 
dec. Decomposes 
DEPT Distortionless enhancement through polarisation transfer 
DMF Dimethylformamide 
DMSO Dimethylsulfoxide 
e.e. Enantiomeric excess 
El Electron impact ionisation 
gc Gas chromatography 
h Hour 
hfc 3 -(heptafluoropropylhydroxymethylene)-(+)-camphorate 
HMTA Hexamethylenetetramine 
hplc High performance liquid chromatography 
IBX 2-Iodoxybenzoic acid 
J Spin coupling constant 
min Minute 
mol% Molar percentage 
mp melting point 
m/z Mass to charge ratio 
Xi 
Abbreviations. 
NAD Nicotinamide adenine dinucleotide (oxidised form) 
NADH Nicotinamide adenine dinucleotide (reduced form) 
NADP Nicotinamide adenine dinucleotide phosphate (oxidised form) 
NADPH Nicotinamide adenine dinucleotide phosphate (reduced form) 
n.d. Not determined 
NIDDM Non-insulin dependent diabetes mellitus 
nmr Nuclear magnetic resonance 
PdIC Dry palladium on activated charcoal 
Ph Phenyl 
ppm Parts per million 
Py Pyridyl 
RF Retention factor (tic) 
RT Retention time (hplc/chiral gc) 
sat. Saturated 
s.g. Specific gravity 
spp. Species 
TBDMS Tertiary butyl dimethyl silyl 
TFA Tnfluoroacetic acid 
THF Tetrahydrofuran 	. 
tic Thin layer chromatography 
Tris Tris(hydroxymethyl)aminomethane 
w/v Weight to volume ratio 
v/v Volume to volume ratio 
YADH Yeast alcohol dehydrogenase 
Introduction. 
1., Introduction'..  
A modern biotransformation involves the harnessing of an enzymatic system, 
whether as an isolated entity or as part of a whole cell micro-organism, to afford a 
chemical transformation usually with high regio, chemo and stereoselectivity and can 
be a powerful tool to a synthetic organic chemist. This introductory chapter intends 
to give a brief history of how this tool emerged, followed by the associated 
advantages, and disadvantages over standard chemical methods, before discussing 
the range of reduction reactions catalysed by such systems. 
1.1 Introduction To Biotransformations.914  
It is widely accepted that the origins of the modern biotransformation are to be found 
in the metabolism of sugar to ethanol by yeast. This began in earnest with the award 
of a patent to Coffey in 1833 for the production of ethanol from fermented grain 
wort. Three years later Payen and Persoz extracted diastase from malted barley which 
was used to separate and break down starch for use in the fermentation process. In 
1838 this use of diastase prompted Berzelius to introduce the term 'catalysis' and 
write: 
'One can hardly assume that this catalytic process is the only one in the vegetable kingdom. On the 
contrary, it gives reason to believe that within living plants and animals thousands of catalytic 
processes are going on between the tissues and the fluids, producing a multitude of chemical 
compounds, the creation of which out of the common raw material, the sap of plants or blood, has 
up to now been unexplained, and which may possibly be found in the future to depend on the 
catalytic power of the living tissues' 
Since these original observations over a century and a half ago the concept has 
flourished. Although the production of ethanol had all but given way to synthetic 
processes based upon petroleum the changing social climate in recent years has led to 
an increase in the use of the fermentation process. 
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Many other fermentation processes still remain and serve us well. In 1934 Reichstein 
introduced a procedure utilising Acetobacter xylinum for the synthesis of ascorbic 
acid, a process which is still the basis of modern manufacturing procedures. Lactic 
acid formation from lactose using Lactobacillus bulgaricus is carried out today, 
based on a process introduced in 1880. Amino acids can be, and are, produced by 
fermentation. For example L-glutamate is produced from starch or molasses by 
Corynebacterium glutamicum. Arguably the most important breakthrough in modern 
medicine was the introduction of penicillins. Both the penicillins and cephalosporins 
are 	secondary metabolites produced by the fungi Pen icillium spp. and 
Cephalosporium spp. and have led to the development of 'semi-synthetic' processes. 
The reason these fermentation techniques have survived is their efficiency. They can 
produce complex molecules with excellent stereoselectivity more easily, and with 
less expense, than the alternatives offered by synthetic organic chemistry. 
1.2 Advantages and Disadvantages of Biocatalysis.9-12'15'16 
It is this stereoselectivity which is the main advantage of biocatalysis. The 
introduction of regulations surrounding the use of racemic mixtures as 
pharmaceuticals has led to an increase in technologies designed to produce 
compounds with high stereoselectivity. One method of achieving this is the use of 
compounds from the 'chiral pool' as starting materials in a synthetic route, although 
there are limitations on the availability of appropriate compounds. Direct resolution 
offers a means for the separation of a racemate into the constituent isomers. Although 
this offers the advantage of producing both enantiomers, the maximum yield 
available of each is 50 %. Theoretically, the use of chiral auxiliaries allows the 
production of a quantitative yield but increases the number of steps involved in a 
synthetic route as the auxiliary needs to be attached before transformation and 
removed afterwards. This is not a factor with chiral catalysts where the catalyst 
imparts stereoselectivity through a transient interaction with the reagent, however 
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they are usually complex molecules requiring complex synthesis by one of the above 
methods. 
The inherent chirality of enzymes, imparted by the presence of L-amino acids, allows 
the 'recognition' of any chirality present in the substrate. As a result, different 
enantiomers of a substrate can react at different rates affording a kinetic resolution. 
This also allows the formation of an optically active product from a prochiral 
compound. Although this constitutes an enzyme's main advantage for an organic 
chemist it can also be a major disadvantage as it is not always possible to obtain the 
other enantiomer, as is possible with a synthetic chiral catalyst, as it is not always 
possible to switch the inherent chiral induction of a particular enzymatic system. 
Enzymes can also exhibit high levels of chemo and regioselectivity. As an enzyme's 
purpose is to act on a single functional group it can do so without affecting other 
functionality in the molecule that may react under chemical conditions. It is also 
possible for an enzyme to act upon one functional group whilst leaving a similar 
group in a different environment untouched. 
Enzymes also act under mild conditions, typically physiological conditions, such as 
neutral pH and temperatures around 30 °C. This helps to minimises side reactions 
that may occur under more extreme conditions. However, this can be a disadvantage. 
If the catalytic process is slow under these conditions there is little scope for 
alteration of the reaction conditions, as extreme pH and elevated temperatures can 
lead to deactivation of the enzyme. 
One serious drawback is that enzymes exhibit highest activity in water, whereas the 
majority of organic compounds are only sparingly soluble in aqueous systems. This 
has led to extensive study centred on the use of biotransformations in organic 
solvents. When water can be used there are obvious advantages in terms of cost and 
the disposal of waste. Enzymes and cells are themselves environmentally acceptable 
as they are completely biodegradable. 
3 
Introduction. 
Enzymes are extremely efficient catalysts with acceptable rates being observed with 
10-10 mol% of the enzyme. Contrast this with the typical 0.1-1 mol% utilised in 
reactions with chemical catalysts and it is evident that the enzyme is a much more 
efficient catalyst. 
One problem associated with the use of enzymes is there capability to produce an 
allergic reaction, also certain organisms are pathogenic. However, most chemicals 
have an associated hazard and, as with chemicals, careful handling of any enzyme 
minimises the risk to the user. 
1.3 Using Biocatalysis : Whole Cell Sytems or Isolated Enzymes ? 9-11,16,17 
Fermentation processes are the life processes of the organism. They involve growing 
the cells with a natural source of elements to produce only natural products of 
metabolism. These processes can be lengthy and make use of many enzymatic steps 
within the cell but can produce many by-products making isolation of the required 
product tedious. They also require large biomass and only produce natural products. 
The majority of modem microbial biotransformations involve harnessing the use of a 
few enzymatic steps to afford a catalytic transformation, such as a carbonyl reduction 
or the hydrolysis of an ester, of either a natural or non-natural substrate. These 
reactions produce few by-products making the isolation of the desired material 
easier. This process is sometimes refered to as 'enzymation' and allows the use of a 
microbial system to carry out one 'synthetic step'. 
An organic chemist may find the idea of using a whole cell system to carry out a 
biotransformation intimidating. This is unsurprising as a certain degree of expertise is 
required in the growth and handling of these organisms. However, the use of 
lyophilised baker's yeast greatly simplifies the process. Indeed Veschambre et al., 
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have described 'a four hour experiment for undergraduate students' involving the 
baker's yeast reduction of a-diketones.18  
The use of whole cells can have several advantages, mainly that the addition of co-
factors and a suitable recycling system is unnecessary. However, expensive 
equipment can be required, work-up is often tedious due to the large volumes 
involved and low concentration tolerance may lead to low productivity. As there are 
many other enzymes present in the system there is always the possibility of side 
reactions occuring. The use of immobilised cells, for example by entrapment in a 
polymer matrix, can allow the re-use of cells but lower activities are often observed. 
Reactions using purified, or partially purified, enzyme preparations can involve 
simpler apparatus, simpler work-up, and due to higher concentration tolerance may 
show better productivity. Highest activities are exhibited when used in water but 
lipophilic substrates are insoluble and work-up involves extraction. When using an 
organic solvent, again, they are easy to perform and lipophilic substrates are soluble 
but can exhibit lower activities. Immobilised enzymes make enzyme recovery easier 
but activity can be lost during immobilisation. 
1.4 Classes of Enzyme.911  
Enzymes are classified by the type of reaction they catalyse and are categorised into 
six groups. The group number constitutes the first of a four figure Enzyme 
Commission (BC) identification number associated with each enzyme. 
Group 1 consists of the oxidoreductase enzymes which are capable of interconverting 
alcohols with aldehydes/ketones, alkenes with alkanes and oxygenating C-H bonds. 
Baeyer-Villiger reactions are also possible. 19-22  The majority are carried out using 
whole cells, as they require a co-factor, particularly baker's yeast (Saccharomyces 
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cerevisiae) due to its availability and ease of use, and there are a wide range of 
dehydrogenases and oxygenases available. 
The second group is made up by the transferase enzymes which catalyse the transfer 
of a functional group (aldehydic, ketonic, acyl, sugar, phosphoryl or methyl) between 
molecules. This class of enzymes includes transketolase (BC 2.2.1.1) which can be 
used to extend the chain of a variety of aldoses stereospecifically by two carbon units 
and is appearing to be a promising catalyst in organic synthesis.2329  
Hydrolases, the most commonly used enzymes in organic synthesis, make up group 
three. These enzymes are capable of hydrolysing esters, amides, lactones, lactams, 
epoxides, nitriles, anhydrides and glycosides. This class of enzymes include lipases, 
the natural role of which is the hydrolysis of triacyiglycerol into glycerol and fatty 
acids. However, lipases are readily available, inexpensive and can have a broad 
substrate range. This has led to them being the most studied enzymes in organic 
synthesis. 
Group 4 consists of lyases, enzymes capable of catalysing the addition-elimination of 
small molecules on C=C, C=O and C=N bonds. Indeed Rhodotorula rubra has been 
shown to catalyse the amination of the cinnamic acid double bond to produce 
optically pure S-amino acids.30 
The last two groups are of little use in organic synthesis. Isomerases (group 5) 
catalyse reactions such as racemisation and epimerisation and include mutarotase 
(BC 5.1.3.3) which converts a-D-glucose to -D-glucose. Ligases make up group 6 
and catalyse the formation-cleavage of C-O, C-S, C-N and C-C bonds with 
concominant triphosphate hydrolysis. 
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1.5 Reduction of Carbonyl Groups.9-1 2,15-17,31-34 
Alcohol dehydrogenases are enzymes that catalyse the oxidation of alcohols and the 
reduction of aldehydes and ketones. These enzymes are dependent on NAD(P)H for 
the reduction of carbonyl groups by delivery of hydride from the reduced form of the 
pyridyl co-factor. 
The majority of the alcohol dehydrogenase systems that have been studied are 
baker's yeast and horse liver alcohol dehydrogenase (HLADH), although others have 
been utilised. There are several general rules that can be applied to these reduction 
reactions. The first regards the size of the substrates accepted by various different 
alcohol dehydrogenases (Fig. 11).9,31,35  While micro-organisms usually show a 
broad range of substrate specificity the range associated with the isolated enzymes 
are generally narrower. Indeed, yeast alcohol dehydrogenases (YADH) only reduce 
aldehydes and short chain ketones whilst Thermoanaerobium brockii alcohol 
dehydrogenase (TADH) is mainly specific for methyl or ethyl ketones. Alkyl 
substituted cyclic aliphatic ketones are reduced by HLADH whilst Pseudomonas 
testosteroni alcohol dehydrogenases (PTADH) displays a wider specificity towards 
polycyclic compounds. Different hydroxy steroid dehydrogenases (HSDH) recognise 
a variety of carbonyl compounds around the steroid template. 
The second rule surrounds the stereochemistry of the resulting alcohol and is 
governed by Prelog's rule.36 This rule was initially based upon the reduction of 
carbonyl groups by Curvularia falcata and defines the groups either side of the 
carbonyl as small and large. If the carbonyl derivative is represented with the smaller 
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Fig. 1-1: Relationship Between Various Alcohol Dehydrogenases and Substrate Size. 
Baker's Yeast 
Fig. 1-2: Diagramatic Representation of Prelog 's Rule. 
Although not all dehydrogenases follow this rule it is constantly used to define the 
mode of hydride addition displayed by each dehydrogenase. In addition to baker's 
yeast, both HLADH and TADH adhere to Prelog's rule, as do hydroxysteroid 
dehydrogenases. On the other hand Pseudomonas spp., Mucor javanicus, 
Lactobacillus kefir and Pichiafarinosa alcohol dehydrogenases do not.9'31'37  
Rhodotorula rubra has been shown to perform several carbonyl reductions and one 
such instance, reported in 1993 by Yamazaki and Kobayashi, related to the growing 
interest regarding the application of enzymes in organic synthesis to organometallic 
chemistry, and focused upon the reduction of(trifluoroacetyl)ferrocene.38 A study on 
the reduction of acetophenone and the mono, di, and tn cc-fluorinated analogues 
showed that the reduction of acetophenone favoured reduction in the Prelog fashion 
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in 98 % e.e.. However, as the number of fluorine atoms increased the e.e. fell until 
the anti-Prelog product was formed in 40 % e.e. in the reduction of 
trifluoroacetophenone. The introduction of fluorine atoms also increased the rate of 
conversion. The cell free extract of Rhodotorula rubra IFO 899 yielded two fractions 
which showed activity towards the reduction of (trifluoroacetyl)ferrocene although 
with opposing stereoselectivities. 
In the previous year Sicsic showed that Rhodotorula rubra ATCC 4056 was capable 
of reducing the carbonyl of both a- and -tetralones to the corresponding tetralols 
with good stereoselectivity.39 The production of optically pure tetralols is of 
importance due to their use as chiral building blocks in organic synthesis. 
0 	 OH 
Rhodotorula rubra MY 2169 
, , 0 , \\O 	 0  0 
7 	 8 
Fig. 1-3. 	Rhodotorula rubra Mediated Reduction of a Ketosulfone. 
In addition it has been shown that Rhodotorula rubrá MY 2169 is capable of 
reducing the ketosulfone 7 to the trans-hydroxysulfone 8 in > 91 % d.e. (Fig. 13).40 
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1.6 Reduction of Carbon-Carbon Double Bonds.9- 12,15,16,31-33,41 
1.6.1 General Points. 
The enantiotopic selective reduction of prochiral carbon-carbon double bonds has 
been studied using a variety of organisms. The enzymes involved are NAD(P)H-
dependent enoate reductases which can be found in organisms such as Clostridium 
spp., Beauveria spp. and baker's yeast. Although several enzymes responsible for the 
reduction have been isolated, the majority of reactions are carried out with whole 
cells of baker's yeast, mainly due to problems of cofactor recycling and the 
sensitivity of the enoate reductases towards oxygen. 
To be effectively reduced by an enoate reductase the double bond has to be 
'activated' by an electron withdrawing substituent, either a carbonyl or nitro group. 
Due to the susceptibility of carbonyl reduction by the numerous dehydrogenases in 
baker's yeast it is unsurprising that, when the double bond is activated by a carbonyl 
group, the alcohol can be readily formed as a side product. 
A variety of different functionalities can be present on the double bond and each 
class of compound will be dealt with in turn with the main focus on yeast reductions. 
1.6.2 Yeast Reductions. 
1.6.2.1 Reduction of Cinnamaldehydes and Cinnamyl Alcohols. 
In 1975, through a series of deuterated studies, Fuganti determined the steric course 
of saturation of the carbon-carbon double bond of cinnamyl alcohol and 
cinnamaldehyde with baker's yeast.42 
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Reduction of the deuterated aldehyde 9 was found to produce the IS alcohol 10 by 
the introduction of a pro-R hydrogen atom (Fig. 1-4). A similar experiment using 
purified YADH, NAD and ethanol reduced the aldehyde in the same manner but left 
the olefinic bond unaffected. 
Reduction of the two deuterated olefins 11 and 13 formed 2S- 12, by introduction of a 
pro-R hydrogen, and 3R-14 respectively. Reduction of 15 to 16 confirmed these 
observations and also showed that exchange of deuterium for a pro-R hydrogen atom 
takes place at position 1. This is in agreement with the stereochemical course of 
carbonyl reduction in 9 as the alcohol would be reduced via the aldehyde. 
This reaction is still used as a source of optically active 3-phenyl-2-methyl-1-
propanols and has been extended to the reduction of 17 and 19.43,44  Fuganti has 
shown that 17 can be reduced to produce 18 which is used in the synthesis of a-
tocopherol, however 19 gives rise to a mixture of 20 and 21 (Fig. 1-5).44  
Later it was noted that, as well as the carbonyl and carbon-carbon double bond 
reduction of cinnamaldehyde, baker's yeast was capable of producing a diol formed 
from the aldehyde and a C2 unit (Fig. 1-6).45 For example, reduction of 2-bromo 
cinnamaldehyde 22 produces 10 % of 23, 5 % of 24 and 50 % of 25, a fact that has 
been exploited in the synthesis of L-amectose, D-(-)-allo-muscarine, L-olivomycose, 
N-trifluoroacetyl-L-acosamine, 4-hexanolide, derivatives of 2,3 ,6-trideoxy-3-C-
methyl-3-aminohexose and (-)-frontalin.4652 It has also been shown that this is 
possible with cc-methyl-3-(2-furyl)acrolein.53  
More recently unjic reported a study of reduction of a series of para derivatives of 
2-methyl cinnamaldehyde 26 by baker's yeast with a high degree of 
enantioselectivity at the a carbon (Fig. 1-7).5455 This is in agreement with Fuganti's 
mechanism which demonstrates enantioselective hydrogen incorporation at either 
end of the double bond (Fig. 1-4). 
11 
Introduction. 




Ph "'~A- "'H 
9 	 10 
Baker's Yeast 
Ph 	OH 	 Ph" )(' oH 
D 	 DH 
11 	 12 
DHP Baker's Yeast 
Ph 	OH 	 Ph 	'"OH 
13 	 14 
HD OH D 	 Baker's Yeast 
PV' (CD2OH 
D 	 DH 
15 	 16 
Fig. 1-4: Determination of the Stereochemical Course ofBaker's Yeast Reduction of 
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Fig. 1-6: Baker's Yeast Reduction of a-Bromocinnamaldehyde 22. 
Reduction of both the carbonyl and the carbon-carbon double bond are reported but 
the saturated aldehyde, often proposed as an intermediate, was not detected. 
However, it was noted that delivery of saturated aldehydes to the system led to 
carbonyl reduction and it was proposed that they were present in very low, steady 
state, concentrations. 
a~ 








H 	 DHDH 
26 	 27 
Fig. 1-7. 	Baker's Yeast Reduction of 26 in D20. 
It was shown that the rate of reduction of the carbonyl is dependent on the nature of 
the para substituent, with an electron withdrawing group enhancing the rate of 
reduction whilst an electron donating group decreased the rate. No such correlation 
was noted for the reduction of the carbon-carbon double bond. 
The reduction of 2-methyl cinnamaldehyde 26 with spray dried yeast in D20 resulted 
in trideuterated 27 which was indicative of incorporation of deuterium into the 

























Fig. 1-8: Proposed Mechanism for Baker's Yeast Reduction of 26. 
Generally it is proposed that 'attack of hydrogen' occurs without specifying the 
anionic or cationic nature of this hydrogen. However, Fuganti and Servi have 
proposed formal hydride delivery to the J3 carbon in the reduction of ct,f3 unsaturated 
lactones (Sect. 1.6.2.6).56,57 unjic postulates that if this was the case here then the 
proton transfer is enantioselective and was probably delivered by the enzyme. 
Enzymatic protonation at the emerging chiral centre was recently proposed for the 
lipase catalysed hydrolysis of prochiral enolacetates.58'59 
Also if it was attempted to reduce a double bond chemically by addition of a proton 
first it would involve the use of a strong acid and a hydride donor.60 If this was to be 
achieved biochemically it would involve the delivery of a strongly acidic proton from 
the active site to the substrate. At the time this was unknown but Smallridge has 
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since reported a mechanism for the reduction of 3-nitrostyrenes that involves 
protonation as the first step.61  
The accumulation of these facts prompted unjic to propose the mechanism outlined 
in Fig. 1-8 as the likely mechanism for the reduction of 26. 
In a study on the reduction of ciimamyl alcohols by baker's yeast Gramatica 
concluded that the alcohol is oxidised to the aldehyde before double bond reduction 
occurs.62 It was noted that although the E alcohols were reduced the Z isomer was 
not. Also 2-methyl and 2-ethyl cinnamyl alcohols were reduced whereas the 3-
methyl was not. 
OL OH 
0 	CHO 
28 	 29 
OH 
R S 	CHO 	R 
30 	 31 
Fig. 1-9: 	Baker's Yeast Reduction 28 and 30. 
Compounds produced by replacement of the phenyl ring of cinnamaldehyde by 
various heterocycles can also be reduced using baker's yeast. For example, a 
collaboration between Fuganti and colleagues with Hogberg has demonstrated the 
reduction of 28 and 30 to 29 and 31 repectively (Fig. 19).63,64  It can be seen that the 
resultant stereochemistry is in agreement with that previously noted (Figs. 1-4 and 1-
7). It was also noted that reduction of 28 involves a slow carbon-carbon double bond 
reduction followed by a fast carbonyl reduction. 64 
The formation of 29 and 31 in this manner has been utilised in a synthesis of a pine 
sawfly sex pheremone.65  
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1.6.2.2 Reduction of a,J3- Unsaturated Ketones. 
Kawai has shown the ability of baker's yeast to reduce the double bonds of a range of 
4-phenylbutenoates 32 to produce mixtures of 33, 34 and 35, a phenomenon 
previously noted by Fuganti.66'67 It is interesting to note that the substitution on the 
ring influences both the extent of reduction and e.e. of the products (Fig 1-10). For 
example introducing a para hydroxyl on the phenyl ring retards reduction whilst 
introduction of meta methoxy group improves both the yield and the e.e.. 
Heteroaromatic rings are also accepted with the pyridyl ring affording racemic 32g; 
however, when a furyl ring is incorporated the major product is the unsaturated 
alcohol 34h. 
Later studies suggested that only one enzyme was involved as reduction of various 
concentrations of 32a produced 33a with approximately 75 % e.e. 68  It was also 
noted that reduction occurs via formal trans addition across the double bond even 
when racemic product is formed, indicating that the lack of stereoselectivity is due to 
random positioning in the active site rather than random stereochemistry of 
reduction. 
Kawai also looked at the reaction pathway and has shown that double bond reduction 
can only occur if it precedes carbonyl reduction.68 This was noted in the reduction of 
28 where the initial reaction is a slow double-bond reduction followed by a fast 
carbonyl reduction.64 This ties in with the fact that only activated double-bonds can 
be reduced. 
It has been shown that the baker's yeast reduction of E- and Z-36 results in the 
formation of 37 (Fig. 1-11).69  Initially it appeared that the reaction, at low 
conversion, proceeded with kinetic resolution as samples of 37 were enantiomencally 
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I 	5-Me-2-Furyl 24 8 0 0 
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Fig. 1-11: Baker's Yeast Reduction of a,/3- Unsaturated Methyl Ketones. 
Deuteration studies showed that, in the reduction of both E- and Z-36, enzymic 
saturation of the double bond occurred in an anti fashion with formal hydrogen 
delivery at position f3 to the carbonyl group from the re face. They also showed that 
the reaction does proceed with kinetic resolution, with the enantiomeric preference 
varying from R to S in going from Z to E. 
The cyclic a43  -unsaturated diketone 38 can also be reduced by baker's yeast as 
shown by Leuenberger et al., in the synthesis of carotenoids.70 An 80 % yield of 
dione 39 was obtained on a 13 kg scale with the production of minor products 40 (6 
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Fig. 1-13: Rhodotorula mucilangosa Reduction of 3-Caren-2,5-dione 42.. 
Similarly Rhodotorula mucilaginosa has been shown to reduce the carbon-carbon 
double bond of 3-caren-2,5-dione 42 (Fig. 113).71  However, in this instance the 
main products are (+)-trans-3-caren-5-on-2-ol 45 and (+)-2-caranon-2-ol 46. 





47 	 48 
Fig. 1-14.• Baker's Yeast Reduction of Woodward 's Lactone. 
Sakai and Utaka have shown that baker's yeast can reduce the terminal double bond 
of 3-alkyl-3-buten-2-ones 49a-e and 3-phenyl-3-buten-2-one Of (Fig. 115).72  In all 
cases the reduction proceeds in accordance with Prelog's rule to produce R-50 in 
varying yields depending on the alkyl chain length. It can be seen that no reaction 
occurs with 49a and 49e with the maximum yield exhibited with 49c. 
Reduction of a terminal double bond is implicated in the formation of propiophenone 
55 in the reduction of 3-chloropropiophenone 52. It has been shown that this occurs 
via formation of the vinyl ketone 54 followed by reduction of the carbon-carbon 
double bond to produce 55 (Fig. 1-16).73  
R)y 
Fermenting Bakers Yeast 
01 R 
49 50 51 
R Time (h) Recovery of Yield of e.e. of Yield of 
49(%) 50 (%) 50 (%) 51 (%) 
a 	C5H11 87 0 0 0 
b C6H13 64 0 24 >99 1 
C 	 C8H 7 22 0 29 >98 6 
d C11 H23 90 20 22 >98 0 
e 	C121125 74 78 0 0 
f Ph 60 0 24 95 6 
Fig. 1-15: Fermenting Baker's Yeast Reduction of 3-alkyl and 3-phenyl-3-buten-2-ones. 
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0 	 OH 
Ph ' i 
52 	 53 
Ph)L 	--------------- 	Ph-'J"-' 
--------------Ph'"-' 
54 	 55 
Fig. 1-16: Formation of Propiophenone 55 on Reduction of 3-Chioropropiophenone 52 
with Baker's Yeast. 
Similarly the 3-hydroxy cc-methylene ketones 56 were reduced in good yield and 
moderate to high e.e. to produce syn-57 (3R,4S) and anti-57 (3R,4R) (Fig. 1-17).74 
Those with the shorter R group were reduced more quickly and the e.e of syn-57 is 
always good; however, as the chain length increases anti-57 becomes more favoured 
and the e.e. of the anti compound falls. 
Fermenting Baker's Yeast 
56 syn-57 anti-57 
R Time (h) Yield (%) syn/anti e.e. (%) 	e.e. (%) 
of 56 of syn-57 of anti-57 
a 	C2H5 24 61 53/47 >98 	>98 
b C3H7 27 64 42/58 >98 72 
C 	 C4H9 69 56 33/67 >98 	67 
d C5H11 114 72 36/64 >98 69 
Fig. 1-17. Baker's Yeast Reduction of/3-Hydroxy a-Methylene Ketones.. 
In recent years the reduction of arylidenecycloalkenes has been studied by Fuganti. 
Initially it was found that the baker's yeast reduction of 58 produced 59 (30 %, 
optically pure), 60 (45 %, 10 % e.e.), 61 (trace) and 62 (trace) and that further 
incubation of 60, under more forcing conditions, resulted in formation of 61 and 62 
in 80 % total yield (Fig. 1-18).75 Later studies have shown that the production of 
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near racemic 60 is due to the keto-enolic equilibrium and that formal hydrogen 
addition to the double bond of the a,13-unsaturated  ketone occurs from the 13-re 
face.35  
OH 	0 
0 	 cIIIIr" Ph(tr 
 Ph 
Ph 	Bakers Yeast 	
59 	60 
OH 	OH 
58 	 J_Ph 	Ph 
61 	62 
Fig. 1-18: Baker's Yeast Reduction of Benzylidenecyclohexanone 58. 
Studies on the related compounds 63 and 64 
0 	 o 
showed a similar distribution of reduction 
products but the e.e. of the unsaturated 	
frPh 
alcohol (eg. 59) decreased on going from 58 	63 	 64 
to 63 to 64.35  
The ability of baker's yeast to reduce 58 in this manner has been exploited in the 
synthesis of (5)-2-methoxycyclohexanone, a key intermediate in the synthesis of 
sanfetrinem, and has been shown to be superior in chemo and stereoselectivity to 
Nocardia opaca, Pichia etchelsii and Mucor subtilissimus.76 
The reduction of compounds of type 65 and 	 o 
66 has been studied by Crout et al.77 -'tLf.CN 	
ácN 
Reduction of 65 with baker's yeast, 
Zygosaccharomyces 	rouxii, 	Candida 	65 	 66 
chalmersi, Pichia capsulata and Pichia farinosa all afford unsaturated alcohol as the 
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major product. In the case of 66 baker's yeast produces the unsaturated alcohol as the 
major product, as does Candida chalmersi and Candida diddensii whereas 
Zygosaccharomyces rouxii and Pichia capsulata produce the unsaturated ketone and 
Pichiafarinosa affords the completely saturated compound as the major product. In 
the case of both 65 and 66 the configuration of the resultant hydroxyl functionalised 
centre varies between organisms. 
1.6.2.3 Reduction of a,/3- Unsaturated Aldehydes and Allylic Alcohols. 
Baker's yeast reduction of cinnamaldehydes and cinnamyl alcohols to the 
corresponding dihydroderivatives has been examined in Sect. 1.6.2.1. 
The first reported example of the reduction of a non-aromatic allylic alcohol was by 
Gramatica in 1982. He showed that it was possible to reduce the activated double 
bond of geranial 67a and geraniol 67b to produce (R)-(+)-citronellol 68, whereas 
neral 69a and nerol 69b produced a mixture of R- and S-68 in a ratio of 6:4, which is 
consistent with the partial cis-trans isomerisation of 69a in the microbiological 
conversion of nerol into citronellol.78 68 can be oxidised, with selenium dioxide, to 
70 which itself can be reduced with baker's yeast to produce 71, whilst 73 can be 
produced from 72 (Fig. 1-19).79 Three conclusions are drawn from the latter two 
reactions: no epimerisation occurs at C-6 during the microbial reduction; introduction 
of hydrogen at C-2 is highly stereospecific and the same absolute stereochemistry is 
produced at C-2 regardless of that present at C-6. 
Baker's yeast has also been shown to reduce the carbonyl activated double bond of 
74 and 76 to produce the alcohols 75 and 77 80 Now it can be seen that when the 
methyl group is 13  with respect to the carbonyl functionality (eg. 67a), the hydrogen 
attacks from the rear (as drawn), but when the methyl group is a to the carbonyl (eg. 
72), it appears that hydrogen is incorporated from the front. This is in agreement with 
the previously noted trans addition of hydrogen in the reduction of cinnamaldehydes 
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and is a fact exploited in the synthesis of natural phytol which is synthesised from 68 
and 7581 
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Fig. 1-20: Baker's Yeast Reduction of Allylic Alcohols. 
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Similarly baker's yeast has been shown to reduce allylic alcohols 78 and 80 (Fig. 1- 
20).82 However, although the same high level of regioselectivity is observed, 
hydrogen seems to be incorporated from the same side of the molecule at both a and 
3 positions. Although it is possible that this could be as a result of syn addition, as 
has been observed in some vegetal systems,83 it could also be the result of more than 
one enzyme acting or due to the positioning in the active site. 
In addition Santaniello has shown that the terminal methylene group of alcohol 82 
can be reduced to produce (25)-3-benzyloxy-2-methyl-1-propanol 83 (Fig. 121).84 
BnOjt,~, OH 	
Baker's Yeast 
10 	BnO OH 
82 	 83 
Fig. 1-21. Baker's Yeast Reduction of an Allylic Alcohol Terminal Double Bond. 
R' 	 R1 
Baker's Yeast 
R2 	 OH 	 R 
R3 	 OH 
84 	 85 
Fig. 1-22: Baker's Yeast Reduction of a-Allenic Alcohols. 
In addition to allylic alcohols primary and secondary cx-allenic alcohols 84 can also 
be reduced by baker's yeast, with the secondary alcohols requiring longer for 
reduction to occur (Fig. 122).85 
1.6.2.4 Reduction of Halogenated Olefins. 
Kitazume showed the capabilities of baker's yeast to reduce the perfluoroalkylated 
carbon-carbon double bond in 86-88. All are reduced in good yield (68-72 %), with 
the esters being recovered intact, and e.e. (67-78 %) although no absolute 
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It has also been shown that reduction of a,13  unsaturated compounds where the 
carbonyl is attached to a perfluoroalkyl group favours production of the saturated 
ketone (Fig. 1-23), for example reduction of 89 produces both 90 (77 %) and 91 (3 
%).87 However, when the perfluoroalkyl group is attached to the carbon-carbon 
double bond reduction favours the saturated alcohol. The reduction of 92 produces 93 
(7 %) and 94 (67 %) after 10 d. However, when measured after 2 d the product 
composition was 81 % 93 and 4 % 94. 















Fig. 1-23. Reduction of Fluorinated Compounds with Baker's Yeast. 
C1 	 C1 
	
Cl 
R 	 R 
	
R 






Fig. 1-24: Reduction of Chlorinated Compounds with Baker's Yeast. 
Takeda has studied the reduction of a,-unsaturated ketones with chlorine 
incorporated on the double bond 95 (R = C2H5, n-05H11, n-05H17).88 It was noted that 
the carbon-carbon double bond is reduced rapidly to produce 96, and is not affected 
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by the increasing chain length, whereas the carbonyl reduction is much slower and is 
impeded by the increasing chain length (Fig. 1-24). 
Baker's Yeast. 












CH2N7 . H CI 
C12HCc 
S-99 
Fig. 1-25: Baker's Yeast Reduction of E and Z Isomers to Produce R and S Enantiomers 
Respectively. 
This example has been developed and utilised in the synthesis of both L- and D-
armentomycin.89 The key reaction in the synthesis is the baker's yeast reduction of 
ester 98, the remarkable feature of which is the formation of R-99 from E-98 and S-
99 from Z-98 (Fig. 1-25). The reduced product is isolated as the hydrolysed acid and 
re-esterification is afforded with diazomethane. R-99 was produced in 65 % (84-92 % 
e.e.) whilst S-99 was produced in 60 % (97-99 % e.e.) after the two steps. 
1.6.2.5 Reduction of a,/i-Unsaturated Esters. 
Utaka extended the study of halogenated olefins to a larger range of (E)- and (Z)-
methyl 2-chloro-2-alkenoates.90 It was found that in each case the reduction products 
were recovered as the free acids, although ethyl 2,4,4-trichiorobutenoate was 
recovered intact with a trace of the reduced acid, indicating that the ester cannot be 
the substrate and that hydrolysis must occur before reduction. 
2-heptenoic acid and its methyl ester were not reduced; however, the corresponding 
2-chioro ester was, indicating that the conjugated carboxyl group in itself is 
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insufficient to activate the double bond towards reduction. In contrast the 3-chloro-2-
alkenoates were not reduced. 
This presence of the electron withdrawing chlorine also increases the rate of reaction 
with 102 being reduced much more quickly than 101 which in turn reacts faster than 
100 (Fig. 1-26). 
C1 	 CI 	 CI 
02Me 	C1 02Me 	C1 02Me 
Cl 	 C1 CI 
100 	 101 	 102 
Increasing Reduction Rate 
Fig. 1-26: Relative Reduction Rate in the Baker's Yeast Reduction of2-Chloro-2-
Alkenoates. 
The presence of the chlorine also plays an important role in directing the 
stereochemistry of the product. All of the Z-isomers produce R-isomers in 95 % 
e.e., although the E-isomers afford products with S configuration and the e.e. is 
generally much lower, 25 - 92 %. It was shown that E does not isomerise to Z and the 
lower e.e. values must be due to lower enantioselectivity of the yeast reductase 
towards the E-isomers. The isopropyl group 100 directs the stereochemistry better 
than ethyl or butyl but not as effectively as the similarly sized highly polar 
dichioromethyl group 101. 
Leuenberger et al. reduced the double bond of ethyl 4,4-dimethoxy-3-methylbut-2-
enoate to the corresponding saturated hydroxy ester with baker's yeast as a key step 
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This reduction was examined in greater detail by Ferraboschi who looked at the 
products from incubation of mixtures of E- and Z-103.92 It was noted that the Z 
isomer was reduced to 104 and was the better substrate, whilst the double bond of E- 
103 was left untouched, although the acetal moiety was hydrolysed and reduced to 
produce hydroxy ester 105 (Fig. 1-27). 
Incubation of hydroxy ester 105 did not produce any reduction product which 
contrasts with results obtained with the similarly configured aldehydes 70, 72, 74 and 
76 where the hydroxyl of 105 is replaced by a formyl group and the ester 
functionality is replaced by an alkyl group.79' 80 
Incubation of aldehyde 106 does produce some of 104. This probably occurs via 
formation of the E-hydroxy ester which may 	
CO2Et 
undergo double bond isomerisation followed by 
conversion to the aldehyde and then saturation of 
the double bond to produce 104. The ratio between 
	106 	 107 
the E-hydroxy ester and 104 was 3:1. However, replacement of the ester moiety with 
the methyl group caused dramatic change in the stereochemical demand of the 
reaction and the carbon-carbon double bond of 107 was reduced, which is in 
agreement with the observations of Gramatica et al.79' 80 




HO 	 HO O 
OMe 
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Fig. 1-28: Baker's Yeast Reduction of a Tetra-Substituted a,/3- Unsaturated Ester. 
Another interesting result is the attempted reduction of the tetra-substituted double 
bond of 108. This was prepared as a probable mixture of E and Z-isomers and 
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incubation produced hydroxy ester 109 (probably E) and lactone 110, a fact which 
highlights the unsuccessful nature of reduction of tetra-substituted double bonds (Fig. 
1-28).92 
	
Also reduction of 111 with baker's yeast and Zygosaccharomyces 	0 
rouxii produces the unsaturated hydroxy ester as the major 	 CO2Et 
product.77 Baker's yeast produces the S isomer whilst Z. rouxii 	
III 
affords the R isomer. 
1.6.2.6 Reduction of a,/3- Unsaturated Lactones. 
The ability of the Basidiomycete Polyporus durus to hydrogenate the ring double 
bond of the (t43-unsaturated lactones 2-decen-5-olide 112 and 2-dodecen-5-olide, 
from Massoi bark oil, has been reported.94 However, Basidiomycetes are slow 
growing and highly demanding and as such are not particularly useful organisms for 
biocatalysis. Van der Schaft et al. have shown that the same reaction was possible 
with baker's yeast.94 
D 
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80 % D20 	
0 H 
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Fig. 1-29: Determination of the Stereocheinical Course ofBaker's Yeast Reduction of 
a, P- Unsaturated Lactones. 
Fuganti, Fronza and Grasselli studied this further and determined the stereochemical 
course by reduction of 2-decen-5-olide 112 with baker's yeast in 80 % D20 to 
produce the dideuterated lactone 113 (Fig. 1-29).95 It was noted that the hydrogen 
addition occurs with trans stereochemistry and that deuterium was incorporated into 
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both position 2 and 3 in 70 and 45 % respectively, indicating that the majority of 
hydrogen added at position 2 arises from water. This indicates the involvement of a 
reduced pyridine nucleotide coenzyme similar to enoyl-CoA reductases. This is the 
same anti addition that was reported in the cinnamaldehyde reduction.42 
Reduction of racemic 112, where deuterium is incorporated at positions 2 and 3, 
results in the formation of R- and S-113. In both cases formal trans addition of 
hydrogen from the 13-re face is observed, irrespective of the stereochemistry at 
position 5, and with kinetic preference for the R isomer. 
Studies were extended to the reduction of nonen-4-olide 114.96  Reduction of racemic 
114 resulted in a preference for the S isomer, although the side-chains are of the same 
length the e.e. exhibited was substantially lower than that observed for R-113. It was 
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Fig. 1-30. Baker's Yeast Reduction of Sterically Hindered a,/3- Unsaturated Lactones. 
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However, although the stereochemical preference is inverted, hydrogenation of S-114 
with baker's yeast in D20 still occurs by anti addition from the P-re face to produce 
5-115. 
In plants alkan-4-olides usually occur in the R configuration. However, in Dipteiyx 
odorata nonan-4-olide holds the S configuration (20 % e.e.) and accompanies nearly 
racemic nonen-4-olide. The link between the two is not known, but if one is formed 
from the other then there is correspondence of the mode of reduction in baker's yeast 
and in the plant. 
In Cladosporium suaveolens degradation of racemic ricinoleic acid, and analogues, 
produces R-7-1actones, whereas isomeric materials, where the hydroxyl group has 
been moved to odd position, produces S-6-lactones. Higher e.e. was noted in this 
oxidation 
3-
when chain length was increased and was higher for 6 than y-lactones.97  
0 Bakers Yeast 




R Yield of 123 (%) 	e.e. of 123 (%) 
a 	OCH20CH2CH20CH3 85 >99 
b OAc 60 n.d. 
C 	 OH 7 n.d. 
d CH2Ph 34 95 
e 	 SPh 41 99 
f S(0)Ph 49 97 
g 	S(0)2Ph 14 77 
Fig. 1-31: Baker's Yeast Reduction of Variousa,13- Unsaturated Lactones. 
It has been reported that during reduction of racemic 116, 118 and 120 the only 
noticeable reaction is a rapid saturation of the 5S isomers ct,f3 unsaturated double 
bonds (Fig. 1-30).57 At 50 % conversion the distribution of the four species appears 
quite similar in all three cases. If the mode of addition is the same as for 112 and 114 
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then it seems reasonable that the 5S isomer is easier to reduce (S-116 versus R-116, 
Fig. 1-31). 
The ability of baker's yeast to reduce a43 unsaturated lactones has been exploited in 
synthesis. For example Schröer and Welzel have used 123a in the synthesis of a 
precursor to (+)-strigol and sorgolactone whilst Takabe has reduced 122b-g to 
produce chiral building blocks for terpenoid synthesis and the synthesis of Factor- 
1.98-100 
1.6.2.7 Reduction of Sulfur-Substituted Olefins. 
Reduction of 124 with baker's yeast produces the saturated alcohol 125 after 3 d 
which after 19 d is converted to the acid 126 (Fig. 132).101 Attempted reduction of 
(E)-3-(1,3-dithian-2-yl)-2-methylpropenoic acid produces no saturated compound 
indicating that the oxidation occurs after reduction of the double bond. Reduction of 
the sulfoxide 127 also produces the saturated acid 128. 
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Fig. 1-32: Baker Yeast Reduction of Sulphated Olefins. 
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Reduction of the allylic alcohol 129 produces 130 in 22 % and 131, resulting from 
double bond migration, in 12 %. However, the incubation of the corresponding 
sulfone and sulfoxide only produced double bond migration and no reduction, 
indicating the importance of the nature of the sulfur moeity. Although incubation of 
the sulfone, corresponding to 129 did not produce any reduced compound 127 did 
indicating that the position of the methyl group is also important. The vinyl alcohol 







Crout et al have looked at the reduction of sulfide 134 sulfoxide 135 and sulfone 136 
with a variety of organisms.77 Baker's yeast reduction of 134 produced both the 
saturated and unsaturated alcohols in similar amounts; however, reduction with 
Zygosaccharomyces rouxii only produced the unsaturated alcohol with the opposite 
configuration than that from baker's yeast reduction. In the case of 135 and 136 only 
carbonyl reduction was observed on incubation with baker's yeast. 
1.6.2.8 Reduction of Nitro-olefins. 
In 1985 Ohta described the reduction of several 3-nitrostyrenes. He had discovered 
the ability of growing cells of Rhodococcus rhodocrous IFO 3338 to reduce the 
olefinic bond of 1-phenyl-2-nitro propene, 1 -(4-hydroxyphenyl)-2-nitropropene and 
1-cyclohexyl-2-nitropropene to afford the corresponding propanes.102 There had 
been few reports of nitro-olefins previous to this due to their antibiotic activity. 103 
Studies were carried out using 1 -phenyl-2-nitropropene and when the substrate was 
added to growing cells during the logarithmic stage it inhibited growth. The best 
yields were demonstrated when the substrate was added at the beginning of the 
stationary phase. Addition of the substrate to a concentration of 0.4 % in acetone (2.5 
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%) allowed quantitative conversion to product. Addition of a higher concentration of 
substrate led to lower conversions. 
Reduction to the amine followed by derivatisation with (-)-
methoxytrifluoromethylphenylacetyl chloride enabled determination of the absolute 
configuration as S. The optically active product was found to racemise, even under 
slightly acidic conditions. At pH 6.5 the product exhibited 43 % e.e. after 9 h and 27 
% e.e. after 48 h. 
Later Ohta reported the ability of fermenting baker's yeast to reduce 1 -nitro-2-
phenyipropene, with the methyl substituent in the a position unlike before (137, R' = 
Ph, R2 = CH3, Fig. 133).104 The reduced compound was determined to have the R 
configuration and was produced in 50% yield and 98 % e.e. 
The substrate specificity was investigated with the ability of the baker's yeast system 
to reduce 1 -nitro-2-phenylpropenes with chioro, bromo and nitro as para substituents 
on the aromatic ring having been determined. 104,105 
R' 	H Baker's Yeast 	RL.. çCH2NO2 
R2 	NO2 	 R 
2 H 
137 	 138 
Fig. 1-33: Baker's Yeast Reduction of Nitro Activated Olefins. 
It was found that R2 could be extended to ethyl and propyl groups when R' was 
phenyl, and could be extended to hexyl when R' was methyl. All were reduced in 
reasonable yield to produce the R enantiomers with high stereo selectivity. 105 
An interesting example was the reduction of E- and Z-2-methyl- 1 -nitro- 1 -octene (R1 
= hexyl, R2 = methyl and W = methyl, R2 = hexyl respectively) where it was found 
that both produced the same enantiomer.105 Two explanations were proposed, firstly 
that the olefins isomerised during reduction or secondly that the enzyme was 
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selective for the same enantiotopic face regardless of configuration. Although no 
definite information was available to distinguish between the explanations, it was 
noted that the reduction of the exomethylene compound 139 produces the same 
product 140 as the reduction of 1-nitro-2-phenylpropene 141 (Fig. 1-34). In this case 
it was expected that the reaction path showed isomensation of the double bond and 
indeed control experiments demonstrated a slow equilibrium between 139 and 
141.105  
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Fig. 1-34: Baker's Yeast Reduction of 139 and 141 
Takeshita further investigated the substrate specificity by showing that both electron 
withdrawing groups (Cl, Br and CN) and electron donating groups (OCH3 and CH3) 
are acceptable at all three positions on the aromatic ring of 138 and 139.106  It was 
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When a nitro group was incorporated on the phenyl ring of 142 the double bond 
reduction was accompanied by reduction of the aromatic nitro group when in the 
ortho position, to produce the amine as a minor product. However, similar 




He also extended the process to heteroaromatic nitroalkenes. The indole based 144 
was reduced when both R' and R2 were hydrogen and also when R' was hydrogen 
and R2 was methyl. However it was not reduced when R' was phenyl and R2 was 
hydrogen. The pyridyl based 145 was also reduced. 
Thiophenes, furans and pyrrols were all incorporated into 146. All were reduced 
when R' and R2 were hydrogen and when R' was hydrogen but R2 was methyl. The 
latter compounds were produced in higher yield. Both thiophenes were also reduced 
when R' was bromine. 
In 1996 Smallridge reported the reduction of 142 using baker's yeast in light 
petroleum, with the addition of a small amount of water. 107 
The reduction of several para substituted analogues of 142 and 143 were reported 
and it was found that those with electron donating groups produced better yields than 
those with electron withdrawing groups. This was the same as in the aqueous system, 
although comparable or higher yields were found in the organic system. 106 
The reduction of 143 resulted in the formation of racemic products, as was noted in 
the aqueous system. In the latter system it was suggested that this was due to the 
slightly basic reaction conditions.102 Incubation of 1 -phenyl-2-nitropropane under 
the reaction conditions but with D70 rather than water showed that racemisation was 














It was known that reduction of a-methyl-3-nitrostyrene produced optically active 
product in the aqueous system and Smaliridge later showed, by the reduction of a-
deutero-3-nitrostyrene, that this was the case in the organic system.61'105 
There followed a study using various deuterated compounds designed to elucidate the 
mechanism of reduction, and in particular the formation of racemic product (Sect. 5-
4). This culminated in the proposal of a mechanism of reduction (Fig. 135).61 
1.6.2.9 Miscellaneous. 
Although it is generally accepted that only activated double bonds are reduced by 
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Fig. 1-36: Baker's Yeast Reduction of an Isolated Styryl Double Bond. 
Das has shown that the isolated styryl double bond of enamides 147 and 148 can be 
reduced in 57 and 62 % respectively with baker's yeast, whilst the rest of the 
functionality remains untouched (Fig. 1-36). The double bonds of piperine 151, 
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1.6.3 Reduction By Other Systems. 
Although the majority of whole cell reduction reactions are catalysed using baker's 
yeast it is important to remember that other organisms are also capable of performing 
similar reactions. In particular reductions using Beauveria bassiana (formerly 
Beauveria sulfurescens) and Clostridium spp. have been well studied and isolated 
incidents exist where other systems, eg. Nicotiana tabacum, have been utilised. 
1.6.3.1 Beauveria bassiana. 
Kergomard and co-workers have shown the ability of this organism to reduce a 
variety of a,-unsaturated double bonds, with the reduction of a,-unsaturated 
ketones having been extended to a variety of fungi. 109 
This was discovered serendipitously during a study with 2-methy1cyc1opentenone 10 
It was envisaged that the organism would hydroxylate the acycle but the only 
isolated product was (R)-2-methylcyclopentanone in 90 % yield. However, it was 
noted that to achieve such reduction the reaction must be carried out with minimum 
aeration and that reduction did not occur with 3-methyl cyclopenten-2-one. Also 
reduction of racemic 2,5-dimethyl-2-cyclopenten-2-one shows a kinetic preference 
for the 5R isomer.111  
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Studies were extended to cyclohex-2-enones which produced both saturated ketones 
and alcohols. It has been shown that the double bond of cyclohex-2-enones, 
substituted with methyl groups in the 4-, 5- or 6- positions are reduced as are (+)- and 
(-)-carvone. However, 2,6-dimethylcyclohex-2-enone and 2,6,6-trimethylcyclohex-2-
enone were not reduced. 112 
A variety of acyclic aldehydes and ketones were also reduced by Beauveria 
bassiana. 24  Studies of the reduction of a,13-unsaturated  aldehydes showed that 
double bond saturation precedes aldehyde reduction. In the case of both acyclic and 
cyclic double bonds it was noted that at least one hydrogen has to be present at the f3 
position on the double bond. 
3J R3 X 2 	 R3X2 
Fig. 1-37.' Beauveria bassiana Saturation of a,/3-unsaturated Enones. 
The mechanism of hydrogenation and the stereochemistry of this fungal reduction 
have also been studied. It was noted that attack of hydrogen at the a carbon occurs 
from the rear if the larger substituent is on the left and from the front if the larger 
substituent is on the right (Fig. 1-37).112,114  It was also found to incorporate a trans 
addition of hydrogen across the double-bond, being incorporated from the a-si and 
P-re faces. 110'115117  
1.6.3.2 Clostridium spp.. 
The majority of the work concerning these anaerobic bacteria has been carried out by 
Simon and co-workers. Although they have shown that it is possible to hydrogenate a 
variety of substrates, including allylic alcohols and a, 13-unsaturated aldehydes, 1 IS-  20 
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the majority of their work has concentrated upon the reduction of 2-enoates.41'121123  
It was noted that the carbon-carbon double bond of these 2-enoates does not require 
an activating group other than the carboxylic acid moeity. 
These reactions are performed under an atmosphere of hydrogen. Anaerobic 
organisms contain hydrogenase enzymes capable of oxidising dihydrogen whilst 
reducing a natural electron mediator such as ferrodoxin. This mediator can then 
regenerate NADH from NAD for use in the reduction reaction.41  
It has also been shown that this natural electron mediator can be replaced by an 
artificial one, such as methyl viologen. The use of an artificial mediator can replace 
one of the three enzymes because the enoate reductase can use the artificial mediator 
directly, without the need for ferrodoxin and ferrodoxin-NAD reductase, and the 
hydrogenase enzyme can reduce the viologen.41 It is also possible to regenerate the 
methyl viologen electrochemically so that only the enoate reductase is required.41'124 
It has been determined that saturation of the double bond occurs with trans 
incorporation of hydrogen and reactions have been carried out using resting cells and 
purified enoate reductases.41'125-127 This has been used in the reduction of the 
monomethyl fumarates 154 and 156 to produce compounds that are chiral by nature 


















Fig. 1-38: Reduction of Monomethyl Fumarates 154 and 156 by an Enoate Reductase 
from Clostridium spp.. 
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Although whole cells of various Clostridium spp. were capable of reducing allylic 
alcohols the purified enoate reductase was not and this reaction required the 
introduction of an aldehyde dehydrogenase. It was noted that the a,3-unsaturated 
alcohol was firstly dehydrogenated to form the 2-enal which was reduced to the 
saturated aldehyde before carbonyl reduction to afford the saturated alcohol. 119 
Kergomard found that the reduction of a,-unsaturated acids could not be achieved 
using Beauveria bassiana and turned his attention to growing Clostridium spp., in 
the anticipation that this would provide a simplified procedure. This system was used 
to reduce the carbon-carbon double bond of both 2-deuterio and 3-deuterio cyclohex-
2-enone which provided further evidence for a trans incorporation of hydrogen. 
However, yields with growing cells were generally less that with isolated 
ones. 129,130 
This reduction of 2-deuterio-2-cyclohexenone was also found to be in agreement 
with the rule proposed by Kergomard to determine the direction of attack a to the 
carbonyl in Beauveria bassiana mediated reductions (Fig. 1-37). 
1.6.3.3 Nicotiana tabacum. 
The cultured cells of Nicotiana tabacum are unusual in that reduction occurs in a syn 
fashion.83'131 This has been shown to occur in the reduction of (1S,55)-verbenone 
158 which is reduced to produce (1S,2R,55)-cis-verbanone 159 (Fig. 1-39). None of 
the trans isomer is produced and (1R,55)-158 is only reduced in trace amounts, 
indicating that the reduction is both enantio and stereospecific. 
Nicotiana tabacum 
o II 
158 	 159 
Fig. 1-39: Nicotiana tabacum Mediated Reduction of (JS,5S)-Verbenone 158. 
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It has also been shown that saturation of the double bond occurs via re-re attack, with 
the hydrogen incorporated at C-2 arising from the pro-4S position of NADPH whilst 
that at C-3 arises from the medium. 
1.6.3.4 Streptomyces cinereocrocatus. 
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Fig. 1-40 	Streptomyces cinereocrocatus Mediated Reduction of(-)-Dihydrogriseofulvin 
160 
Sato has studied the Streptomyces cinereocrocatus mediated reduction of (-)-
dihydrogriseofulvin 160 to produce (+)-griseofulvin 161.132  It has been shown that 
this occurs by anti addition with the hydrogen incorporated a to the carbonyl arising 
from the pro-4R position of NADPH whilst that P to the carbonyl is delivered from 
the reaction medium. 
1.6.3.5 Cotynebacterium equi IFO 3730. 
Ohta has demonstrated the ability of Corynebacterium equi IFO Ph 	H 
3730 to reduce the double bond of chalcone 162; however, the HPh 
regiochemistry of 162 is not discussed. 133,134 	 0 
162 
Reduction was possible with a variety of both electron donating and electron 
withdrawing groups in the para position of the phenyl rings and yields could be 
excellent with the unsubstituted chalcone exhibiting quantitative conversion and 
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isolated yield. No carbonyl reduction was detected and, when present, aromatic nitro 
groups were left untouched. 
1.6.4 Metabolic Pathways. 
The enzymes being utilised during a biotransformation have a natural role in the life 
cycle and metabolism of the cell. Carbon-carbon double bond reduction plays an 
important role in these metabolic pathways, for example in the synthesis of fatty 
acids and steroids. 
Enoyl reductase enzymes catalyse the final step in the condensation-reduction-
dehydration-reduction cycle that lengthens the chain of a fatty acid by -CH2CH2- at 
each turn of the cycle. In 1980 Sedgewick reported the mechanism of double bond 
reduction in yeast.135 This was found to involve anti addition with 2-si, 3-si attack 
on the double bond with the hydrogen at C-3 being delivered from the pro-4R 
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Fig. 1-41: Stereochemical Course of Yeast Enoyl Reductase Carbon-Carbon Double 
Bond Saturation. 
It has been shown that the 5a-reductase from Pen icillium decumbens reduces the 
double bond of the deuterated testosterone 163 to the 5a-dihydrotestosterone 164 in 
an anti fashion. 136 
Introduction. 
Biosynthetic studies with Streptomyces collinus have shown that the 
cyclohexanecarboxylic acid moiety of anastrienin A 167 is derived from shikimic 
acid 165 via 1-cyclohexenecarboxylic acid 166 (Fig. 143).137 
nu 
163 	 164 
Fig. 1-42. Stereochemical Course of Reduction of a Steroidal Double Bond by the 5a-
Reductase from Penicillium decumbens. 
CO2H 	 CO2H 
HO 	OH 	 - 
OH 
165 	 166 
Me 
Fig. 1-43: Stereochemical Fate ofD-(-)-[2-13C]Shikimic Acid in the Conversion to the 
Cyclohexylcarbonyl Moiety of Ansatrienin A 167. 
It was noted that a NADPH-specific enoyl-CoA reductase from Streptomyces 
collinus converts 168 to 169 by hydride delivery form the pro-4S position of 
NADPH to the si face of the 3-carbon of 168 and anti incorporation of hydrogen 
from solvent at the a-carbon (Fig. 1-44). 
*H H 
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168 	 169 
Fig. 1-44. Reduction of 168 With an NADPH-Specific Enoyl-CoA Reductase From 
Streptomyces collinus. 
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2. Results & Discussion. Synthesis of Potential Substrates 
This chapter deals with the synthesis of a range of potential substrates for the 
Rhodotorula rubra CBS 6469 biotransformation. 
The mainstay of this synthesis is the Knoevenagel condensation between a range of 
benzaldehydes and benzophenones with various five membered heterocycles to 
produce compounds based on (Z)-5-(benzylidene)thiazolidine-2,4-dione, with 
modified substitution patterns and varying constituent atoms of the heterocyclic ring 
(Fig. 2-1). 
R2 	o o 0 
R 	 r~NH 
X -4e L I__ NR 	> 
X 
Fig. 2-1. 	Retrosynthesis of Potential Substrates Based Upon 
(Z)-5-(benzylidene)thiazolidine-2, 4-dione. 
This condensation reaction will be discussed initially, along with the associated 
regiochemistry of the products, followed by the synthesis of the non-commercially 
available aldehydes. The next sections focus on the synthesis of the benzylidene 
precursors to the Pfizer drug Englitazone and a Lilly compound which has also 
shown pharmacological activity towards NTDDM. The final section discusses 
expansion of the template including the synthesis of one alkene where the phenyl 
ring has been replaced by a cyclohexyl ring. This also includes the ring opening of 
(Z)-5 -(4-methoxybenzylidene)-2-thione-thiazolidine-4-one and subsequent functional 
group transformations to produce a class of compounds based upon (Z)-2-sulfanyl-3-
phenyipropenoic acid. 
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2.1 Synthesis of Potential Substrates Based Upon 5-Benzylidene Thiazolidine-
2,4-dione. 
2.1.1 Knoevenagel Condensation of Various Benzaldehydes and Benzophenones 
With Five Membered Heterocycles. 
The Knoevenagel condensation belongs to the family of reactions, based around the 
Aldol reaction, involving the attack of a carbon-hetero atom multiple bond by a 
carbanion. The Knoevenagel reaction involves the attack of an aldehyde or ketone, 
usually without a hydrogens, by the carbanion of a carbon centre flanked by two 
electron withdrawing groups to stabilise the negative charge. 138 
By changing the heterocycle involved it was possible to vary X' and X2. It was also 
possible to change R' by changing the substituent and substitution pattern on the 
carbonyl compound used, whilst using a ketone instead of an aldehyde introduced 
substitution at R2 (Fig. 2-2 and Table 2-1). After the condensation step it was 




R2 + 	NH 	
(i), (ii), (iii) or 	
R' NR 
xI._.__ x2 	 x2 
(i) 	Toluene, AcOH (cat.), Piperidine (cat.), Dean and Stark conditions. 
AcOH, NaOAc. 
Pipendine. 
(iv) NH4CI (aq.), NH3(aq.). 
Fig. 2-2: 	Knoevenagel Condensation. 
Although four sets of reaction conditions were employed the majority of the 
compounds, 170-191, resulted from the condensation of 4-substituted benzaldehydes, 
or benzaldehyde itself, with thiazolidine-2,4-dione. All of these, except 189 and 190, 
were prepared by heating at reflux in toluene, under Dean and Stark conditions, with 
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acetic acid and piperidine as catalyst. All were prepared in moderate to good yield 
(62-90 %) except for 176, 180 and 186-188 which exhibited yields between 34-44 %. 
None of the yields shown were optimised and all aldehyde condensations were 
complete within the reaction time shown. 171-188 were purified by recrystallisation 
from ethanol and it is possible that the yields could have been improved by use of a 
different solvent for this procedure. However, it was imperative that these 
compounds could be produced quickly and ethanol appeared to be a universal solvent 
for their purification. 
189 and 190 were prepared, in 77 and 78 % yield respectively, by heating the 
appropriate benzaldehyde and thiazolidine-2,4-dione at reflux in acetic acid with 
sodium acetate for 3 and 21 h respectively. It has been reported that these compounds 
were not formed under the Dean and Stark procedure; however, attempts to produce 
189 by this method resulted in 96 % crude yield. 139 
Similarly, thiazolidine-2,4-dione was condensed with 2-, 3- and 2,6-dimethoxy 
benzaldehydes to produce 197-199 under the Dean and Stark conditions in 77-82 % 
yield, after recrystallisation from ethanol. 200 resulted from a similar condensation 
with 3,5-di-tert-butyl-4-hydroxy benzaldehyde in 80 % yield on recrystallisation 
from toluene. 
Condensations were carried out between thiazolidine-2,4-dione and three 
benzophenones to produce potential substrates with tetra-substituted double bonds, 
201, 202 and 203 in 52, 29 and 50 % yield respectively. The reaction times increased 
relative to the corresponding benzaldehydes and as the length of the alkyl chain 
increased. The condensations were allowed to proceed for 50 h, 47 h and 10 d 
respectively; however, none had produced quantitative conversion to product within 
this time. 201 and 202 were purified by recrystallisation from toluene, with the latter 
requiring further purification by column chromatography, while 203 was purified by 




R' 	R2 	R3 	X' 	X2 	Conditions Reaction Yield ZIE 	H (ppm) 	Lit. 811 (ppm)a 3C,H 
Time (h) 	(%) 	 (Hz) 
170 H H H S 0 (i) 27 80 Z 7.77 
171 4-OH H H S 0 (i) 27 76 Z 7.69 
172 4-OMe H H S 0 (i) 25.5 75 Z 7.72 
173 4-OEt H H S 0 (i) 20 65 Z 7.68 
174 4-OPr H H S 0 (i) 18 71 Z 7.68 
175 4-OBu H H S 0 (i) 22.5 84 Z 7.71 
176 4-OPr1 H H S 0 (i) 18 44 Z 7.74 
177 4-OBu' H H S 0 (i) 18 64 Z 7.69 
178 4-OBn H H S 0 (i) 24 82 Z 7.74 
179 4-SMe H H S 0 (i) 24 72 Z 7.69 
180 4-Me H H S 0 (i) 24 37 Z 7.74 
181 4-Et H H S 0 (i) 24 78 Z 7.70 
182 4-Pr H H S 0 (i) 22 90 Z 7.71 
183 4-Bu H H S 0 (i) 22 88 Z 7.69 
184 4-Bn H H S 0 (i) 22 88 Z 7.74 
185 4-F H H S 0 (i) 24 65 Z 7.80 
186 4-Cl H H S 0 (i) 47 40 Z 7.74 
187 4-Br H H S 0 (i) 24 41 Z 7.76 
188 4-I H H S 0 (i) 30 34 Z 7.87 
'References to literature data are included in chapter 6 with the details of the synthesis of each of these compounds. 
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By carrying out the condensation using imidazolidine-2,4-dione (hydantoin) instead 
of thiazolidine-2,4-dione it was possible to switch the ring sulfur in the benzylidene 
compound for nitrogen. Three such compounds were made, 192-194, utilising the 
procedure reported by Billek, by heating to 130 °C in piperidine at a concentration of 
5 moldm 3 for between 30 and 100 mm.140 Due to the nature of the reaction 
conditions, monitoring by tic proved extremely difficult. Each of the three 
compounds were produced in poor yield on recrystallisation from acetic acid and 
washing with ethanol (37, 26 and 26 % respectively). 
196 and 195 have the carbonyl at position 2 replaced by a thiocarbonyl and imine 
respectively. The latter was prepared by the Dean and Stark procedure, using 4-
methoxybenzaldehyde and thiazolidine-2-imine-4-one (pseudothiohydantoin), in 30 
% yield on recrystallisation from acetic acid, followed by washing with water and 
diethyl ether. The low yield arises due to polarity of the pseudothiohydantoin and 
195 which makes monitoring the procedure by tic difficult as well as the purification 
of the compound. The former was synthesised, by Gaudry and Mclvor's procedure, 
in 59 %, by condensing 4-methoxy benzaldehyde with thiazolidine-2-thione-4-one 
(rhodanine) in aqeous ammonia and ammonium chloride followed by 
recrystallisation from ethanol. 141  However, it was possible to produce 196 using the 
Dean and Stark method in 55 % on recrystallisation from ethanol. 
2.1.2 Protection of Ring Nitrogen. 
The final position that has been changed is R. This was achieved by treating 172 
with sodium hydride in THF and DMF followed by methyl iodide or benzyl bromide 
to produce 204 and 205 respectively. Both were produced in quantitative yield (Fig. 
2-3). 
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Fig. 2-3: 	Protection of Ring Nitrogen. 
2.1.3 Regio-chemistrv of Benzylidene Compounds. 
In the case of the three hydantoin based compounds 192-194 a comparison can be 
made between 8H  of the olefinic proton in these three compounds and that reported in 
the literature for the Z isomers. From Table 2-1 it can be seen that in all three cases 
these values are in good agreement. 
However, there is a lack of reports concerning characterisation data for pure isomers 
of the majority of the potential substrates which makes the assignment of EIZ more 
difficult. 
Vogeli and von Philipsborn have shown that the regiochemistry about the double 
bond of tn-substituted alkenes can be determined by observing the J,,1 vicinal 
coupling in the 'H coupled '3C nnir spectra. 142  Although these values have been used 
to determine the double bond geometry in several natural products it has been noted 
that unless good model compounds are available this alone is not an adequate means 
of determining the regiochemistry as the 	ratio can vary. 
It has been shown that these differences are due to a number of factors including 
substituent electronegativity, 7c bond order, bond angle, torsional angle, steric 
interactions and the hybridisation of the '3C involved in the coupling. 
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The closest models available are a range of benzylidene 5(4H)-oxazolones where 
these constants have been measured to be 12.5 and 5.5 Hz for the trans and cis 
coupling respectively. 143  The former corresponds to E geometry about the double 
bond and the latter to the Z geometry (Fig. 2-4). Although the heterocyclic ring of the 
potential substrates differs from the 5(4H)-oxazolones the variations in it bond order, 
bond angle, torsional angle and steric interactions were expected to be negligible, and 
hence have little effect on the 3jC ,H between classes of compounds. The main 
difference was the change in electronegativity of a substituent attached directly to the 
double bond as the nitrogen had been replaced by sulfur in most cases. 
Vogeli and von Philipsborn examined each of the contributing aspects individually, 
on a range of simple ethylene based compounds, and found that an increase in 
electronegativity of an atom attached directly to the double bond resulted in a slight 
decrease of both cis and trans 3CH•  Replacing the nitrogen with sulfur would 
increase the C,H  values as the electronegativity has decreased. 
3JcHtrans 12.5 H 
3 '  
C,H cis 5.5 Hz 
H \O 
NN 





Fig. 2-4: 	3JCH Coupling Used To Determine Regio-chemistry About the Double 
Bond In 4-Benzylidene-2-substituted-5(4H)-oxazolones. 
X-ray crystallography has shown that 172, 179 and 181 are all Z isomers (Appendix 
2). The latter two produced yellow needles and colourless plates on crystallisation 
from ethanol while the former was crystallised as its DMSO solvate. This was 
achieved by diffusion of diethyl ether into a saturated solution of 172 in DMSO to 
produce a colourless block. The vicinal C,H  of these three compounds has been 
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measured, at 63 MHz in DMSO-d6, and found to be 6.5 Hz, which appears to be in 
good accordance with the anticipated value of 3CH  for a cis interaction arising from Z 
geometry about the double bond. 
Table 2-1 shows that, with the exception of 189 where 3CH  6.0 Hz, the majority of 
the thiazolidine-2,4-dione based compounds exhibited 3CH  6.5 Hz. Although this 
coupling has not been measured for all such compounds there is enough evidence to 
assume the formation of the Z isomer in each case. 
196 and 195 posessed C,H  values of 6.0 and 5.5 Hz respectively. Although this 
differs slightly from the thiazolidine-2,4-dione based compounds it is still indicative 
of the Z configuration, with the difference presumably arising from the differing 
electonegativity of the functionality at position 4 of the heterocycle. 
Although this system is useful when dealing with a tri-substituted double bond the 
incorporation of an alkyl group at R2 makes the determination of the double bond 
geometry more difficult. Due to the difference in shielding of the olefinic proton 
between regioisomers there is a distinct difference in 8H  of the olefinic proton in tn-
substituted compounds. It would be expected that a similar scenario would exist for 
the tetra-substituted compounds 201-203. In each of these compounds there was only 
one signal for the alkyl group at W. As it is clear that the phenyl ring prefers a trans 
relationship to the carbonyl compound, it can be assumed that the Z isomers are 
formed as it is unlikely a small alkyl group imparts a large enough effect to 
completely reverse the regiochemistry of these compounds. 
In the case of 204 and 205 the procedure for protection of the ring nitrogen should 
not have caused isomerisation of the double bond and it is assumed that these retain 
the Z geometry inherent from 172. 
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2.2 Synthesis of Non-Commercially Available Aldehydes. 
2.2.1 Synthesis of 4-Iodobenzaldehyde 209 and 0-544-methoxybenzylidene-d) 
thiazolidine-2.,4-dione 215. 
Although it is possible to carry out the transformation from acid to aldehyde more 
directly the use of well established reactions has certain advantages. As with the 
Knoevenagel condensations there was emphasis on a quick, versatile route to various 
compounds and the chosen route provides this. There was little development 
involved and the route is adaptable to the synthesis of other benzaldehydes from any 
of the appropriate commercially available intermediates. 






OMe Et20 	 OH le 94% 













Fig. 2-5: 	Synthetic Route to 4-Iodobenzaldehyde 209. 
All steps are easily carried out with simple purification of the crystalline 
intermediates. The esterification of 4-iodobenzoic acid 206 was complete after 
heating at reflux overnight producing ester 207, in 94 % yield after recrystallisation 
from methanol. Subsequent reduction of ester 207 by lithium aluminium hydride for 
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1 h produced alcohol 208 in 88 % after purification by column chromatography. 144 
This was oxidised to aldehyde 209, in 75 % after column chromatography, by 
treatment with IBX 210 in DMSO for 15 mm. IBX 210 itself was readily prepared by 
treatment of 2-iodobenzoic acid in aqueous sulfuric acid with potassium bromate.145  
It was possible to use crude 207 and 208 in the next stage, although 209 required 
column chromatography to remove traces of DMSO. This meant that without further 
purification of the intermediate compounds acid 206 can be transformed into 
aldehyde 209 within twenty four hours. The aldehyde 209 was then condensed with 
thiazolidine-2,4-dione (Sect. 2.1.1). 
This route also allowed the introduction of deuterium by reduction of the ester with 
lithium aluminium deuteride. This has been utilised in the synthesis of 4-
methoxybenzaldehyde-d 214 (Fig. 2-6). 
The ester 212 was prepared in almost quantitative yield from the acid 211, without 
further purification, which in turn was reduced with lithium aluminium deuteride to 
produce the di-deutero 4-methoxy benzyl alcohol 213 in 68 %, after column 
chromatography. Again esterification was complete after heating at reflux overnight 
and the reduction took four hours. Alcohol 213 was oxidised smoothly with IBX 210 
in 45 min to produce the deuterated aldehyde 214 in 88 % after column 
chromatography. In this instance the alcohol and aldehyde were not crystalline. 
The aldehyde was condensed with thiazolidine-2,4-dione using the Dean and Stark 
procedure to produce 215 in 81 % yield. It was assumed that the regio-chemistry of 
215 mirrors that of 172 as they were produced in the same way and differ only in the 
presence of deuterium. 
'H nmr of 213-215 did not show any signs of the presence of non-deuterated 
compound. The level of deuteration in 215 was calculated to be 98.6 % by mass 
spectrometry. 
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Fig. 2-6: 	Synthetic Route to (Z)-5-(4-Methoxybenzylidene-d)thiazolidine-2, 4-dione 143. 
2.2.2 Synthesis of 4-Propyl and 4-Butylbenzaldehdye, 216 and 217. 
EtO 0Et 	 0 
H 	
2 M HCI 	
H 
R 	 R 
R= Pr 	10 21684% 
R=Bu IN 21795% 
Fig. 2-7: 	Deprotection of 4-Propyl and 4-Butylbenzaldehyde Diethyl Acetal. 
Aldehydes 216 and 217 were both prepared by deprotection of the corresponding 
diethyl acetals, by stirring for one hour at ambient temperature in 2 M hydrochloric 
acid, in 84 and 95 % respectively (Fig. 2-7). 
Attempted acetal cleavage to produce 216 with wet silica gel in DCM and sodium 
acetate in aqueous acetic acid proved unsuccessful. 146'147  
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Both aldehydes were condensed with thiazolidine-2,4-dione in good yield (Sect. 
2.1.1). 
2.2.3 Synthesis of 4-i-Propoxy and 4-i-Butoxy Benzaldehyde, 218 and 219. 
0 	 0 
RI, K2CO3,  DMF ----- YO.- e H HO 	 RO 
R=Pr'01 21868% 
R=Bu' 	21922% 
Fig. 2-8: 	Protection of 4-Hydroxybenzaldehyde. 
Aldehydes 218 and 219 were both produced by heating 4-hydroxybenzaldehyde and 
1.1 equivalents of 2-iodopropane and 1 -iodo-2-methylpropane respectively, with 1.1 
equivalents of potassium carbonate, in DMF at 55 °C. After 4 and 5 d, respectively, 
starting material still remained which was removed by column chromatography to 
produce 218 and 219 in 68 and 22 % respectively. 
The procedure was adapted from that used by Sargent in the synthesis of Psoromic 
acid and Juncunone.148'149 Although the yields, particularly of 219, were poor, 
enough aldehyde was produced for use in the Knoevenagel condensation with 
thiazolidine-2,4-dione to produce 176 and 177 (Sect. 2.1.1). 
2.2.4 Synthesis of 4-Benzylbenzaldeyde 222. 
4-Benzylbenzaldehyde 222 was prepared in two steps from 4-bromobenzophenone 
220 via 4-benzyl bromobenzene 221 (Fig. 2-9) according to the methods utilised by 
Gribble to produce the same compound. 150 
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Fig. 2-9: 	Synthesis of 4-Benzylbenzaldehyde 222. 
The first step involved the reduction of the ketone of 4-bromobenzophenone with six 
equivalents of sodium borohydride in trifluoroacetic acid to produce 221 in 76 %151 
The second step involved initial metal-halogen exchange between the bromine of 221 
and the lithium from n-butyl lithium to produce the aromatic anion. This was then 
reacted with N-formylpiperidine to produce the aromatic aldehyde 222 in quantitative 
yield. 152 
222 was then condensed with thiazolidine-2,4-dione to produce 184 in 59 % (Sect. 
2.1.1). 
2.3 Synthesis of the Benzylidene Precursor to Englitazone and its Isomer, R-
and S-231. 
The benzylidene precursor to the Pfizer drug Englitazone, (Z)-5-[(2R)-benzyl-3,4-
dihydro-2H- 1 -benzopyran-6-yl)methylidene]thiazolidine-2,4-dione, R-231 and its 
enantiomer S-231, are interesting potential substrates as they allow investigation of 
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whether the substitution pattern on the benzene ring is accepted by the yeast and, if 
so, whether or not there is any preference for one enantiomer. 
The preparation of these two compounds consisted of two main stages. The initial 
stage involved formation of the dihydrobenzopyran skeleton upon which the 
benzylidene compounds are based and the resolution of 2,3-dihydrobenzopyran-2-
carboxylic acid ethyl ester 227 with Lipase PS to produce the (R)-ester and the (5)-
acid (Fig. 2-10). The second stage involved the conversion of R- and S-227 into R-
and S-231 (Fig. 2-11). 
Formation of the skeleton was achieved by treatment of a mixture of 2-
hydroxyacetophenone 223 and diethyl oxalate 224 with sodium ethoxide followed by 
hydrochloric acid, to produce 225 in 61-64 %•153  Hydrogenation over palladium on 
activated charcoal, at elevated temperature and pressure, removed the c 
unsaturated system to produce racemic 2,3-dihydrobenzopyran-2-carboxylic acid 226 
in 56-57 %154 
Esterification with ethanol and sulfuric acid in DCM afforded racemic 227 in 72-90 
% which was suitable for resolution using Lipase PS, from Pseudomonas 
fluorescens. This resolution was utilised by Pfizer in a reported synthesis of 
Englitazone, and has been used previously in the resolution of the corresponding 7-
hydroxy ester. 155J56  
The resolution was carried out in water, without organic co-solvent, with the pH 
being maintained at pH 7.0 by addition of 1.0 M sodium hydroxide by means of a pH 
autotitrator. As the reaction proceeded there was a reduction in the rate of addition of 
the alkali solution indicating a reduction in rate of ester hydrolysis. Extraction of the 
aqueous mixture after addition of 0.55 equivalents of base afforded R-227 in 43 % 
with 97 % e.e. (by chiral gc). Acidification of the remaining aqueous fraction 
followed by ethyl acetate extraction afforded S-226 in 37 % which, on conversion to 
the S-227 exhibited 77 % e.e. by chiral gc. 
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Fig. 2-10.' Synthesis of 2,3-Dihydrobenzopyran-(2R)- and (2S)-Carboxylic Acid 
Ethyl Ester. 
A second treatment of S-227 increased the e.e. to 84 % on esterification, for which 
there is literature precedence. 156 
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Both enantiomers were converted into the benzylidene precursor to Englitazone with 
relative ease (Fig. 2-11).155  Initially ester 227 was reduced to the alcohol 228 by 
sodium borohydride in excellent yield. Each alcohol was then converted to the triflate 
which was displaced with phenyl magnesium bromide. Although isolated, the triflate 
was used immediately in the next step to produce the benzyl compounds 229 in 87-
89 % (two steps). Vilsmeier formylation para to the cyclic heteroatom, with 
phosphorous oxychioride and N-methylformanilide, produced aldehydes R-230 and 
S-230 in 53 and 59 % respectively. 
Thiazolidine-2,4-dione 
Toluene 
o 	AcOH (cat.) 
Ph 	
Piperidine (cat.) 	 0 
NH 	 H 
S 





Fig. 2-11: 	Conversion of 227 into 231. 
It was reported that the formylation reaction produces both ortho and para 
formylation products, relative to the cyclic heteroatom, and a sodium bisulfite 
preparation was used to isolate the para formylated compound. However, in the two 
reactions performed tic indicated the presence of numerous compounds. In each case 
the use of column chromatography allowed the isolation of the para formylated 
compounds. 'H nmr of R-230 and S-230 were in good agreement with the reported 
data. 
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Both aldehydes were condensed with thiazolidine-2,4-dione by heating at reflux in 
toluene under Dean and Stark conditions, with piperidine and acetic acid as catalyst, 
to produce the benzylidene compounds R-231 and S-231 in 94 and 86 % respectively. 
'H nmr of R-231 and S-231 were in good agreement with the reported data. lic,H  was 
measured to be 6.5 Hz for both compounds which is indicative of the Z isomer. 
2.4 Synthesis of (Z)-5- [(2-benzoyl-5-benzofuranyl)methylidene] thiazolidine-
2,4-dione 235. 
235 is the unsaturated precursor to one of a class of similar saturated compounds 
developed through a collaboration between Tanabe Seiyaku Co. Ltd. and Eli Lilly 
and Co. that have been synthesised and have shown pharmacological activity towards 
NIDDM.157 It makes an interesting potential substrate as the phenyl ring has been 
replaced by a benzofuran system which allows investigation of expanded substitution 
patterns at this end of the initial template. 
Using the reported procedure 2-bromoacetophenone 232 was readily prepared by 
Friedel-Crafts acylation of benzene with bromoacetyl bromide in 74 % whilst 5-
formylsalicylaldehyde 233 was prepared in 76 % by formylation of 4-
hydroxybenzaldehyde with HMTA and TFA (Fig. 2-12). Condensation between 232 
and 233 with potassium carbonate at reflux in acetonitrile proceeded readily within 
22 h to produce aldehyde 234 in 56 % after washing with acetonitrile and water. 
Although it was reported that the reaction is complete within 3-6 h the mechanism of 
benzofuran formation means that disappearance of either 232 or 233 could not be 
used to evaluate reaction progress. To compensate the reaction was left at reflux 
overnight but the resultant yield is significantly less than the 84 % reported. The 
resulting aldehyde was condensed with thiazolidine-2,4-dione in acetonitrile with 
pyrrolidine as base. After heating at reflux for20 h the crude product is removed by 
filtration and washed with acetonitrile to produce 235 in 63 %. 
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Fig. 2-12. Synthesis of (Z)-5-[(2-benzoyl-5-benzofuranyl)methylidene]thiazolidine-2, 4-
dione 235. 
The reported procedure did not discuss the regio-chemistry of the double bond; 
however, 3CH = 6.5 Hz which was indicative of a cis coupling and hence the Z 
isomer has been formed. 
2.5 Expanding the Template. 
Varying the substituent groups and constituent atoms at each of the five positions 
outlined has produced an array of compounds to probe the reductase system within 
the organism. However all these compounds consist of two main features, a 
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substitued phenyl methylidene unit and a five membered heterocycle. In order to 
ascertain if these are required structural features in themselves alkenes were prepared 
from the condensation of cyclohexane carboxaldehyde with thiazolidine-2,4-dione 
and by alkaline ring opening of 196. 
2.5.1 Knoevenagel Condensation Between Cyclohexane Carboxaldehyde and 
Thiazolidine-2,4-dione. 
Replacing the phenyl ring of the template with a similarly sized aliphatic ring should 
help determine if the phenyl ring is required to achieve reduction of the carbon- 
carbon double bond. 
e H + 
Toluene, AcOH (cat.) 
	
o 	Piperidine (cat.) 
(j( 	





:H S  
236 
Fig. 2-13: Knoevenagel Condensation Between Cyclohexane Carboxaldehyde and 
Thiazolidine-2, 4-dione. 
236 was synthesised using the Dean and Stark method in 90 % on purification by 
column chromatography (Fig. 2-13). 	was measured to be 6.0 Hz which is 
indicative of the Z isomer. 
2.5.2 Ring-Opening of 196. 
The affinity of both 2-heteroatom and 2-carbon substituted 3-phenylpropanoic acids 
towards NTDDM has been reported by SmithKline Beecham, although the reported 
syntheses do not use the Rhodotorula rubra CBS 6469 reduction to produce these 
compounds from the corresponding propenoic acid. 15859  
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All the potential substrates synthesised so far consist of a five-membered heterocycle 
attached to the double bond. In order to ascertain whether or not the heterocyle is an 
essential feature of a proposed substrate, a series of compounds based upon (Z)-2-
sulfanyl-3-phenylpropenoic acid have been prepared. 
These compounds were synthesised readily from 196 and retain several structural 
features of the parent heterocycle, namely the sulfur atom and the carbonyl at 
position 4 in rhodanine (Fig. 2-14). 
196 can easily be converted to (Z)-2-methylsulfanyl-3-(4-methoxyphenyl)propenoic 
acid 238 by the procedure reported by Nishio and Ito.  160 This involved reaction with 
sodium hydroxide solution at 90 °C followed by the addition of methyl iodide. On 
quenching with hydrochloric acid the product precipitated from the mixture and was 
recovered in 59 % yield on recrystallisation from methanol, compared with the 49 % 
reported yield. 
'H coupled 13C nmr spectra of 238 showed that the 3CH  coupling between the olefinic 
proton and the carbonyl carbon was 6.0 Hz which is indicative of the Z geometry 
having been retained. 
237 was prepared in a similar manner from 196, the difference being the omission of 
the methyl iodide and the addition of an increased amount of hydrochloric acid, to 
produce the free thiol compound 237. A similar method has been used by Ogawa in 
the synthesis of 2-sulfanyl-3 -(3' -methyl-5-isoxazolyl)propenoic acid. 161  Purification 
by washing with methanol resulted in a 94 % yield. Again 'H coupled '3C nmr 
spectra of 237 showed the 3CH  to be 6.0 Hz, again indicating retention of the Z 
configuration. 
Three further functional group manipulations have been carried out on 238, the 
methyl and ethyl esters, 239 and 240, were prepared by heating at reflux in DCM 
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with a catalytic amount of sulfuric acid and approximately five hundred fold excess 








20 % w/v NaOH. 




MeOH, XOH, I 
DCM, / DCM, 	/ 
H2SO4 	/ H2SO4 / 
90  83 %// 











237 	 R=OMe 239 	R=OEt 240 	 R=NH2 241 
Fig. 2-14: 	Synthesis of Compounds Based on 2-sulfanyl-3-phenylpropenoic acid. 
The third manipulation, to produce 241, involved two steps. The first was the 
preparation of the acid chloride by action of oxalyl chloride and DMF on 238 
according to Burgstahler's procedure, although in DCM rather than benzene. 162 
Although isolated the acid chloride was not characterised but instead carried through 
to the second procedure which involved conversion to the amide. This was achieved 
by stirring the crude acid chloride with 1,1,1,3,3,3-hexamethyldisilazane in 
anhydrous DCM for two days, according to Pellegata and Palmisano's method. 163 
Both steps were carried out in an overall yield of 77 %. 
As none of the procedures used to synthesise the three carboxylic acid derivatives 
were expected to cause isomerisation about the double bond it was assumed that all 
three retained the Z geometry. 
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3. Results & Discussion : Biotransformation. of Substrates. 
This chapter examines the activity of Rhodotorula rubra CBS 6469 towards the 
potential substrates already synthesised. Initially optimisation of the reaction will be 
discussed, including SmithKline Beecham work, followed by the preparative 
bioreduction and screening of the compounds previously synthesised. 
3.1 Development of Biotransformation Conditions. 
The majority of this section is based upon work by SmithKline Beecham, who have 
optimised the reaction conditions for the formation of BRL 49653 2.7  Initially, 
various yeasts including Candida, Saccharomyces and Pichia spp., were screened 
with only the red yeasts showing significant conversion to product. Although 
conversions were low, Rhodotorula rubra CBS 6469 produced the highest 
conversion. The introduction of a water miscible co-solvent, 20 % v/v of 
ethylacetoacetate, increased the conversion of 6 to 26 %, from 13 %, after 24 h with 
Rhodotorula glutinis CBS 4406. It was found that the best conversions were 
exhibited when 1,4-dioxane was used as co-solvent with Rhodotorula rubra CBS 
6469. However, there appears to be a discrepancy within the publication regarding 
the volume of co-solvent used. The discussion of the paper strongly advocates the 
use of 12 % v/v of 1 ,4-dioxane as the optimum co-solvent concentration, whereas the 
reported experimental procedure states that the substrate was added in 18.75 % v/v of 
1,4-dioxane. The percentage reduction to product was found to be similar at pH 8.0 
and pH 9.0 with both these exhibiting higher percentage conversions than was 
observed at pH 7.0. Temperature optimisation studies showed an increase of reaction 
rate above 24 °C with both 28 and 30 °C appearing optimal. 
67 
Results & Discussion Biotransformation of Substrates. 
In addition the reported SmithKline Beecham procedure does not utilise all the cells 
which have been grown. Instead the cells from 90 cm' of broth were resuspended in 
69 cm' of buffer and 40 cm' of this was used to afford the reduction. 
Initial experiments utilising the cells from 180 cm' of broth to afford the reduction of 
thazolidine-2,4-dione 172 showed that by resuspending all the cells to a total volume 
of 80 cm' the rate of reaction was enhanced. These experiments also showed that the 
reaction rate was enhanced by use of 12 % v/v 1,4-dioxane as opposed to 18.75 % 
v/v. However, the rate was further enhanced by the use of DMSO, rather than 1,4-
dioxane, as co-solvent (Table 3-1). DMSO was tested as a co-solvent due to the 
increased solubility of the benzylidene compounds, particularly those incorporating a 
large aliphatic chain, compared to 1 ,4-dioxane. Also, previous work within the group 
has shown that 7.5 % v/v DMF as co-solvent enhances the rate of reaction over the 
SmithKline Beecham procedure.139 As the experiments were performed in an 
unventilated environment, DMSO was employed rather than DMF due to its lower 
toxicity. 
Experiment 1 (Table 3-1) utilised the SmithKline Beecham conditions and involved 
the use of part of the total cell suspension and 1,4-dioxane (18.75 % v/v) as co-
solvent. Experiment 2, while using 1,4-dioxane (18.75 % v/v) as co-solvent, utilised 
the whole of the biomass. Experiment 3 utilised all the cells produced and employed 
1,4-dioxane (12 % v/v) as co-solvent. Finally, experiment 4 involved the use of the 
whole cell suspension and employed DMSO (7.5 % v/v) as co-solvent. In each case 2 
cm  aliquots of cell suspension were incubated with 150 tl of a solution of 
thiazolidine-2,4-dione 172 (55 mM in DMSO) to provide a control between batches 
of yeast. All reactions were incubated for 24 h at 30 °C and 220 rpm. In each case the 
average conversion measured for the two control incubations was scaled so it was 
equal to 100. This produced a scaling factor which, when multiplied by the 
conversion exhibited by the main reaction produced, a relative conversion rate. This 
allowed the comparison of reactions using different batches of cells. 
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Experiment 	 1 	2 	3 	4 
Volume of Growth Medium 
Used (CM) 
Total Volume of Cell 
Suspension (cm') 
Volume of Cell Suspension Used 
(cm) 
Co-solvent Used 
Volume of Co-solvent used 
(% v/v) 
Conversion after 24 h (%) 
Conversion of Control (%) 
Relative Conversion 
180 180 180 180 
138a' 84b 84b 84b 
80 80 80 80 
1,4- 1,4- 1,4- DMSO 
dioxane dioxane dioxane 
18.75 18.75 12.0 7.5 
24 49 73 58 
62 59 79 57 
39 83 92 102 
a 
To provide aliquots of cell suspension for the control experiments the cells were initially resuspended to a total of 84 cm'. 
From this two 2cm3 aliquots were removed. The remaining suspension was diluted to a total volume of 138 cm'. 
b 
The cells were resuspended to a total volume of 84 cm3. From this two 2 cm' aliquots were removed for use in control 
experiments. The use of the remaining 80 cm' constitutes use of all the cells produced 
Table 3-1 	Results of Initial Optimisation Studies with Thiazolidine-2, 4-dione 172. 
Along with the reduction of thiazolidine-2,4-dione 6, SmithKline Beecham have 
reported the capability of Rhodotorula rubra CBS 6469 to reduce the double bond of 
a range of related compounds 242a-f (Fig. 3-1). However, relative conversions were 
not reported and each compound was added to a concentration of 0.79 mgcm 3 in 1,4-
dioxane, although due to the difference in molecular weight of thiazolidine-2,4-
diones 242a-f this equates to between 1.9 and 2.1 mM. 
The previous four reactions (Table 3-1) were all carried out on 75 mg of thiazolidine-
2,4-dione 172 which equates to 3.4 mM (experiment 4) or 3.7 mM (experiments 1 
and 2) depending on the resultant total volume. Use of a similar weight of 
thiazolidine-2,4-dione 6 in experiment 4 would equate to 2.5 mM, so in these initial 
reactions the concentration of substrate in the reaction has increased by a factor of 
approximately 1.5 over those carried out by SmithKline Beecham. 
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However, the use of this concentration of thiazolidine-2,4-dione 172 showed that it 
was possible to reduce a larger quantity of compound with the same biomass. This 
concentration also produced approximately 60 % conversion of 172 within 24 h 
which favoured the use thiazolidine-2,4-dione 172 in this concentration as a standard. 
It was imperative that, if relative reaction rates between compounds were to be 
measured, a good control was available between batches of cells and the same molar 





a Benzoxazol-2-yl 	 2 
NH b 2-Pyridyl 	 4 
c 2-Quinolyl 2 
R(Me)N(CH2) d 1-Isoquinolyl 	 2 
o e 3-Chloro-2-pyridyl 	2 
242 f 3,5-Dichloro-2-pyridyl 2 
Fig. 3-1: Benzylidene Compounds that SmithKline Beecham have Shown to be Reduced 
by Rhodotorula rubra CBS 6469. 
The effect of the co-solvent concentration on the rate of reaction was determined by 
small scale incubations of thiazolidine-2,4-dione 172 containing various amounts of 
DMSO and 1 ,4-dioxane and is represented graphically (Fig. 3-2). The graph clearly 
indicates a trend of increasing relative conversion as the amount of co-solvent 
decreases. 
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Fig. 3-2: Graph of Co-solvent (% v/v) Against Conversion (%) for DMSO and 1,4-
Dioxane. 
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However, experiment 4 in Table 3-1 and the value from the graph corresponding to 
the use of 7.5 % v/v DMSO exhibited conversions of 57 % and 33 % respectively, 
although the concentrations of substrate, co-solvent and biomass were the same. This 
difference served to highlight the problem of achieving consistency between 
reactions, and batches of yeast, and also the importance of standardisation using 
control reactions. Indeed it has been noted that as the time the organism is 
maintained on agar slopes increases the relative reaction rate produced by the 
organism decreases. Although the use of control experiments overcame this 
deterioration it was vital that cells from fresh agar slopes were employed in order to 
achieve good consistency between reactions. 
Although the co-solvent concentration trend was evident, the conditions used in 
experiment 4 (Table 3-1) were selected for use in subsequent reactions. The use of 
7.5 % v/v of DMSO guaranteed the solubility of all the potential substrates in the co-
solvent. Several potential substrates were partially insoluble in the 'window' of 1,4-
dioxane concentrations where conversion was exhibited. 
3.2 Preparative Scale Biotransformations. 
Preparative scale biotransformations were carried out on several compounds, with 
varying R' and X', using the conditions discussed in Sect. 3-1 (Fig. 3-3, Sect. 7.4). 
Initially, several of the benzylidene thiazolidine-2,4-diones 172, 186, 189 and 190 
were incubated with the yeast in this manner, with all four exhibiting complete 
reduction and being isolated in good yield. It could also be seen that changing R1 
could have a dramatic effect on the reaction rate with the nitro and cyano groups 
increasing the reaction rate relative to the methoxy and the chloro. 
The reduction of thiazolidine-2,4-done 172 was monitored at intervals throughout the 
course of the reaction. The resultant graph shows a linear relationship between 
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conversion and time and is indicative of a constant rate of reaction, thus showing that 
product inhibition was not occurring (Fig. 3-4). 
Rhodotorula rubra CBS 6469. 
0 	0.1 M Tris-HCI buffer (pH 8.0), 	 0 
containing 5 % w/v sucrose, DMSO. 	
NH NH 
 Substrate 	R' 	X' 	Time Conversion Isolated Yield Product 
(h) 	(%) 	(%) 
172 OMe 5 58 100 
186 Cl S 50 100 
189 CN S 17 100 
190 NO2 S 17 100 
192 OMe NH 164 0 





Fig. 3-3: 	Result of Initial Preparative Scale Biotransformations. 
Fig. 3-4: Conversion Against Time For Rhodotorula rubra CBS 6469 Mediated 
Reduction of 172. 
It was imperative that the biotransformation achieved quantitative reduction of the 
benzylidene compounds as, exhibiting identical RFs on tic, they could not be 
separated from the corresponding reduced compounds by column chromatography. 
As the substrates and products could not be separated by tic, hplc was used to 
monitor the reactions. In the case of 172, 186 and 189 authentic samples were 
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produced by catalytic hydrogenation to show that separation of substrate and product 
was achievable under the hplc conditions (Chapter 4, Appendix 1). These 
hydrogenations also provided standards for the comparison of characterisation data. 
Also, once complete conversion had been achieved, it was essential that product 
recovery was high. Ideally product isolation would have been achieved by 
centrifugation to remove the cells followed by a simple extraction of the supernatant 
with an organic solvent, though the low solubility of the compounds involved led to 
precipitation when centrifuged with enough force to pellet the cells. Filtration has 
also been shown to be an inadequate method of biomass removal hence product 
recovery was achieved by continuously extracting the whole biotransformation 
mixture into 150 cm' of DCM for 18 h.164 However, continuous extraction also 
removed the DMSO from the reaction mixture, which remained after evaporation of 
the DCM. There were two methods available to remove the product from the DMSO, 
column chromatography over silica gel or Kugelrohr distillation. The former was the 
method of choice as it also removed traces of other organic material present after the 
extraction, and afforded a cleaner product. 
Monitoring the attempted bioreduction of the hydantoin based compounds (192 and 
193) by hplc did not indicate any signs of the presence of reduced compound (Fig. 3-
3). In the case of 192 a standard was prepared by catalytic hydrogenation (Chapter 4) 
and it was shown to be possible to separate substrate and product under the hplc 
conditions (Appendix 1). Work up of the attempted biotransformation of 193, using 
Kugelrohr distillation to ensure all organic matter was retrieved, did not produce any 
evidence of reduced product, by 'H nmr or electrospray mass spectrometry. These 
observations showed that substitution of the ring sulfur by nitrogen stops all activity. 
From these initial preparative scale biotransformations it could be seen that sulfur at 
X' appears to be essential for a potential substrate to be accepted by the reductase 
system, provided a useful insight into the structural features required of a substrate. 
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3.3 Screen of Potential Substrates Against Rhodotorula rubra CBS 6469. 
A procedure for screening the compounds was developed which substantially 
decreased the time involved for the assay. This procedure involved preparing the 
cells in the same manner as for the preparative biotransformations (Sect. 7.5). 
In carrying out this screening it was possible to derive a series of relative reaction 
rates. In order to do this it was essential that a comparison could be made between 
batches of cells. The necessity for standardisation between batches of cells was 
eluded to in Sect. 3.1 where consistency was achieved by performing small scale 
biotransformations using aliquots of cell suspension from each batch of cells grown. 
An alternative to this method was the standardisation of biomass from each batch 
using a 'thy weight curve'. 
Standardisation using a 'dry weight curve' involved producing a graph of the weight 
of cells in a suspension against its optical density at 600 nm (Fig. 3-5). Production of 
this graph was achieved by suspending the cells to a total volume of 80 cm' before 
various volumes were removed and diluted by a factor between 1 in 40 and 1 in 4 to 
a total of 20 cm'. The resulting suspension was further diluted, 1 in 25, and the 
absorbance was measured. 
When carrying out the small scale screening and attempting to use this graph the 
difference in the measured optical densities was negligible. However, it has already 
been shown that the reaction rates produced between different batches of yeast can be 
quite different (Sect. 3.1). Presumably this was because the use of a 'dry weight 
curve' does not account for differences in the reaction conditions after substrate 
addition. 
By reverting to comparing the conversion of a standard thiazolidine-2,4-dione 
compound 172 produced by an aliquot from each batch of cells it was possible to 
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calculate a scale factor which set the conversion of 172 arbritrarily at 100. The 
reaction rates of the other compound are relative to this (Table 3-2). 
Volume of Original Cell Suspension (cm3) 
Fig. 3-5: 	Volume of Original Cell Suspension v Optical Density for Rhodotorula rubra 
CBS 6469. 
From the preparative biotransformations it has been shown that the reduced 
compounds exhibit shorter hplc retention times than the benzylidene compounds 
(Appendix 1). During the screening of compounds the presence of a peak in the hplc 
trace, exhibiting a shorter retention time than the benzylidene compound, established 
a positive result. However, failure to detect such a peak did not necessarily constitute 
a negative result and could be due to the fact that the reduced compound was not 
being separated from the starting material, or that the benzylidene compound was not 
being reduced. 
When no such peak was detected the eluent composition was varied in an attempt to 
afford separation. If separation was still not achieved then an authentic sample of the 
reduced compound was prepared by catalytic hydrogenation (Chapter 4). If it was 
possible to separate this authentic sample from the benzylidene compound then it 
was deemed that the benzylidene compound was not a substrate. However, failure to 
separate this authentic sample from the benzylidene compound meant that it was not 
possible to determine whether or not the benzylidene compound was a substrate. 
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The initial piece of information that was determined from the screen results was 
whether or not a compound is accepted as a substrate (Table 3-2). 
All compounds with apara alkoxy group at R' 172-178 were accepted as substrates 
as were those with a hydrogen atom 170, hydroxy group 171 and thiomethyl group 
179 in this position. However, of those with a para alkyl group at R' 180-184 only 
180, with a methyl group present, was accepted. 
All four compounds withpara halogen atoms at R' 185-188 were substrates, as were 
189, 190 and 191 which have a para cyano, nitro and trifluoromethyl group in this 
position respectively. 
Of the compounds possessing a 2-, 3- or disubstituted aromatic ring only 198 (R' = 
3-OMe) was reduced by the organism. However, in the case of 197 and 199 (R' = 2-
OMe, 2,6-OMe respectively) it was not possible to tell whether or not they had been 
reduced by the organism during the screening process. 
It could also be seen that 195 and 196 did not produce a positive result in the screen. 
Due to the presence of an imine and thiocarbonyl group respectively these 
compounds were difficult to reduce chemically (Chapter 4). However, incubation of 
195 and 196, in a manner similar to that used for the preparative biotransformations, 
for 48 h, followed by Kugelrohr distillation of the residual DMSO, showed that, by 
'H nmr and elecrospay mass spectrometry, reduction had not occured. 
Benzylidene compounds containing a tetra-substituted double bond 201-203 did not 
show any signs of conversion under the screen conditions. Attempted reduction of 
the tetra-substituted carbon carbon double bond of ester 108, by Santamello and co-
workers, also proved unsuccessful.92 
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From the preparative biotransformations it is known that the hydantoin compounds 
192 and 193 do not show any reduction. This result, and the fact that 194 is not a 
substrate, was confirmed by the screening process. However both N-substituted 
thiazolidine-2,4-diones 204 and 205 compounds were accepted as substrates. 
Other compounds were also subjected to the screening process. Neither the 
benzylidene precursor to Englitazone R-231, nor its enantiomer S-231, were accepted 
a substrates. The precursor to the Lilly drug 235 did show signs of reduction with the 
appearance of two new peaks in the hplc chromatogram. This was unsurprising as 
235 contains a carbonyl group that could also be reduced. The reduction of 6, the 
precursor to the SmithKline Beecham compound BRL 49653 2, was also attempted 
although it was not possible to tell whether or not reduction took place as 6 and 2 
could not be separated under the hplc conditions. 
Rhodotorula rubra CBS 6469. 
0 	0.1 M Tris-HCI buffer (pH 8.0), 
	 0 
rTS 





Fig. 3-6: Rhodotorula rubra CBS 6469 Reduction of 236. 
The compounds that do not conform to the initial template upon which most of the 
potential substrates are based were also tested. Replacement of the phenyl ring by a 
cyclohexyl ring 236 did not stop reduction. Unusually the screen showed formation 
of a compound exhibiting a longer hplc retention time than the unsaturated precursor. 
It was confirmed that the observed product was indeed the anticipated reduced 
compound by production of a standard by catalytic hydrogenation (Chapter 4). 
Further confirmation was obtained by yeast reduction of 236 on a preparative scale. 
This produced 247 in 82 % yield, after column chromatography, with quantitative 






H OH 237 
Me OH 238 
Me OMe 239 
Me OEt 240 
Me NH2 241 
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The range of compounds based upon (Z)-2-sulfanyl-3-phenylpropenoic acid 237-241 
did not produce particularly clear hplc chromatograms which rendered the screening 
process non-viable for these compounds. Therefore these compounds were incubated 
with Rhodotorula rubra CBS 6469, on a preparative 
scale, for 48 h before being extracted. Also, as there was 
the possibility of the presence of hydrolytic enzymes 
within the yeast the residual DMSO was removed by 
Kugelrohr distillation to ensure retrieval of all the 
organic material. However, 'H nmr and electrospray 
mass spectrometry showed that only starting material 
remained after the incubation period. 
Having established which structural features were required for reduction to occur it 
was possible to construct a 'map' detailing these structural features, based around the 
initial template (Fig. 3-7). 
Able to accomodate large para 
groups at R'. 
Para alkoxy, up to benzyloxy, 
were readily accepted. 
Para methyl was accepted, 
although longer chains were not. 
Para halogens accepted, as were 
para cyano, nitro, thiomethyl and 
trifluoromethoxy, 
Meta methoxy was accepted. 
Cyclohexyl ring accepted in place 
of the phenyl ring. 
Reaction only with 
H present. 
Able to accomodate 
methyl and benzyl groups. 
Hiç) X1I NR 
1 	2 	Reaction only with 
oxygen present. 
Reaction only when 
sulfur present in ring. 
Fig. 3-7: 	'Map' Showing Structural Features Required to Effect Reduction. 
There were several factors contributing to the success or failure of an attempted 
reduction: 
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Uptake of Substrate. 
The ability of a substrate, or product, to diffuse through the cell wall is 
important. Apparently substances that are not part of the normal intracellular 
environment are taken up by simple (or passive) diffusion which is governed 
by the molecular size and lipophilic properties of the material. The cell wall 
does not present much of a barrier to small molecules, but it excludes 
molecules with a relative molecular mass greater than 600. However facilitated 
diffusion and active transport are also available. 165 
Active Site Fit. 
The ability of the substrate to 'fit' into the active site of the enzyme involved. 
As enzymes are catalysts they increase the rate of reaction by forming a 
complex with the substrate and lowering the energy of the transition state. The 
lower the energy of this transition state complex the quicker the reaction rate. 
If this complex cannot form then no reaction will take place. 
Solubility. 
Reaction rates may be increased by greater solubility of substrate. 
Inhibition. 
Substrates and products can have a toxic effect on the organism involved. The 
monitoring of the reduction of thiazolidine-2,4-dione 172 (Fig. 3-4) showed a 
constant rate throughout the reaction. This indicated that product inhibition 
was not occurring. 
In the case of the longer chain para alkyl groups at Rt it appeared that the size of the 
molecule is not the problem as similarly sized para alkoxy groups were accepted, as 
was the bulky TBDMSO group 248. A more likely explanation is that the removal of 
the oxygen from the chain produced a more hydrophobic molecule which could 
decrease the solubility of the compound and impede its reduction. It would also be 
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expected that the para halogens 185-188, cyano 189, nitro 190 and trifluoromethoxy 
groups 191 were more hydrophilic than the long chain alkyl compounds. 
Similarly, the fact that R2 had to be hydrogen could stem from a solubility or 
diffusion problem or the inability of the enzyme's active site to accommodate a 
larger group in this position. The inability of the organism to reduce tetra-substituted 
double bonds could also be mechanistically relevant. On the other hand it is clearly 
possible to accommodate a larger group at R3. 
These results also showed that it was necessary to have sulfur and oxygen present as 
X' and X2 respectively but again this could be a result of any of the above factors. 
Clearly, from these results, it is impossible to implicate any one of these effects when 
accounting for the success or failure of a reaction. However, it can be said that under 
these conditions the substrate required the structural features highlighted in Fig. 3-7 
if reduction was to occur. 
The nature of the screening process allowed the calculation of relative reaction rates 
for each of the substrates (Table 3-2). These were obtained by measuring the 
conversion of each substrate by hplc and scaling them against the conversion of 172 
as a standard. 
Obviously an error is introduced in this process. In each round of screening two 
aliquots of cells were used to reduce 172 with the average value used to calculate the 
weighting factor. The largest variation between the two 172 conversions was 
measured in the screening of 187 where the average of 74 % was a result of measured 
conversions of 70 and 78 %. Using the scale factor associated with a standard 
conversion of 74 % the relative reaction rate of 187 was calculated as 114; however, 
the maximum and minimum values, based on 78 and 70 % respectively, were 120 
and 108. This gave an estimation of the error involved in the process as 
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Fig. 3-8 shows the relative conversion rates of substrates with para substitution at R'. 
Although the values plotted are subject to a ± 5 % error there are still clear patterns 
present. 
The alkoxy series of compounds exhibited an interesting pattern. The factors 
contributing to whether or not a compound was accepted as a substrate also affect the 
relative rate at which the compounds that are accepted were reduced. In the case of 
the alkoxy series it could be seen that the rate decreases on introduction of a hydroxy 
group (171 versus 170). The rate continued to increase through methoxy 172 and 
ethoxy 173 before decreasing through propyloxy 174, butyloxy 175 and benzyloxy 
178. Based on hydrophobicity of the compounds alone, which would be expected to 
increase with increasing chain length, it was expected that the rate would decrease as 
the chain length increased. This is clearly not the case and other factors, such as 
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Substituent at Position 4 on Phenyl Ring 
Fig. 3-8 
	
Graphical Representation of the Effect of Substitution at Position 4 on Relative 
Reduction Rate. 
It could also be seen that the rate decreases along the series : 4-trifluoromethoxy 191; 
4-methoxy 172; 4-thiomethyl 179 and 4-methyl 180. Although all substituents were a 
similar size, there is a large difference in the electronegativity of the varying 
substituents with the reaction rate dropping in line with this electronegativity. It 
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could also be seen that the polar nitro 190 and cyano groups 189 exhibited large 
relative reduction rates. 
All four halogen compounds were reduced, with the more electronegative fluorine 
185 giving rise to the largest relative reduction rate. Again this varying rate could be 
due to the increased polarity of the compound or could be due to the decrease of size 
relative to the iodo compound 188. The variation in the physical size of the substrates 
does not appear to be crucial as 248, incorporating a large TBDMSO group, was 
readily accepted and reduced at a relatively high rate. 
The relative reaction rates have been calculated for three other types of compound 
which so far have not been mentioned (Fig. 3-9). These compounds include 198 
where a meta methoxy group was incorporated at R'. It was seen that the switching 
of position from para to meta drastically reduced the reaction rate. This rate 
reduction could have been as a result of the active site being less accommodating to 
substitution at this position. 
204 and 205 have substitution, on the 
ring nitrogen, at R3 in the form of a 
methyl and benzyl group respectively. 
Incorporation of these groups did not 
really affect the rate of reduction. This 
was surprising, particularly as it was 
expected that the hydrophilicity of 205 
would differ greatly from that of 172, 
and may well have been due to the 
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Relative Reduction Rates. 
236, where the phenyl ring has been replaced by a cyclohexyl ring, exhibited a rate 
twice as fast as 172 and almost three times quicker than the unsubstituted aromatic 
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ring 170. This rate increase could have been due to the greater flexibility of the 
cyclohexyl ring allowing easier diffusion through the cell membrane and easier 
incorporation into the active site. 
It was also envisaged that there may be a relationship between the polarity of the 
double bond and the relative reduction rate. However, calculation of the electron 
densities of several substrates using CAChe v3.0 showed no such correlation. For 
example the electron density of the double bond of 190 was calculated as +0.006 (13 
position) and -0.444 (a position) whilst a similar calculation for 248 found +0.108 (13 
position) and -0.365 (a position). Although there is a marked difference in the 
polarisation of the double bonds of 190 and 248 they exhibit similar relative 
reduction rates (Table 3-2, Fig. 3-8). 
3.4 Biotransformations With Dried and Immobilised Rhodotorula rubra CBS 
6469. 
There are certain advantages associated with the use of dried cells, which appear in 
two forms. The popularity of baker's yeast as a biocatalyst stems in part from the 
availability of the organism as a lyophilised preparation. A similar preparation can be 
achieved by dehydrating the organism with cold acetone to produce an 'acetone 
powder'. 
It is also possible to entrap the organism within a polymer matrix. This can improve 
purification after reaction as the cells usually in the form of beads, can easily be 
recovered by filtration and re-use of these beads is possible. 166 
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3.4.1 Lyophilisation of Rhodotorula rubra CBS 6469. 
Several attempts were made to utilise freeze-dried Rhodotorula rubra CBS 6469. 
Initial efforts focused on the use of cells lyophilised from 0.1 M Tris-HC1 buffer (pH 
8.0), containing 5 % w/v sucrose. The lyophilised cells were reconstituted by 
addition of water but did not afford any conversion of thiazolidine-2,4-dione 172. 
It was envisaged that as the buffer solution became more concentrated the pH may 
change leading to a deactivation of the enzyme system. It was then attempted to 
lyophilise the cells from water. Five portions of the lyophilised cells prepared from 
water were resuspended in 2 cm' 0.1 M Tris-HCl buffer (pH 8. 0), containing 5 % w/v 
sucrose, to a concentration of 50 mgcm 3. Each suspension was incubated at 30 °C 
and 220 rpm for between 0 and 5 h before 150 l of a 55 mM solution of 
thiazolidine-2,4-dione 172 in DMSO was added. All were incubated for a further 16 
h under the same conditions but none afforded reduction of the substrate. 
3.4.2 Preparation of an Acetone Powder of Rhodotorula rubra CBS 6469. 
The majority of acetone powder preparations in the literature are from animal 
sources. However, Nakamura et al, reported the reduction of ketones with the 
acetone powder of Geotrichum candidum in 1996 which was later used by Fujisawa 
et al., to afford (5)-alcohols from (trifluoroacetyl)biphenyl derivatives. 167,168 
Rhodotorula rubra CBS 6469 was grown and the cells produced were washed with 
acetone (-20 °C). This was performed twice with the yeast being left in the acetone 
for 5 and 10 mm. The powdered yeast was resuspended in 10 cm' 0.1 M Tris-HCl 
buffer (pH 8.0), containing 5 % w/v sucrose, to a concentration of 25 mgcm 3. 1.5 
cm  of a 117 mM solution of thiazolidine-2,4-dione 172 in DMSO was added. In 
each case no product was detected by hplc. 
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3.4.3 Immobilisation by Gel Entrapment in Calcium Alginate. 
Immobilisation by entrapment within a polymer matrix is possible with a variety of 
polymers. In the case of polyacrylamide the polymerisation reaction between 
acrylamide and bis-acrylamide is carried out with the cells present but the monomers 
involved can have a toxic effect on viable cells. Entrapment procedures using i-
carrageenan and agar suffer from the drawback that the procedure is carried out at 
elevated temperatures. Calcium alginate is the method of choice for the entrapment 
of living cells as the procedure is carried out under mild conditions. This polymer is 
the major structural polysaccharide of marine brown algae, and the entrapment 
process involves the replacement of monovalent sodium ions by divalent calcium 
cations which leads to gelation of the polymer. 169 
SmithKline Beecham have reported a procedure for the reduction of 6 to 2 by 
Rhodotorula rubra CBS 6469 entrapped in calcium alginate beads.7 The procedure is 
described in detail except for the type and source of the sodium alginate used, along 
with details of how the beads were formed. Instead it states that "the cells were 
immobilised into beads by standard methodology" and cites an article by Smidsrød 
and Skjâk-Brk)70 In addition the reported reduction only affects 87 % conversion 
to product. 
In any entrapment of cells there has to be a balance between the rigidity of the 
polymer in order to prevent leakage of cells from the beads and the diffusion 
properties of the matrix, both of which stem from the degree of cross-linking of the 
polymer. The success of the procedure greatly depends upon the sodium alginate 
used, as increasing the concentration of alginate results in a higher degree of cross-
linking within the matrix. Also, alginates constitute a family of unbranched 
copolymers, of 1-4 linked 13-D-mannuronic acid and a-L-guluronic acid, of widely 
varying structure and sequence depending on their source. 
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The entrapment procedure results in formation of beads, the size of which are crucial 
in order to develop a reproducible procedure. The production of smaller beads leads 
to an increase in surface area which aids diffusion, the rate limiting factor in single 
step reactions. 169 
If the development of a reproducible protocol for immobilisation of Rhodotorula 
rubra CBS 6469 led to the cells being reusable it could greatly reduce the time spent 
growing the organism making the process less labour intensive. 
The calcium alginate entrapment was attempted by growing the organism in medium, 
washing with 0.1 M Tris-HCl (pH 8.0), containing 5 % w/v sucrose, before 
resuspending in the same buffer system. This suspension was mixed with a 2 % w/v 
solution of medium viscosity sodium alginate in the same buffer in a 1.0 : 1.0 ratio. 
The mixture was extruded from a syringe into 0.2 M aqueous calcium chloride and 
allowed to harden for 25 min before being removed and thoroughly washed with 
water. The beads were then resuspended in the same buffer and thiazolidine-2,4-
dione 172 (5.0 mM) was added in 1,4-dioxane (18.75 % v/v). This resulted in 20 % 
conversion to product after 24 h which remained constant. 
By utilising low viscosity sodium alginate in an identical procedure the conversion 
was increased to 97 %. The scale of the reaction was then increased, with the 
organism being grown in twice the volume of medium, and the ratio of cell 
suspension to alginate solution altered. The cells were resuspended and mixed with a 
2 % w/v solution of low viscosity sodium alginate solution in buffer in a 1.2 : 1.0 
ratio. Again the beads were formed by extrusion into 0.2 M aqueous calcium chloride 
By adding thiazolidine-2,4-dione 172 (3.7 mM) in DMSO (7.5 % v/v) to the 
resupended beads it was possible to achieve quantitative conversion within 44-48 h 
and isolate the product in 58 % yield. Quantitative conversion with the free cells was 
achieved in 58 h; however, there were no systems in place to compare conversion 
between the two methods. 
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Although the beads were easily removed by filtration the resulting solution appeared 
slightly cloudy. This cloudiness was evidence of leakage from the beads, and indeed 
streaking of the filtrate on agar plates showed the presence of viable cells. This is 
problematic as it led to the formation of emulsions when attempting to extract the 
product and therefore it is necessary to continuously extract the product into DCM. 
An attempt was made to re-use the polymer beads but the second attempt at reduction 
of 172 reached a maximum value of 75 % conversion after 44.5 h. This inability to 
re-use the alginate beads, and the failure to simplify the purification procedure, 
meant that, without further development, the use of the immobilised cells would not 
have greatly improved the overall procedure for performing preparative scale 
reductions. 
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4. Results & Discussion :.Chemical Reduction. 
In investigating the biotransformation of the substrates it was necessary to produce 
several reduced compounds as standards which were mainly used to compare hplc 
retention times. This was of particular importance during the screening of 
compounds. If there was no sign of product by hplc it was essential to show that the 
starting material and anticipated product could be separated under the hplc conditions 
before it could be demonstrated that the benzylidene compound was not a substrate. 
4.1 Reduction of Tr-substituted Double Bonds. 
4.1 .1 Hydrogenation. 
0 
H2, 10% Pd/C, 
R' H 	
1,4-dioxane. 
	R' 	 NH 
Fig. 4-1. 	Hydrogenation of Tn -substituted Double Bonds. 
For the majority of tn-substituted alkenes that required reduction it was possible to 
achieve this by hydrogenation over 10 % Pd/C in 1,4-dioxane (Table 4-1, Fig. 4-1). 
Three different methods were employed with more catalyst being required when X' 
is sulfur. In the main yields were high with the notable exception of the 4-CN 
compounds 245 (29 %) and 255 (45 %). In each case it is possible that reduction of 
the nitrile functionality could have occurred to a certain extent. If nitrile reduction 
was occurring then the resultant polar amine would have been removed during 
column chromatography. In the production of 245 the low yield can partially be 
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attributed to the loss of insoluble material during removal of the catalyst by filtration 
through CeliteTM. 
Hydrogenation of 190 (R' = NO2, X' = S) under similar conditions produced a 
complex mixture of products from which nothing of interest could be extracted. 
Three other compounds have all been reduced in this manner to produce 259 (56 %), 
2 (64 %) and 247 (78 %) respectively (Fig. 4-2). 
	
R1' 	
H21  10% Pd/C, 	
H 
NH RNH 
S_. 1,4-dioxane. 	 s o  
Starting Material R Time (h) Yield (%) Product 




48 64 2 
236
(D 
27 78 247 
Fig. 4-2.' 	Results of Hydrogenation ofR-231, 6 and 236 over 10 % Pd/C. 
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4.1.2 Other Methods. 
Hydrogenation of 195 and 196 did not appear 
appropriate due to the presence of the imine and 	 0 





presence of the thiazolidine-2,4-dione  facilitates the  
need to use a large proportion of catalyst, presumably 	x2 = I'W1 195 
due to catalyst poisoning by the sulfur atom. The 	
X' = S 196 
presence of another sulfur atom in 196 would lead to 
further catalyst poisoning. 
It was attempted to reduce 196 using zinc dust and acetic acid according to the 
procedure reported by Hansen. 171  Although it was noted that this procedure leads to 
thiocarbonyl removal it was reported that material can be produced where the alkene 
double bond is reduced and the thiocarbonyl group left intact (Fig. 4-3). 
0 	 0 	 0 
Ph 	NH Zn/AcOH Ph NH + Ph 	NH 
80% 	 S--/ 	
s__.s 
2:1 
Fig. 4-3: 	Reported Zinc and Acetic Acid Reduction. 
Attempts to reproduce this procedure on 196 were unsuccessful as purification 
proved difficult because the solid crude product was not amenable to column 
chromatography. o 
Attempts to hydrogenate 237, 238 and 240 were MCO R'  
unsuccessful, with 'H nmr not indicating the presence of R' R2 







Me OMe 239 
Me OEt 240 
Me NH2 241 
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Therefore it was attempted to reduce 239 and 241 using dissolving magnesium in 
methanol but 'H nmr and electrospray mass spectrometry did not show any signs of 
reduced product.7  
Also, attempted reduction of 195 and 196 with magnesium in methanol did not 
reduce the carbon carbon double bond. 
4.2 Reduction of Tetra-substituted Double Bonds. 
	
0 	 R 0 
__ TA 	
H2, 10% Pd/C, 
R, 	 NH NOW 	R I 	 NH s—./ I ,4-dioxane. 
0 	 0 
Starting R' R2 Time Yield d.c. 	d.e. Product 
Material 	 (h) 	(%) 	(%, by (%, by 
hplc) 'Hnmr) 
201 H Me 27 93 	31 20 260 
202 OMe Me 27 80 54 40 261 
203 OMe Et 27 80 	38 30 262 
215 OMe D 24 78 40 263 
Fig. 4-4: 	Results of Hydrogenation of Tetra-substituted Alkenes over 10 % Pd/C. 
As the three tetra-substituted alkenes 201-203 did not appear to produce any reduced 
compound on incubation with the yeast they were hydrogenated over 10 % PdJC in 
1,4-dioxane (Fig. 4-4). All three products exhibit an excess of one diastereomer, as 
does 263. 
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Me 	o 	 This diastereomeric excess is a 
NH 	 peculiar result which requires some 
s-J 
explanantion. It would be expected 
201 	 that hydrogen addition across the 
double bond would produce a 
H2, 10%Pd!C, 
I ,4-dioxane 	 statistical mixture of compounds as 






een enantiotopic faces of the 






However, when hydrogen is added 
statistically in a syn fashion two 
o=c 	s 	 s 	C=O 
Ph Ph 	 enantiomers are created (eg. 260a 
260a 	• 	 260b 
and 260b, Fig. 4-5). It is known that 
RACEMISATION 	 the centre a to the sulfur atom is 





produce a further two compounds 
260c and 260d which are 
\ / 	
0 	\ / 	 enantiomers of each other but 
Ha 	 Ha 	diastereomers of 260a and 260b. 
Me 	HP 	 HJMe 
s'c=o : o=c'r's 
Ph 	 Ph 	 The Newman projection formulae 
260c 	 260d of 260a and 260b clearly show that 
Ha, H and the methyl group are in 
Fig. 4-5: 	Proposed Mechanism for the 
the same environment in both Formation of Two Diastereomers 
in the Hydrogenation of 201. 	molecules, hence they would 
produce the same nmr spectrum. 
Projections of 260c and 260d show a similar scenario. 
However, on going from 260a to 260c, and similarly from 260b to 260d, it can be 
seen that racemisation changes the environment of H and the methyl group. 
95 
Results & Discussion: Chemical Reduction. 
So, although 260a and 260b exhibit the same spectrum, as do 260c and 260d, they 
differ from each other. 
This explanation accounts for the discrepancies in d.e. values measured by hplc and 
'H nmr for 201-203. The data from hplc was collected first and indicates a higher d.e. 
than the 'H nnir data (Fig. 4-4). It is feasible that the racemisation is slow, leading to 
a decrease in d.e. in the time between acquiring both sets of data. 'H nmr's were 
recorded in CDC13 which may be slightly acidic and could increase the rate of 
racemisation. 
This mechanism would also account for the d.e. exhibited by 263. By following the 
process as outlined in Fig. 4-5 for the hydrogenation of 215 a similar scenario 
emerges where the methyl group of 260 is replaced by a deuterium atom. No hplc 
data is available for 263 as the chirality f3 to the sulfur arises as a result of isotope 
incorporation. 
In each instance 260-263 the more abundant species has the smallest coupling 
between Ha and H. The reduction of 201 would be expected to produce a majority of 
260a and 260b, with a syn relationship between Ha and H. 
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5. Results & Discussion : Biotransformation Mechanism 
This chapter describes work directed towards the elucidation of the mechanism of the 
double bond reduction using Rhodotorula rubra CBS 6469. 
5.1 Biotransformation of (Z)-5-(4-methoxybenzy1idene-d) thiazolidine-2,4-dione 
215. 
D 	0 	
Rhodotorula rubra CBS6469 	 D 	o 
0.IM Tris-HC1, containing 5% w/v 
I 	 NH 	





215 	 264 
Fig. 5-1. Biotransformation of (Z)-5-(4-methoxybenzylidene-d)thiazolidine-2, 4-dione 
215 in Hydrated Medium. 
3.0 
Fig. 5-2: 	'H nmr of 264 	 Fig. 5-3: 2H nmr of 264 
The initial experiment carried out in this area involved the biotransformation of the 
deuterated substrate 215 (Fig. 5-1) which produced two separate products in a 1:1 
ratio. A similar result was noted in the hydrogenation of 215 to produce 263. It was 
proposed that the formation of two compounds in the hydrogenation of 215 resulted 
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from syn addition of hydrogen followed by racemisation a to the sulfur (Sect. 4-2). 
However, in the case of 264 the initial reduction product would be expected to fully 
racemise under the reaction conditions. 
Two modes of double bond saturation, syn and anti, are possible which, after 












































































o=c- r- s 
Ph 
264a 
Fig. 5-4: Possible Products From the Rhodotorula rubra CBS 6469 Mediated Saturation 
of the Carbon-Carbon Double Bond of 215. 
264a-d consists of two pairs of enantiomers as can be seen from the Newman 
projection formulae (dashed lines represent mirror planes). It can be seen that 264a 
and 264b can be formed from syn addition or from anti addition followed by 
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racemisation. Similarly 260c and 260d can be formed by anti addition or by syn 
addition followed by racemisation. 
This shows that there are two chemically different species present. One with a syn 
relationship between Ha and H, 264a and 264b, and another with an anti 
relationship between Ha  and H, 264c and 264d. 
The two species are clearly evident in both the 'H and 2H nnir spectra (Figs. 5-2 and 
5-3). One exhibits a doublet (J 9.5 Hz) at 6H  3.07, arising from H, and a doublet (J 
9.5 Hz) at 6H 4.49, arising from Ha, whilst the other exhibits a doublet (J 4.0 Hz) at 
OH  3.43, arising from H, and a doublet (J 4.0 Hz) at 6H 4.49, arising from Ha. The 
difference in the environment of H is greatly different between the two species 
leading to a large difference in 6H'  however the difference in environment of Ha  is 
much smaller so both doublets arising from Ha  appear to be almost superimposed. 
Although the Newman projections show a similar dihedral angle between Ha  and H, 
in both species, it has to be remembered that these are diagramatic representations 
designed to aid the clarity of explanation and do not represent the exact structure of 
the two species. As they both display different coupling constants between Ha  and H 
the dihedral angle between these two protons must differ between species. 
It is impossible to tell the absolute stereochemistry of either centre and, therefore, 
from which face H is incorporated. 
215 has a deuterium content of 98.6 %, as measured by low resolution mass 
spectrometry. A similar treatment of 264 gives no indication of the presence of non-
deuterated compound indicating that no loss of deuterium has occurred. 
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5.2 Biotransformation of (Z)-5-(4-methoxybenzyIidene)thiazoIidine-2,4djone 
172 in Deuterated Medium. 
0 	
Rhodotorula rubra CBS 6469 	 D 	o 
0.1M Tris-HCI, containing 5% w/v 
sucrose, in D20, [2H6] DMSO 





172 	 265 
Fig. 5-5: Biotransformation of (Z)-5-(4-methoxybenzylidene)thiazolidine-2, 4-dione 172 
in Deuterated Medium. 
In a complementary experiment, the reduction of 172 using Rhodotorula rubra CBS 
6469 was conducted in deuterated buffer (Fig. 5-5). 
The use of deuterated buffer dramatically reduced the rate of reaction. This reaction 
required seven days to effect 87 % conversion as opposed to approximately two days 
to reach quantitative conversion in non-deuterated medium. This is indicative of 
some type of deuterium isotope effect, although the exact nature of the effect is 
impossible to ascertain. 
Examination of the 'H nmr of 265 at 600 MHz revealed the presence of six different 
isotopomers in the product mixture (Fig. 5-8). 
The region arising from Ha in the reduced compound at 4.49 ppm (Fig. 5-6a) 
indicates the presence of three species. The deuterium decoupled spectrum (Fig. 5-
6b) is more informative and the four smaller peaks, labelled 1-4, exhibit the same 
chemical shift and coupling constants as the reference material 243 (Fig. 5-6c), 
prepared by catalytic hydrogenation (Chapter 4). In this case Ha  is coupled to the two 
protons at H with J4.0 Hz (peaks 1-2) and 9.5 Hz (peaks 1-3) (Fig. 5-8, 265C11). 
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a 	 b 	 c 
Fig. 5-6: a. 'H nmr Expansion; b. 'H nmr Expansion with Deuterium Decoupling; 
c. 'H nmr Expansion of 243 as Reference. 
Two doublets were also present in the deuterium decoupled spectrum, one with J 4.0 
Hz (peaks 5-6) and the other J 9.5 Hz (peaks 7-8), indicating that two further species 
are present. These species appeared to coincide with the two products present in 264, 
one with a syn relationship between Ha and H (Fig. 5-8, 265A) and another with an 
anti relationship between Ha  and H (Fig. 5-8, 265BH). It has to be remembered that 
the stereochemistry protrayed for 265AH and 265BH is relative and that the 
enantiomers of both these compounds may also be present. 
Although it is not possible to determine which doublet arises from which species it is 
assumed that the syn relationship between Ha  and H 265AH gives rise to J4.0 Hz. 
The integrals across this region showed that the ratio of the three isotopomers was 
1.00:1.00:1.28 (265AH:265B11:265CH). 
Further evidence for the presence of these three isotopomers is available in the two 
regions of the 'H nmr spectrum arising from H (Fig. 5-7). The non-deuterated 
species 265CH exhibits a characteristic doublet of doublets in both of these regions, 
as the reference spectra (Fig. 5-7a) showed, which were identified in the deuterium 
decoupled spectrum of the mixture of biotransformation products (Fig. 5-7d, peaks 9-
12, and Fig. 5-7e, peaks 17-20). The coupling constants of 4.0 and 14.0 Hz, in the 
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region at lower field, and 9.5 and 14.0 Hz, in the region at higher field, are in good 
accordance with those exhibited in the reference spectrum. 
265AH should exhibit a doublet with J 4.0 Hz in the lower field region whilst 265BH 
should give rise to a doublet with J9.5 Hz in the higher field region. 
it A 
3!43!33!2313!Q. 
3.48 	 3.45 	 3.44 	 3.43 	 3.42 
b C 
15 
d 	 e 
Fig. 5-7: 	a. 'H nmr Expansion of 243 as Reference. 
JH nmr Expansion of H6 at Lower Field. 
'H nmr Expansion of Hfl at Higher Field. 
'H nmr Expansion of H,q at Lower Field with Deuterium Decoupling. 
IH nmr Expansion ofHq at Higher Field with Deuterium Decoupling. 
102 
Results & Discussion : Biotransformation Mechanism. 
Although peaks 19 and 20 are part of the doublet of doublets arising from 265CH 
their intensities were greater than expected from the 'roofing' pattern exhibited by 
the reference material. It is possible that these overlap with a doublet with J 9.5 Hz, 
whilst in the similar spectrum from the proton at lower field (Fig. 5-7d) there was a 
doublet with J4.0 Hz, peaks 14-15. 
It is known that the reduced product is susceptible to racemisation at pH 8 which in 
this case would lead to incorporation of deuterium at Ha  and hence it is feasible that 
there are such compounds, corresponding to each of the three compounds identified, 
where deuterium has been incorporated at Ha.7'172  This racemisation would give rise 
to 265AD, 265BD and 265CD (Fig. 5-8). It is important to remember that the 
stereochenistry drawn for 265AD, 265BD, and 265CD are relative and that the 
enatiomer of each one may be present. 
Peaks 13 and 15 in Fig. 5-7d appeared as a doublet with J 14.0 Hz. A similar pattern 
was exhibited between peaks 21 and 22 in Fig. 5-7e. These patterns were 
characteristic of coupling between the two H sites, but with no coupling to Ha, and 
were indicative of the presence of 265CD. 
A singlet in each of the H positions was indicative of 265AD and 265BD and peak 16 
(Fig. 5-7d) does not appear to couple to any of the other peaks in this region. It was 
possible that a similar peak occurs in the other H region, but was obscured. A 
similar phenomenon was seen with peaks 19 and 20 and further evidence for this was 
obtained by looking at the integrals across both these positions. 
Each of the H regions were considered in turn, starting with that at lower field 
(Table 5-1). Peaks 9-12 arose from 265CH and each displayed the same integral, 
whilst peak 15 coupled to both 13 and 14 and arose from both 265CD and 265A11. 
The relative integral of 15 was equal to the total displayed by 13 and 14 as expected 
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compounds were calculated based on the total integral exhibited by each species in 
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Ph 
265C0 
Fig. 5-8: Proposed Composition of the Product Mixture Based on 'H nmr. 
Peak No. 	 9 	10 	11 	12 	13 	14 	15 	16 
Total Relative Integral. 	6 6 6 6 11 11 22 15 
Relative Integral Arising from 265CH 	6 	6 	6 	6 	--- 	 --- 
	
Relative Integral Arising from 265AH --- 	 --- 	 --- 	 11 	11 
Relative Integral Arising from 265CD --- 	 --- 	 11 	--- 	 11 
Total Relative integral Left 	0 0 0 	0 	0 0 0 	15 
> Relative Integral Arising from --- 	 --- 	 --- 	 --- 	 --- 	 --- 	 --- 	 15 
265AD 
Table 5-1: Relative Integrals, and Composition of Peaks 9 to 1 6from Fig. 5- 7d. 
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Compound 265A11 265AD 265C11 265CD 
Total Integral 	22 	15 	24 	22 
Relative Ratio 1.47 1.00 1.60 1.47 
Table 5-2: 	Relative Ratios of 265AH, 265AD, 265CH and 265C0. 
Peak No. 	 17 18 	19 20 and 22 21 
Total Relative Integral. 	6 	6 15 	41 	11 
Relative Integral Arising From 265CH 	6 6 	6 6 
Relative Integral Arising From 265BH --- 	--- 9 	9 
Relative Integral Arising From 265CD 	--- --- 	--- 11 	11 
Total Relative Integral Left. 	0 	0 0 	15 0 
	
=> Relative Integral Arising from 265BD --- --- 	--- 15 
Table 5-3: Realtive Integrals, and Composition of Peaks 17 to 22 from Fig. 5- 7e. 
Compound 265BH 265BD 265CH 265CD 
Total Integral 	18 	15 	24 	22 
Relative Ratio 1.20 1.00 1.60 1.47 
Table 5-4: Relative Ratios of 265BH, 265BD, 265C11 and 265CD. 
Peak overlap and manual measurement of integrals leads to significant errors in the 
calculation of relative ratios. However it could be seen, in terms of the percentage 
make-up of the mixture, that 265CH > 265A and 265CD  > 265AD (where 265AH and 
265CD were similar). 
The relative integrals of peaks 17 to 22 arising from H at higher field, Fig. 5-7e, are 
shown in Table 5-3. Due to the extent of overlap the total integral across peaks 20 
and 22 is quoted. 
265CH gave rise to peaks 17-20, although 17 and 18 had the same integral 19 and 20 
were significantly larger (Table 5-3). If the pattern exhibited in the other HD  region 
was repeated here then part of 19 and 20 (equal in intensity to 17 and 18) was due to 
265CH. It follows that the remaining integral of peak 19 must have arisen from 
265BH as did a similar portion of peak 20. 
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This has accounted for the total integrals displayed by peaks 17-19, however it left a 
fraction of the integral of peak 20/22 unaccounted for. This unaccounted area was 
greater than the total area of peak 21 and it is proposed that 20 and 21 arose from 
265CD, if the relative area of 21 is subtracted from the unaccounted portion of 20/22 
then it leaves a region of peak 22 which accounts for the obscured singlet arising 
from 265BD. 
Again, relative ratios of these four compounds were calculated based on the ratios of 
the total integral exhibited in this region of the spectrum (Table 5-4). From these 
ratios it was possible to say that in terms of the percentage make up of the mixture 
then 265CH > 265C > 265BH > 265BD. 
In summary, four conclusions can be drawn from examination of the 'H nmr. Firstly, 
there was evidence for the existence of all six isotopomers shown in Fig. 5-8 and 
from the integrals at Ha  the ratio between 265A11, 265BH and 265CH is 
1.00:1.00:1.28. The integrals exhibited in the H region at lower field (Fig. 5-7d) 
showed that 265CH > 265CD and 265AH > 265AD (where 265AH and 265C0 are 
similar) whilst H at higher field (Fig. 5-7e) showed that 265CH  > 265CD > 265B11 > 
265BD. 
Compound 	265AH + 265AD 265BH + 265BD 265AD  + 265BD  + 265CD 
Relative Ratio 1.00 	 1.00 	 1.70 
Table 5-5: Relative Ratios as Determined by 2H nmr (Fig. 5-9) 
nmr showed the relative amount of deuterium incorporated at each of the three 
positions (Table 5-5 and Fig. 5-9). As the ratio of 265AH to 265BH was 1:1 (Fig. 5-
6b), and the ratio of the totals of 265A and 265B was 1:1, it follows that the ratio 
between 265AD and 265B0 must also be 1:1. 
The six isotopomers gave rise to three molecular ion peaks 237, 238 and 239, with an 
intensity ratio of 1.00:2.46:1.40, as determined by low resolution electron impact 
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mass spectrometry. The composition of each of these molecular ion signals is shown 
in Table 5-6. 
'H nmr has shown that the ratio 
265AH:265BH:265CH is 1.00:1.00:1.28 
(or 0.78:0.78:1.00) and therefore the 
contribution of 265AH and 265BH to m/z 
238 must have been 1.56, whilst that of 
265CD was 0.90. 'H and 2H nmr have 
also shown that the ratio of 
265AD:265BD is 1.00:1.00 and therefore 
each contributed equally to m/z 239, 
with a value of 0.70 each. This allowed 
the calculation of the relative ratios of 
all six isotopomers (Table 5-7). These 
.O 	.6 	 3.0 	3.0 
PPM 
figures are in accordance with the 
hypotheses based on both 'H and 2H 
Fig 5-9: 2H nmr at 360 MHz of 265. 
nmr spectra. 
m/z 	Composition 	Relative Intensities 
237 265C11 1.00 
238 	265CD + 265AH + 265BH 	2.46k  
239 265AD + 265BD 	 1.40 
Table 5-6. Predicted Composition of m/z Values Along With Relative Intensities. 
265AH : 265BH : 265CH : 265AD : 265BD : 265CD 
0.78 	: 	0.78 	: 	1.00 	: 	0.70 	: 	0.70 	: 	0.90 
Table 5-7: Final Calculated Ratios of 265A - 265CH. 
Shaking 265, in CDC13, with sat. aqueous sodium hydrogen carbonate removed Da  to 
leave 265AH, 265BH and 265CH which greatly simplified the spectroscopic data. 
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'H nnir at H exhibited the same pattern as before and indicated a ratio between 
265AH, 265BH and 265CH of 1.00:1.00:1.29 (compared to the previous 
1.00:1.00:1.28). Similarly H at lower field showed a ratio between 265AH and 
265CH of 1.00:1.15 whilst H at higher field showed a ratio between 265BH and 
265C11 of 1.00:1.58. This gives an average ratio between 265AH, 265BH and 265CH 
of 1.00:1.00:1.34. 
Electron impact mass spectrometry showed peaks with m/z 237 (265CH) and 238 
(265AH and 265BH) in a ratio of 1.30:2.00. This translated to a ratio between 265AH, 
265BH and 265CH of 1.00:1.00:1.30. 
Both these calculations compared favourably with the previously calculated ratio of 
1.00:1.00:1.28 (265A:265B:265C). 
The level of deuteration at the 13  position can be calculated as 61 %. Although it is 
known that the a centre is prone to racemisation the 13 centre should remain fixed. It 
was confirmed that the 13 centre is indeed fixed by performing several simple 
experiments. 
Initially the non-deuterated reduced compound 243, prepared by catalytic 
hydrogenation (Chapter 4), was shaken in deuterated buffer and DMSO, in the same 
proportions as used for the biotransformation to produce 265, for 7 d. 'H nrnr did not 
show any evidence of exchange between the H positions and the buffer/co-solvent 
mixture. Similarly the reduced compound 243 was shaken, for 7 d, with Rhodotorula 
rubra CBS 6469 in deuterated buffer/co-solvent. Again, 'H nnir did not provide any 
evidence of exchange between the H positions and the yeast. 
In light of the results of these two experiments it can be said that the 61 % 
incorporation of deuterium at H occurs during the reduction process. 
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By taking the weight of the cell pellet, resulting from washing and centrifugation, it 
was possible to lyophilise the pellet to constant weight and hence calculate the 
amount of water present in the pellet. Furthermore by taking the dry cells and 
resuspending them in the volume of water that had been removed it was possible to 
work out the volume taken up by the cells in the final cell suspension. As the total 
volume of the resultant cell suspension used in the biotransformation was known it 
was possible to work out the amount of D20 present as a function of the total amount 
of 'water' present, this was calculated to be 79 %. 
5.3 Attempted Biotransformations to Afford Enantiomerically Enriched 
Product. 
SmithKline Beecham have shown that by reducing the pH from 8.0 to 3.75 it is 
possible to produce R-2, as its hydrochloride monohydrate, in 99.5 % e.e. and 18 % 
yield.7 
Due to the racemisation occurring at the a position it is difficult to determine from 
which enantiotopic face the reductase system adds hydrogen at the 3 position. It was 
envisaged that yeast reduction of 215 at low pH, to impart a degree of 
enantioselectivity at the a position, would simplify the process. Initially it was 
attempted to reduce 172 at pH 3.75. 
The main problem associated with performing such a reaction concerns the 
measurement of any e.e., as the chiral hplc conditions used by SmithKline Beecham 
for 2 did not afford any separation of 243. As the biotransformation is at low pH it is 
necessary to basify the buffer before the product can be extracted which could lead to 
racemisation. An ideal situation would thus involve having an on-line method to 
quantify the e.e. in the reaction mixture before work-up. Several chiral hplc columns 
were tested with the Chiralpak AD exhibiting excellent separations of 243 and other 
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reduced standards. However, this system was not robust and reproducing the 
chromatography proved difficult. 
Chiral shift analysis by 'H nmr, in CDC131  of 243 in the presence of Eu(hfc)3 afforded 
separation of the aromatic doublet at lower field and it was envisaged that this could 
be used to quantify the e.e. of the final product. 
Initial attempts involved reproducing the SmithKline Beecham procedure with 172 
instead of 6, however this only produced 22 % conversion after 41 h. 1,4-dioxane 
was retained as the co-solvent as the use of DMSO would complicate the purification 
procedure. Reducing the concentration of 1,4-dioxane from 13.6 to 8.5 % v/v, and 
the concentration of 172 from 2.8 to 2.2 mM, increased conversion to 49 % after 44 
h, considerably longer than the 3 h 20 min that the SmithKline Beecham reduction 
took. The ratio of biomass to substrate was increased with combined cells from 180 
and 220 cm3 of medium being used instead of the cells from 220 cm' of medium. 
These were resuspended in the same volume of 0.1 M citrate buffer and used to 
reduce 172 (2.2 mM) with 1,4-dioxane (8.5 % v/v/) as co-solvent. This resulted in 50 
% conversion after 4 h. Using the cells from 2 x 220 cm3 of growth medium' and 1.8 
mlvi 172 resulted in quantitative conversion after 6 h. 
Once quantitative conversion had been achieved within a reasonable timescale the 
cells were removed by centrifugation. However, the supernatant remained slightly 
cloudy and formed an emulsion on extraction with DCM which was partially avoided 
by filtration through a 0.45 jim nylon membrane. 
Initial attempts to extract the product involved basification to pH 8.0 with 10 % 
ammonia solution followed by extraction into DCM. The solvent was dried and 
removed to leave a gummy solid but chiral shift 'H nmr analysis of this with Eu(hfc)3 
in CDC13 showed that the racemate had formed. SmithKline Beecham's reduction of 
6 involves dissolving this gummy solid in aqueous hydrochloric acid and allowing 
the hydrochloride monohydrate of 2 to crystallise overnight at low temperature. It is 
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reported that this improves the e.e. from 88 %, at the end of the incubation period, to 
> 99.5 %. Treatment of the crude product in this manner did produce the salt of 243 
in 12 % yield which was insoluble in CDCI3. 
A racemic sample of 243 hydrochloride monohydrate was prepared and subjected to 
'H nmr chiral shift analysis with Eu(hfc)3 in (CD3)2C0. Again separation of the 
aromatic doublet at lower field was achieved. Although examination of the 
biotransformation product indicated that there may be a slight excess of one 
enantiomer present, it was not possible to achieve baseline separation of the aromatic 
peaks to enable quantification of the e.e. 
5.4 Conclusions. 
Although it is not possible to determine which enantiotopic 13  face hydrogen is 
incorporated from it can be seen that when the reaction is performed in D20 the 
incorporation of deuterium at the 13 position is greater than at the a position (61 
versus 48 %), even though it is believed that the a centre incorporates deuterium by 
racemisation. 
In the reduction of lactone 112 it has been shown that 
reduction occurs via formal hydride delivery from the 13- 	 0 
re face.57 However when the reduction is carried out in 80 	 112 
% D20 the incorporation of deuterium at positions 2 and 3 is 70 and 45 % 
respectively.95 These values show that deuterium is incorporated to a lesser extent at 
the site of hydride addition. 
Reduction of 172 in 79 % D20 was found to incorporate deuterium in 48 and 61 % at 
the a and 13 centres respectively which would imply that the polarity of the double 
bond is reversed with hydride addition occurring at the a position. One possible 
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mechanism is outlined in Fig. 5-10, which indicates formation of the R configuration 
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Fig. 5-10: Possible Mechanism of Reduction By Rhodotorula rubra CBS 6469. 
Smaliridge has shown a similar phenomenon in the baker's yeast reduction of - 
nitrostyrenes in petroleum ether and has proposed the mechanism outlined in Fig. 5-
11.61 This mechanism involves a reversible non-stereoselective protonatión at the 13-
carbon followed by stereoselective hydride attack at the a-carbon. However in the 
reduction by Rhodotorula rubra CBS 6469 it is not possible to tell whether or not 
incorporation of hydrogen at the 13  position is non-stereoselective. 






R1 	 R' 
Fig. 5-11: Mechanism of /3-Nitrostyrene Reduction By Baker's Yeast. 
Smallridge's proposition for a reversible protonation is based upon two key facts. 
Firstly that reduction of 3-deutero-f3-nitrostyrene resulted in an 80 % loss of 
deuterium during the reduction. By showing that exchange does not occur between 
the reduced product and the water present, or between reduced product and protons 
bound to the yeast, he concluded that exchange at the 13-centre must be occuring 
before product formation. Secondly, it was noted that in an incomplete reduction of 
13-deutero-13-nitrostyrene non-deuterated starting material remained, along with 
deuterated and non-deuterated reduced compound, indicating that the non-deuterated 
product resulted from the reduction of the non-deuterated double bond. 
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Although an incomplete reduction of 215 with Rhodotorula rubra CBS 6469 was 
never attempted there was no loss of deuterium during the reduction indicating that, 
in this case, incorporation of hydrogen at the 3 centre is not reversible. 
It is also difficult to establish whether or not the proton comes directly from the 
yeast. Smaliridge achieves this by reducing j3-deutero-3-nitrostyrene in petroleum 
ether and D20. This resulted in loss of deuterium in both the reduced compound and 
the recovered starting material from which he concluded that the protonation at the 13-
centre is not only yeast catalysed but also that the proton is delivered by the yeast 
rather than coming from the water present. Sunjic has also proposed an enzyme 
assisted protonation at an emerging chiral centre in the reduction of 2-methyl 
cinnamaldehyde 26 (Fig. 1-8). 
There are two possible explanations for the formation of non-deuterated product 
when the Rhodotorula rubra CBS 6469 reduction is carried out in D20. As this 
reduction is carried out in 79 % D201  if the proton is derived from the water present 
then either a proton or deuteron could be incorporated. Similarly if the proton is 
delivered by the yeast it is feasible that initially a proton will be transferred which 
may be replaced by a deuteron in the yeast which is in turn delivered to the substrate. 
The ability to utilise lyophilised Rhodotorula rubra CBS 6469 could have been 
exploited here. 
The necessity for the presence of sulfur could arise from its ability to stabilise an a 
positive charge. There are two mechanisms for such stabilisation : inductive and 
resonance stabilisation. 
Inductive stabilisation is linked to electronegativity with atoms with a higher 
electronegativity more readily attracting electrons from the already electron-deficient 
centre and destabilising the positive charge. On the Pauling scale of electronegativity 
sulfur has a value of 2.5 whilst nitrogen exhibits an electronegativity of 3.0. 
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A more powerful effect is that of resonance stabilisation. This involves the donation 
of electrons into the empty p orbital of the carbocation. Both sulfur and nitrogen 
possess lone pairs of electrons capable of stabilising the carbocation in this manner. 
As the heteroatom is adjacent to a carbonyl group the nitrogen lone pair electrons 
would be delocalised by overlap with this carbonyl group's 7t orbital, an effect well 
established in the structure of amides. This would decrease the stabilising effect of 
the nitrogen lone pair electrons on the a carbocation. 
Based upon. the observations made, the apparent reversal of polarity of the carbon-
carbon double bond compared to Fuganti's lactone reduction, the requirement of the 
sulfur atom, the possible formation of a racemic centre 0 to the sulfur atom and the 
reported reduction at low pH to produce the R enantiomer at the a position, it is 
feasible to propose a possible mechanism for reduction (Fig. 5-10) which accounts 
for these observations. 
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6 Experimental Synthesis 
6.1 General Experimental. 
Melting points were determined using a Gallenkamp Electrothermal Melting Point 
apparatus and are uncorrected. 
Optical rotations were recorded at 589 nm on an AA-1000 polarimeter with a path 
length of 0.5 dm. Concentrations (c) are given in g/100 cm' and [OC]T  values are 
quoted in 10' degcm2g. 
Tlc was performed on Merck 60F254 (0.25 mm) glass backed silica plates. The plates 
were developed by uv visualisation and by treatment with an aqueous alkaline 
potassium permanganate solution followed by heating. Column chromatography was 
performed using Merck silica gel 60H (230-400 mesh). Eluent compositions are 
quoted as v/v ratios. 
Elemental analysis (CHN) was performed on a Perkin Elmer 2400 CHN Elemental 
Analyser. 
Infrared spectra were recorded either as thin films (on sodium chloride plates) or as 
KBr disks and are denoted by (Film) or (KBr) repectively. Spectra were recorded on 
a Perkin Elmer Paragon 1000 FT-JR with frequencies being measured in 
wavenumbers (cm-'). 
Nmr spectra were recorded, either on a Bruker AC200, a Bruker AC250, a Bruker 
WH360 or a Varian Inova 600 spectrometer. Chemical shifts in CDC131  [2H6] DMSO 
or (CD3)2C0 are referenced to tetramethylsilane. Spin coupling constants (J) are 
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measured in Hertz (Hz) and are rounded to the nearest 0.5 Hz whilst chemical shifts 
() are given in parts per million (ppm). For 1,4-disubstituted benzene rings only the 
3J coupling constant is quoted. The following abbreviations are used in the 
assignment of splitting patterns in the nmr spectra: s (singlet); d (doublet); t (triplet); 
q (quartet); spt (septuplet), dd (doublet of doublets); tspt (triplet of septuplets); tq 
(triplet of quartets); in (multiplet); br (broad). '3C nmr are broad band decoupled and 
are assigned as quartemary carbon (qC), methine (CH), methylene (CH2) and methyl 
(CH,) by use of DEPT. 
Mass spectrometry was carried out using electron impact (El) ionisation and a 
Finnigan 4500 instrument and values are quoted as m/z values 
Hplc was carried out using a Waters 600 Controller/Pump on a Phenomenex 
Sphereclone 5j.im ODS2 column (250 mm x 4.6 mm), eluting with 50 mM sodium 
phosphate buffer (pH 7.0) and acetonitrile at a flow rate of 1.0 cm3min. Eluent 
composition varies between reactions and is detailed, with retention times (RT in 
mm), in Appendix 1. Samples, 10 pJ, were injected using a Waters 717+ autosampler 
with detection at 245 nm using a Waters 486 Tunable Absorbance Detector. 
Chromatograms were recorded and manipulated using Millenium Chromatography 
Manager v.2.15 software. All hplc samples were filtered through 0.45 tm nylon 
syringe filters prior to analysis. 
Chiral gc was carried out using a Shimadzu GC-17 on a Supelco Beta-dex fused 
silica capillary column, 30 in, 0.25 mm ID, 0.25 tm film thickness with helium as 
carrier gas, 125 cm3min'. The injector had a split ratio of 50:1 and was at 250 °C 
whilst the detector was at 300 °C. The column was initially at 150 °C for 50 mm 
before heating to 250 °C at 20 oCmin l Chromatograms were monitored and 
integrated using a Shimadzu C-R6A Chromapac. 
Anhydrous reactions were performed in oven dried glassware (overnight at 150 °C) 
under an argon or nitrogen atmosphere. THF and DCM were dried by distillation 
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from sodium benzophenone ketyl and calcium hydride respectively. TFA was dried 
by distillation from trifluoroacetic anhydride and piperidine was dried over 
potassium hydroxide followed by fractional distillation. Anhydrous diethyl ether and 
pyridine were purchased from Aldrich. Lipase PS was supplied by Amano Enzyme 
Europe Ltd.. All other solvents and reagents were purchased from commercial 
suppliers. 
Where literature data is available the citation is denoted by (lit.,') after the reported 
data, except literature melting points and optical rotations which are quoted. For 
compounds where two regioisomers can exist then the literature is only cited where 
the appropriate isomer has been previously reported. 
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S 	 ~O 
Toluene, AcOH (cat.), Piperidine (cat.). 
AcOH, NaOAc. 
6.2.1 General Procedures. 
General Procedure 1 
Thiazolidine-2,4-dione (47.0 mmol) and 4-substituted benzaldehyde (47.0 mmol) 
were heated at reflüx in toluene (400 cm'), containing piperidine (0.1 cm') and acetic 
acid (0.1 cm'), under Dean and Stark conditions. The solution was allowed to cool 
and the product recovered by filtration and recrystallised from ethanol. The mother 
liquors were reduced and recrystallised to obtain a second crop of crystals. 
General Procedure 2: 
Thiazolidine-2,4-dione (10.0 mmol) and 4-substituted benzaldehyde (10.0 mmol) 
were heated at reflux in toluene (65 cm'), containing piperidine (0.30 mmol) and 
acetic acid (0.30 mmol), under Dean and Stark conditions. The solution was allowed 
to cool and the product recovered by filtration. 
General Procedure 3 
Thiazolidine-2,4-dione (15.0 mmol) and 4-substituted benzaldehyde (15.0 mmol) 
were heated at reflux in toluene (100 cm3), containing piperidine (0.44 mmol) and 
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acetic acid (0.44 mmol), under Dean and Stark conditions. The solution was allowed 
to cool and the product recovered by filtration and recrystallised from ethanol. The 
mother liquors were reduced and recrystallised to obtain a second crop of crystals. 
General Procedure 4: 
Thiazolidine-2,4-dione (42.0 mmol) and 4-substituted benzaldehyde (42.0 mmol) 
were heated at reflux in acetic acid (50 cm'), containing anhydrous sodium acetate 
(58.0 mmol). The acetic acid was removed by co-evaporation with ethanol and the 
crude product was washed with water (2 x 50 cm'). The crude product was 
recrystallised from ethanol and the mother liquors were reduced and recrystallised to 
obtain a second crop of crystals. 
6.2.2 (Z)-5 -benzylidenethiazolidine-2,4-dione 170. 
0 
H- 	NH 
General procedure 2, for 27 h, afforded the title compound as a yellow powder on 
recystallisation from toluene (1.65 g, 8.0 mmol, 80 %); mp 242-244 °C (From 
toluene) (lit.,173 230 °C); RF  (EtOAc-hexane, 1:1) 0.46; Ofliax  (KBr)/cm' 3032 
(olefinic C-H/Ph-H), 1739 (C=O), 1689 (C=O), 1610 (Ph), 1595 (Ph) and 760 (Ph-H) 
(lit., 173); 6H  (250 MHz; [2H6] DMSO) 7.51 (5H, in, Ph), 7.77 (1H, s, olefinic H), 
12.65 (1H, br s, NH) ppm (lit.,173); 8c (63 MHz; [2H6] DMSO) 123.66 (qC), 129.46 
(CH), 130.17 (CH), 130.57 (CH), 131.95 (CH), 133.17 (qC), 167.47 (qC), 168.05 
(qC) ppm; m/z (El) 205 (M, 38 %) and 134 (M-C(0)NHC(0), 100); (Found: M (El), 
205.01933. C10H7NO2S requires 205.01975). 
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6.2.3 (Z)-5-(4-hydroxybenzylidene)thiazolidine-2,4-djone 171. 
HOm NH 
General procedure 2, for 27 h, afforded the title compound as a yellow powder on 
recrystallisation from ethanol (1.69 g, 7.56 mmol, 76 %); mp 291-293 °C (From 
toluene) 	174  >290 °C); RF (EtOAc-hexane, 1:1) 0.21; Umax (KBr)Icm' 3404 (0-H 
stretch), 2996 (olefinic C-H/Ph-H), 1726 (C=0), 1677 (C=0), 1592 (Ph), 1573 (Ph), 
1510 (Ph) and 826 (Ph-H); oH (200 MHz; [2H6] DMSO) 6.91 (2H, d, J9.0, Ph), 7.45 
(2H, d, J9.0, Ph), 7.69 (1H, s, olefinic II), 10.36 (1H, br s, OR), 12.46 (1H, br s, Nil) 
ppm; 8c (50 MHz; [2H6] DMSO) 102.55 (CH), 116.37 (CH), 119.02 (qC), 123.98 
(qC), 132.44 (CH), 159.93 (qC), 167.55 (qC), 168.10 (qC) ppm; m/z (El) 221 (M, 99 
%) and 150 (M-C(0)NHC(0), 100); (Found: M (El), 221.01477. C10H7NO3S 
requires 221.01466). 
6.2.4 (Z)-5 -(4-methoxybenzylidene)thiazolidine-2,4-dione 172. 
NH 
MeO  
General procedure 1, for 25.5 h, afforded the title compound as a yellow fibrous solid 
(8.72 g, 37.1 mmol, 75 %); mp 212-213 °C (from EtOH) (lit.,173 210 °C); RF 
(EtOAc-petroleum ether (bp 40-65 °C), 1:1) 0.49; (Found : C, 55.76; H, 3.69; N, 
5.80. C11H9NO3S requires C, 56.17; H, 3.83; N, 5.96 %); Um , (KBr)/cm' 3017 
(olefinic C-H/Ph-H), 2771 (CH3), 1727 (C=0), 1700 (C=0), 1580 (Ph), 1510 (Ph), 
1468 (CH3), and 823 (Ph-H) (lit.,173); OH  (250 MHz; [ 2H6] DMSO) 3.81 (3H, s, 
OCH3), 7.07 (2H, d, J9.0, Ph), 7.53 (2H, d, J9.0, Ph), 7.72 (1H, s, olefinic B) ppm; 
(63MHz; [ 2H6] DMSO) 55.57 (CH3), 115.00 (CH), 120.41 (qC), 125.61 (qC), 
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131.94 (CH), 132.19 (CH), 161.11 (qC), 167.58 (qC), 168.09 (qC) ppm; m/z (El) 235 
(M, 31 %) and 164 (M-C(0)NHC(0), 100); (Found M (El), 235.03067. C11H9NO3S 
requires 235.03032). 
6.2.5 (Z)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione 173. 
NH 
General procedure 3, for 20 h, afforded the title compound as yellow needles (2.41 g, 
9.67 mmol, 65 %); mp 189-191 °C (From EtOH); RF (EtOAc-petroleum ether (bp 
40-65 °C), 1:1) 0.69; (Found : C, 57.88; H, 4.42; N, 5.67. C12H11NO3S requires C, 
57.82; H, 4.45; N, 5.62 %); Umax  (KBr)/cm' 2983 (CH2/CH3), 1739 (C=O), 1686 
(C=O), 1593 (Ph), 1568 (Ph), 1510 (Ph), 1478 (CH2/CH3), 1392 (CH3), 828 (Ph-H) 
and 719 (CH2); H  (250 MHz; [2H6] DMSO) 1.32 (3H, t, J7.0, OCH2CH3), 4.05 (2H, 
q, J 7.0, OCH2CH3), 7.02 (2H, d, J 9.0, Ph), 7.47 (211, d, J 9.0, Ph), 7.68 (111, s, 
olefinic H), 12.48 (1H, br s, NH) ppm; 6 (63MHz; [2H6] DMSO) 14.59 (CH3), 63.60 
(CH2), 115.31 (CH), 120.17 (qC), 125.41 (qC), 131.98 (CH), 132.19 (CH), 160.40 
(qC), 167.50 (qC), 168.03 (qC) ppm; m/z (El) 249 (M, 27 %) and 178 (M-
C(0)NHC(0), 100); (Found: M (El), 249.04600 (C12H11NO3S requires 249.04597). 




General procedure 3, for 18 h, afforded the title compound as a yellow powder (2.81 
g, 10.7 mmol, 71 %); mp 189-190 °C (From EtOH); RF  (EtOAc-petroleum ether (bp 
121 
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40-65 °C), 1:1) 0.66; (Found : C, 59.29; H, 4.96; N, 5.30. C13H13NO3S requires C, 
59.30; H, 4.98; N, 5.32 %); Umax  (KBr)/cm' 2964 (CH2ICH3), 1736 (C=O), 1687 
(C0), 1591 (Ph), 1568 (Ph), 1513 (Ph), 1474 (CH2/CH3), 828 (Ph-H) and 729 
(CH2); H (250 MHz; [2  H6]DMSO) 0.95 (3H, t, J7.5, OCH2CH2CH3), 1.71 (2H, dd, J 
7.0 7.5, OCH2CH2CH3), 3.94 (2H, t, J 7.0, OCH2CH2CH3), 7.01 (2H, d, J 9.0, Ph), 
7.47 (2H, d, J 9.0, Ph), 7.68 (1H, s, olefinic H), 12.47 (1H, br s, NH) ppm; E 
(63MHz; [2H6] DMSO) 10.38 (CH3), 22.03 (CH2), 69.36 (CH2), 115.31 (CH), 120.16 
(qC), 125.39 (qC), 131.96 (CH), 132.16 (CH), 160.53 (qC), 167.49 (qC), 168.00 (qC) 
ppm; m/z (El) 263 (M, 24 %) and 192 (M-C(0)NIHC(0), 50); (Found M (El), 
263.06124. C13H13NO3S requires 263.06162). 
6.2.7 (Z)-5-(4-n-butoxybenzylidene)thiazolidine-2,4-dione 175. 
0 
I 	NH 
General procedure 3, for 22.5 h, afforded the title compound as a yellow powder 
(3.49 g, 12.6 mmol, 84 %); mp 171-172 °C (From EtOH); RF (EtOAc-petroleum 
ether (bp 40-65 °C), 1:1) 0.67; (Found C, 60.86; H, 5.55; N, 4.99. C14H15NO3S 
requires C, 60.63; H, 5.46; N, 5.05 %); Umax (KBr)/cm 2962 (CH2/CH3), 1741 
(CO), 1693 (C0), 1588 (Ph), 1511 (Ph), 1469 (CH2/CH3), 1389 (CH3) and 830 
(Ph-H); 6H (250 MHz; [2H6] DMSO) 0.91 (3H, t, J7.0, OCH2CH2CH2CH3), 1.43 (2H, 
tq, J 7.0, OCH2CH2CH2CH3)
1  1.67 (2H, tt, J6.5 7.0, OCH2CH2CH2CH3), 4.00 (2H, t, 
J6.5, OCH2CH2CH2CJi3), 7.04 (2H, d, J9.0, Ph), 7.50 (2H, d, J9.0, Ph), 7.71 (1H, s, 
olefinic H), 12.49 (1H, br s, NH) ppm; 6 (63MHz; [2H6] DMSO) 13.74 (CH3), 18.78 
(CH2), 30.69 (CH2), 67.62 (CH2), 115.36 (CH), 120.17 (qC), 125.40 (qC), 131.98 
(CH), 132.17 (CH), 160.56 (qC), 167.49 (qC), 168.01 (qC) ppm; m/z (El) 277 (M, 25 




6.2.8 (Z)-5 -(4-benzyloxybenzylidene)thjazoljdjne-2,4-djone 178. 
H 
General procedure 3, for 24 h, afforded the title compound as a yellow powder (3.79 
g, 12.2 mmol, 82 %); mp 218-220 °C (From EtOH); R (EtOAc-hexane, 1:1) 0.44; 
(Found : C, 65.78; H, 4.35; N, 4.49. C17H13NO3S requires C, 65.58; H, 4.21; N, 4.50 
%); Umax  (KBr)/cm' 3031 (olefinic C-H/Ph-H), 2870 (CH2), 1744 (C=O), 1693 
(C=O), 1600 (Ph), 1565 (Ph), 1508 (Ph), 1456 (CH2), 824 (Ph-H) and 724 (Ph-H); 6H 
(250 MHz; [2H6] DMSO) 5.18 (2H, s, OCH2Ph), 7.16 (2H, d, J9.0, Ph), 7.40 (5H, m, 
Ph), 7.55 (2H, d, J 9.0, Ph), 7.74 (1H, s, olefinic II'), 12.52 (1H, br s, NH) ppm; 
(63MHz; [2  H6]DMSO) 69.59 (CH,), 115.79 (CH), 120.49 (qC), 125.77 (qC), 127.90 
(CH), 128.11 (CH), 128.58 (CH), 131.89 (CH), 132.16 (CH), 136.57 (qC), 160.16 
(qC), 167.50 (qC), 168.03 (qC) ppm; m/z (El) 311 (M, 17 %) and 149 (M-
C(0)NHC(0)-CH2Ph, 9); (Found M (El), 311.06120. C17H13NO3S requires 
311.06162). 




General procedure 3, for 24 h, afforded the title compound as a yellow solid (2.72 g, 
10.8 mmol, 72 %); mp 206-208 °C (From EtOH); RF  (EtOAc-hexane, 1:1) 0.50; Umax 
(KBr)/cm' 2998 (olefinic C-H/Ph-H), 1737 (C=O), 1685 (C=O), 1605 (Ph), 1585 
(Ph), 1430 (CH3) and 814 (Ph-H); 6H  (250 MHz; [2H6] DMSO) 2.48 (3H, s, SCH3), 
123 
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7.33 (2H, d, J 8.5, Ph), 7.46 (2H, d, J 8.5, Ph), 7.69 (1H, s, olefinic II), 12.56 (1H, br 
s, NI]) ppm; 8c (63MHz; [2 H6]DMSO) 14.16 (CH,), 122.03 (qC), 125.78 (CH), 
129.20 (qC), 130.58 (CH), 131.58 (CH), 142.47 (qC), 167.49 (qC), 167.93 (qC) ppm; 
m/z (El) 251 (M, 69%) and 180 (M-C(0)NHC(0), 100); (Found M(EI), 25 1.00738. 
C1 1 H9NO2S2 requires 251.00747). 




General procedure 3, for 24 h, afforded the title compound as a yellow powder (1.20 
g, 5.48 mmol, 37 %); mp 222-224 °C (From EtOH); RF (EtOAc-hexane, 1:1) 0.44; 
Umax (KBr)/cm' 3050 (olefinic C-H/Ph-H), 1737 (C=O), 1686 (C=O), 1600 (Ph), 
1510 (Ph), 1340 (CH3) and 828 (Ph-H); oH (200 MHz; [2H6] DMSO) 2.35 (3H, s, 
CH3), 7.34 (211, d, J 8.5, Ph), 7.48 (211, d, J 8.5, Ph), 7.74 (1H, s, olefinic H) ppm; O 
(50MHz; [2H6] DMSO) 21.19 (CH3), 122.49 (qC), 130.06 (CH), 130.18 (CH), 130.39 
(qC), 131.94 (CH), 140.82 (qC), 167.59 (qC), 168.09 (qC) ppm; m/z (El) 219 (M, 56 




6.2.11 (Z)-5-(4-ethylbenzylidene)thjazoljdjne-2,4-djone 181. 
Q1NH 
General procedure 3, for 24 h, afforded the title compound as a yellow powder (2.73 
g, 11.7 mmol, 78 %); mp 183-185 °C (From EtOH); RF (EtOAc-hexane, 1:1) 0.53; 
(Found C, 61.52; H, 4.91; N, 6.10. C12H11NO2S requires C, 61.79; H, 4.76; N, 6.01 
%); 0 a (KBr)/cm' 3028 (olefinic C-H/Ph-H), 2966 (CH2/CH3), 1737 (C=O), 1688 
(C=O), 1600 (Ph), 1508 (Ph), 1434 (CH2/CH3), 1380 (CH3) and 833 (Ph-H); 5H (250 
MHz; [2H6] DMSO) 1.15 (3H, t, J 7.5, CH2CH3), 2.60 (2H, d, J 7.5, CH2CH3), 7.31 
(2H, d, J 9.0, Ph), 7.44 (2H, d, J 9.0, Ph), 7.70 (1H, s, olefinic H) ppm; & (63MHz; 
[2H6] DMSO) 15.33 (CH3), 28.33 (CH2), 122.49 (qC), 128.91 (CH), 130.37 (CH), 
130.68 (CH), 132.10 (qC), 146.99 (qC), 167.58 (qC), 168.14 (qC) ppm; m/z (El) 233 
(M, 52%) and 162 (M-C(0)NHC(0), 100); (Found M(EI), 233.05059. C12H11NO2S 
requires 233.05 105). 
6.2.12 (7)-5 -(4-fluorobenzylidene)thjazoljdjne-2,4-djone 185. 
General procedure 3, for 24 h, afforded the title compound as a yellow powder (2.17 
g, 9.73 mmol, 65 %); mp 215-216 °C (From EtOH); RF (EtOAc-petroleum ether (bp 
40-65 °C), 2:1) 0.59; (Found : C, 53.81; H, 2.70; N, 6.36. C10H6NO2SF requires C, 
53.81; H, 2.71; N, 6.28 %); Ufliax (KBr)/cm' 3043 (olefinic C-H/Ph-H), 1728 (C=O), 
1700 (C=O), 1595 (Ph), 1585 (Ph), 1506 (Ph), 1250 (C-F), and 832 (Ph-H); OH  (250 
MHz; [2  H6]DMSO) 7.36 (1H, d, J 9.0, Ph), 7.40 (1H, d, J 9.0, Ph), 7.66 (1H, d, J 
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9.0, Ph), 7.68 (111, d, J 9.0, Ph), 7.80 (1H, s, olefinic 11) ppm; 6, (63MHz; [2116] 
DMSO) 121.40 (CH), 121.74 (CH), 128.31 (qC), 134.81 (qC), 135.78 (CH), 137.47 
(CH), 137.61 (CH), 165.93 (qC), 172.35 (qC), 172.83 (qC) ppm; m/z (El) 223 (M, 21 
%) and 152 (M-C(0)NIHC(0), 100); (Found W (El), 223.01095. C10H6NO2SF 
requires 223.0 1033). 





General procedure 1, for 47 h, afforded the title compound as a yellow solid (4.35 g, 
18.2 mmol, 40 %); mp 228-229 °C (From EtOH); RF  (EtOAc-petroleum ether (bp 
40-65 °C), 1:1) 0.52; (Found: C, 49.87; H, 2.33; N, 5.60. C10H6NO2SC1 requires C, 
50.10; H, 2.51; N, 5.85 %); Umax (KBr)/cm' 3050 (olefinic C-H/Ph-H), 1757 (C=O), 
1693 (C=O), 1607 (Ph), 1552 (Ph), 816 (Ph-H) and 741 (C-Cl); 6H  (250 MHz; [2 H61
DMSO), 7.55 (4H, s, Ph), 7.74 (11-1, s, olefinic II) ppm; ö (63MHz; [2H6] DMSO) 
124.38 (qC), 129.42 (CH), 130.51 (CH), 131.67 (CH), 132.00 (qC), 135.10 (qC), 
167.27 (qC), 167.67 (qC) ppm; m/z (El) 239 (M(35C1), 35 %) and 168 (M-









General procedure 3, for 24 h, afforded the title compound as a yellow solid (1.76 g, 
6.20 mmol, 41 %); mp 231-233 °C (From EtOH); RF (EtOAc-hexane, 1:1) 0.47; 
(Found C, 42.25; H, 2.38; N, 4.84. C10H6NO2SBr requires C, 42.41; H, 2.14; N, 
4.95 %); Umax (KBr)/cm 3051 (olefinic C-H/Ph-H), 1748 (C=O), 1719 (C=O), 1610 
(Ph), 1578 (Ph), 816 (Ph-H) and 696 (C-Br); 6. (250 MHz; [2H6J DMSO), 7.53 (211, 
d, J 8.5, Ph), 7.72 (2H, d, J 8.5, Ph), 7.76 (1H, s, olefinic H) ppm; ö, (63MHz; [2146] 
DMSO) 124.03 (qC), 124.53 (qC), 130.63 (CH), 131.90 (CH), 132.43 (CH), 167.34 
(qC), 167.73 (qC) ppm; m/z (El) 283 (M(79Br), 98 %) and 212 (M-C(0)NHC(0), 69); 
(Found M (El), 282.93154 C10H6NO2S79Br requires 282.93026). 
6.2.15 (Z)-5-(4-cyanobenzylidene)thiazolidjne-2,4-djone 189. 
NC 	
NH JO 
General procedure 4, for 3 h, afforded the title compound as a yellow powder (7.48 g, 
32.5 mmol, 77 %); mp 315 °C dec. (From EtOH); RF (EtOAc-petroleum ether (bp 
40-65 °C), 1:1) 0.48; Umax (KBr)/cm' 3003 (olefinic C-H/Ph-H), 2229 (CN), 1717 
(C=O), 1696 (C=O), 1609 (Ph), 1572 (Ph), 1504 (Ph) and 834 (Ph-H); 6H (250 MHz; 
[2H6] DMSO) 7.59 (1H, s, olefinic 1]), 7.72 (211, d, J 8.5, Ph), 7.92 (2H, d, J 8.5, Ph) 
ppm; 8c (63MHz; [2H6] DMSO) 110.82 (qC), 118.80 (qC), 125.02 (CH), 130.04 
(CH), 132.90 (CH), 133.98 (qC), 139.25 (qC), 171.21 (qC), 174.94 (qC) ppm; m/z 
127 
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(El) 230 (M, 14 %) and 159 (M-C(0)NHC(0), 100); (Found M (El), 230.01478. 
C11H6N202S requires 230.01450). 




General procedure 4, for 21 h, afforded the title compound as a light brown powder 
(7.78 g, 31.1 mmol, 78 %); mp 265-266 °C (From EtOH); RF  (EtOAc-petroleum 
ether (bp 40-65 °C), 1:1) 0.64; (Found : C, 47.99; H, 2.55; N, 11.10. C10H6N204S 
requires C, 48.00; H, 2.40; N, 11.20 %); Umax (KBr)/cm' 1752 (C=O), 1675 (C=O), 
1607 (Ph), 1593 (Ph), 1532 (NO2), 1348 (NO2) and 847 (Ph-H); 5H  (250 MHz; [2H6] 
DMSO) 7.75 (2H, d, J9.0, Ph), 7.81 (1H, s, olefinic II), 8.27 (2H, d, J9.0, Ph) ppm; 
(63MHz; [2H6] DMSO) 124.01 (CH), 128.00 (qC), 129.02 (CH), 130.71 (CH), 
139.36 (qC), 147.37 (qC), 166.89 (qC), 167.03 (qC) ppm; m/z (El) 250 (M, 21 %) 
and 179 (M-C(0)NIHC(0), 100); (Found M (El), 250.00483. C10H6N204S requires 
250.00483). 




General procedure 3, for 30 h, afforded the title compound as a yellow powder (2.67 
g, 9.24 mmol, 62 %); mp 146-148 °C (From EtOH); RF  (EtOAc-hexane, 1:1) 0.56; 
(Found: C, 45.39; H, 1.75; N, 5.00. C11 H6NO3SF3 requires C, 45.67; H, 2.09; N, 4.85 
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%); Umax (KBr)/cm' 3046 (olefinic C-HIPh-H), 1755 (C=O), 1722 (C=O), 1611 (Ph), 
1584 (Ph), 1507 (Ph), 1282 (C-F) and 826 (Ph-H); 8H  (250 MHz; [2H6] DMSO) 7.45 
(2H, d, J 8.5, Ph), 7.67 (2H, d, J 8.5, Ph), 7.77 (.1H, s, olefinic H) ppm; ö (63MHz; 
[2H6] DMSO) 118.03 (qC), 121.55 (CH), 124.81 (qC), 130.22 (CH), 132.05 (CH), 
132.32 (qC), 149.22 (qC), 167.27 (qC), 167.70 (qC) ppm; m/z (El) 289 (M, 33 %) 
and 218 (M-C(0)NHC(0), 100); (Found M (El), 289.00147. C11 H6NO3SF3 requires 
289.00205). 
6.3 Knoevenagel Condensation Between 4-Substituted Benzaldehydes and 
Other Five-Membered Heterocycles. 
0 	 0 	 0 
-:" H + ('NH 
	or 
xl___ R 	 x2 	 R J7 2 
Toluene, AcOH (cat.), Piperidine (cat.). 
Piperidine, A. 
NH4CI (aq.), N113(aq.). 




4-Methoxybenzaldehyde (1.39 g, 10.2 mmol) and imidazolidine-2,4-dione (1.01 g, 
10.1 mmol) in anhydrous piperidne (2 cm3) were heated to 130 °C, under argon, for 
75 mm. The heating was removed and hot water (60 °C, 40 cm') added before 
stirring for 2.5 h, whilst being allowed to cool to ambient temperature. The resulting 
green solution was filtered and the filtrate acidified with 10 M hydrochloric acid (5 
cm3). The solution was allowed to stand overnight. The precipitate was recovered by 
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filtration, dried under vacuum and recrystallised from acetic acid. Traces of acetic 
acid were removed by co-evaporation with ethanol to afford the title compound as a 
yellow powder (811 mg, 3.72 mmol, 37 %); mp 249-250 °C (From AcOH) (lit.,175  
247 °C); RF (EtOAc-hexane, 1:1) 0.23; Dma,( (KBr)/cm t 3040 (olefinic C-HIPh-H), 
1757 (C=O), 1712 (C=O), 1654 (C=C), 1601 (Ph), 1517 (Ph), 1438 (CH3), 1371 
(CH3) and 825 (Ph-H) (lit.,175,176); 8H (250 MHz; [2H6] DMSO) 3.79 (3H, s, OCH3), 
6.39 (1H, s, olefinic II), 6.96 (2H, d, J9.0, Ph), 7.59 (2H, d, J9.0, Ph), 10.47 (1H, br 
s, NH), 11.17 (1H, br s, Nil) ppm (lit.,175177); & (63MHz; [2H6] DMSO) 55.38 
(CH3), 108.80 (CH), 114.41 (CH), 125.55 (qC), 126.17 (qC), 131.22 (CH), 155.78 
(qC), 159.55 (qC), 165.74 (qC) ppm (lit.,176'177); m/z (El) 218 (M, 90 %) and 147 
(M-C(0)NHC(0), 100); (Found M (El), 218.06933. C11 H10N203 requires 
218.06914). 




4-Chlorobenzaldehyde (1.41 g, 10.5 mmol) and imidazolidine-2,4-dione (1.05 g, 10.5 
mmol) in anhydrous piperidine (2 cm3) were heated to 130 °C, under argon, for 100 
mm. The heating was removed and hot water (60 °C, 40 cm') added before stirring 
for 1.5 h, whilst being allowed to cool to ambient temperature. The solution was 
acidified with 10 M hydrochloric acid (5 cm3). This was stirred for a further 30 mm 
before the precipitate was recovered by filtration, dried under vacuum and 
recrystallised from acetic acid. Traces of acetic acid were removed by co-evaporation 
with ethanol to afford the title compound as a yellow powder (571 mg, 2.56 mmol, 
26 %); mp 293-294 °C (From AcOH) (lit.,176 295.5-296 °C); RF  (EtOAc-hexane, 
1:1) 0.41; Omax  (KBr)/cm1  3074 (olefinic C-H/Ph-H), 1798 (C0), 1737 (C0), 1666 
(C=C), 1588 (Ph), 826 (Ph-H) and 654 (C-Cl) (lit.,176); OH (250 MHz; [2H6] DMSO) 
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6.40 (1H, s, olefinic H), 7.44 (2H, d, J 8.5, Ph), 7.64 (2H, d, J 8.5, Ph), 10.62 (1H, br 
s, NH), 11.29 (111, br s, NH) (lit.,176177) ppm; & (63MHz; [2H6] DMSO) 106.91 
(CH), 125.58 (qC), 128.84 (CH), 131.13 (CH), 132.05 (qC), 132.89 (qC), 155.80 
(qC), 165.55 (qC) ppm (lit.,176'177); m/z (El) 222 (M(35C1), 99 %) and 151 (M-
C(0)NHC(0), 100); (Found M(EI), 222.02015. C10H7N20235C1 requires 222.01961). 
6.3.3 (Z)-5 -(4-cyanobenzylidene)imidazolidine-2,4-dione 194. 
NH 
NC N 
4-Cyanobenzaldehyde (1.32 g, 10.1 mmol) and imidazolidine-2,4-dione (1.06 g, 10.6 
mmol) in anhydrous piperidine (2 cm) were heated to 130 °C, under argon, for 30 
mm. The heating was removed and hot water (60 °C, 40 cm3) added before 
acidification with 10 M hydrochloric acid (5 CM)  . This was stirred for 1 h before the 
precipitate was recovered by filtration, dried under vacuum and recrystallised from 
acetic acid. Traces of acetic acid were removed by co-evaporation with ethanol to 
afford the title compound as a yellow solid (542 mg, 2.55 mmol, 26 %); mp 319 °C 
dec. (From AcOH) (lit.,177 322 °C dec. (From AcOH)); RF  (EtOAc-hexane, 1:1) 
0.27; Umax  (KBr)/cm' 3048 (olefinic C-H/Ph-H), 2222 (CN), 1798 (C=O), 1737 
(C=O), 1666 (C=C), 1588 (Ph) and 837 (Ph-H); 6H (250 MHz; [2H6] DMSO) 6.44 
(1H, s, olefinic H), 7.78 (2H, d, J8.5, Ph), 7.84 (211, d, J8.5, Ph), 11.15 (2H, br s, 
NH) ppm (lit.,177); 6, (63MHz; [2H6] DMSO) 105.90 (CH), 110.00 (qC), 118.91 
(qC), 129.94 (CH), 130.39 (qC), 132.56 (CH), 137.98 (qC), 155.85 (qC), 165.43 (qC) 
ppm (lit.,177); m/z (El) 213 (M, 51 %) and 142 (M-C(0)NHC(0), 100); (Found M 
(El), 213.05325. C11H7N302 requires 213.05383). 
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6.3.4 (Z)-5-(4-methoxybenzylidene)thiazoljdjne-2-jmjne-4-one 195. 
0 
NH JO MeO 	 s 
NH 
4-Methoxyacetophenone (2.04 g, 15.0 mmol) and thiazolidine-2-imine-4-one (1.74 g, 
15.0 mmol) were heated at reflux in toluene (30 cm'), containing piperidine (38 mg, 
0.45 mmol) and acetic acid (27 mg, 0.45 mmol), under Dean and Stark conditions, 
for 21 h. The reaction mixture was allowed to cool and the crude product recovered 
by filtration and recrystallised from acetic acid. Traces of acetic acid were removed 
by stirring the product with water (150 cm') for Ca. 1 h. This was repeated three 
times, removing the water by filtration each time, before washing with diethyl ether 
(2 x 50 cm') to afford the title compound as a light orange/brown powder (1.06. g, 
4.50 mmol, 30 %); mp 290-291 °C dec.; Umax (KBr)/cm' 3191 (=N-H), 3002 (olefinic 
C-H/Ph-H), 2834 (CH3), 1673 (C=O), 1600 (Ph), 1505 (Ph), 1420 (CH3), 1373 (CH3) 
and 820 (Ph-H); 8H(250 MHz; [2H6] DMSO) 3.80 (3H, s, OCH3), 7.07 (2H, d, J 9. 0, 
Ph), 7.52 (2H, d, J9.0, Ph), 7.55 (1H, s, olefinic If), 9.15 (1H, br s, NH), 9.38 (1H, br 
s, NI]) ppm; & (63MHz; [2H6] DMSO) 55.52 (CH3), 114.89 (CH), 126.61 (qC), 
129.19 (CH), 131.40 (CH), 160.42 (qC), 175.59 (qC), 180.77 (qC) ppm; m/z (El) 234 
(M, 56 %), 233 (M-H, 63) and 164 (M-C(NIH)NHC(0), 81); (Found M (El), 
234.04723. C11H10N202S requires 234.04630). 
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6.3.5 (Z)-5-(4-methoxybenzyljdene)thjazojjdjne-2-thjone.4one 196.141  
0 
MeO jo S  NH 
Thiazolidine-2-thione-4-one (2.29 g, 17.2 mmol) was added to a suspension of 4-
methoxybenzaldehyde (2.33 g, 17.1 mmol) in 32 % aqueous ammonia (1.5 cm'), 
followed by a solution of ammonium chloride (1.50 g, 28.1 mmol) in hot water (3 
cm3). The mixture was stirred for approximately 5 mm, until it had solidified, before 
water (100 cm3) was added and the suspension filtered. The resulting solid was 
recrystallised from ethanol, and a second crop of crystals obtained from the mother 
liquors, to afford the title compound as orange needles (2.55 g, 10.2 mmol, 59 %); 
mp 250-251 °C (From EtOH); RF (EtOAc-hexane, 1:1) 0.62; Umax (KBr)/cm' 3006 
(olefinic C-H/Ph-H), 2838 (CH3), 1686 (C0), 1584 (Ph), 1565 (Ph), 1510 (Ph), 
1445 (CH3), 1200 (C=S) and 824 (Ph-H); 5H (250 MHz; [2H6] DMSO) 3.82 (3H, s, 
OCH3), 7.07 (2H, d, J9.0, Ph), 7.52 (2H, d, J9.0, Ph), 7.56 (1H, s, olefinic B) ppm; 
S (63MHz; [2H6] DMSO) 55.63 (CH3), 115.13 (CH), 122.28 (qC), 125.54 (qC), 
131.94 (CH), 132.74 (CH), 161.41 (qC), 169.46 (qC), 195.51 (qC) ppm; m/z (El) 251 




6.4 Knoevenagel Condensation Between Thiazolidine-2,4-dione and 2-, 3-, Di- 
or Tr-substituted Benzaldehydes. 
0 	0 
10 




6.4.1 General Procedure. 
General Procedure 1 
Thiazolidine-2,4-dione (15.0 mmol) and the appropriate benzaldehyde (15.0 mmol) 
were heated at reflux in toluene (40 cm'), containing piperidine (0.45 mmol) and 
acetic acid (0.45 mmol), under Dean and Stark conditions. The solution was allowed 
to cool and the product recovered by filtration. 
General Procedure 2 
Thiazolidine-2,4-dione (6.00 mmol) and the appropriate benzaldehyde (6.00 mmol) 
were heated at reflux in toluene (40 cm'), containing pipendine (0.18 mmol) and 
acetic acid (0.18 mmol), under Dean and Stark conditions. The solution was allowed 
to cool and the product recovered by filtration and recrystallised from ethanol. The 
mother liquors were reduced and recrystallised to obtain a second crop of crystals. 
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6.4.2 (Z)-5-(2-methoxybenzylidene)thiazolidine-2,4-djone 197. 
OMe 
6#ThANH 
General procedure 1, for 24 h, afforded the title compound as a yellow powder on 
recrystallisation from ethanol (2.72 g, 11.6 mmol, 77 %); mp 238-239 °C (From 
EtOH); RF (EtOAc-hexane, 1:1) 0.38; Umax (KBr)/cm' 3012 (olefinic C-H/Ph-H), 
2841 (CH3), 2770 (Cl3), 1740 (C=O), 1695 (C=O), .1586 (Ph), 1461 (CH,) and 755 
(Ph-H); 8H (250 MHz; [2H6] DMSO) 3.85 (3H, s, OCH3), 7.06 (2H, m, Ph), 7.40 (2H, 
m, Ph), 7.94 (1H, s, olefinic II), 12.53 (1H, br s, Nil) ppm; & (63MHz; [2 H6] DMSO) 
55.81 (CH3), 111.87 (CH), 120.97 (CH), 121.57 (qC), 123.41 (qC), 126.61 (CH), 
128.64 (CH), 132.44 (CH), 158.14 (qC), 167.46 (qC), 168.18 (qC) ppm; m/z (El) 235 
(M, 40 %) and 164 (M-C(0)NHC(0), 100); (Found M (El), 235.03063. C11H9NO3S 
requires 235.03032). 




General procedure 1, for 24 h, afforded the title compound as a yellow powder on 
recrystallisation from ethanol (2.86 g, 12.2 mmol, 81 %); mp 196-198 °C (From 
EtOH); RF (EtOAc-hexane, 1:1) 0.39; Umax (KBr)/cm' 3030 (olefinic C-HIPh-H), 
2809 (Cl3), 1732 (C=O), 1682 (C=0), 1603 (Ph), 1574 (Ph), 1490 (CH3), 1381 
(Cl3) and 771 (Ph-H); 6 (200 MHz; [2H6] DMSO) 3.79 (3H, s, OCH3), 7.09 (3H, m, 
Ph), 7.44 (11, t, J 8.0, Ph), 7.75 (1H, s, olefinic ii), 12.65 (1H, br s, Nil) ppm; 6 
(63MHz; [2H6] DMSO) 55.39 (Cl3), 115.41 (CH), 116.39 (CH), 122.02 (CH), 
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Experimental: Synthesis. 
124.00 (qC), 130.53 (CH), 131.87 (CH), 134.49 (qC), 159.74 (qC), 167.58 (qC), 
167.94 (qC) ppm; m/z (El) 235 (M, 32 %) and 164 (M-C(0)NHC(0), 100); (Found 
M(EI), 235.02929. C11H9NO3S requires 235.03032). 
6.4.4 (Z)-5-(2,6-dimethoxybenzylidene)thiazolidine-2,4-dione 199. 
OMe 
NH 
L OMe  
General procedure 2, for 18 h, afforded the title compound as a yellow powder (1.31 
g, 4.94 mmol, 82 %); mp 233-235 °C (From EtOH); RF (EtOAc-hexane, 1:1) 0.44; 
Umax (KBr)/cm' 3030 (olefrnic C-H/Ph-H), 1727 (C=O), 1691 (CO), 1588 (Ph), 
1573 (Ph), 1478 (CH3), 1386 (CH3) and 777 (Ph-H); 8H  (200 M}lz; [2H6] DMSO) 
3.85 (611, s, 20CH3), 6.73 (2H, d, J 8.5, Ph), 7.43 (1H, t, J 8.5, Ph), 7.90 (111, s, 
olefinic H) ppm; 8c (50MHz; [2H6] DMSO) 55.79 (CH3), 104.22 (CH), 109.88 (qC), 
125.37 (qC), 125.78 (CH), 133.24 (CH), 158.28 (qC), 167.99 (qC), 169.08 (qC) ppm; 
m/z (El) 265 (M, 63 %) and 194 (M-C(0)NHC(0), 100); (Found M(EI), 265.04069. 
C12H11N04S requires 265.04088). 
6.4.5 (Z)-5-(3 .5 -di-t-butyl-4-hydroxybenzylidene)thiazolidine-2,4-djone 200. 
General procedure 1, for 36 h, afforded the title compound as a light brown powder 
on recrystallisation from toluene (3.99 g, 12.0 mmol, 80 %); mp 226-228 °C (From 
toluene) (lit.,174 238-240 °C (from EtOH)); RF  (EtOAc-hexane, 1:1) 0.47; Umax 
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(KBr)/cm' 2964 (CH3), 1743 (C=O), 1687 (C0), 1594 (Ph), 1474 (CH3), 1361 
(CH3) and 808 (Ph-H) (lit.,174); 6H (250 MHz; [2H6] DMSO) 1.39 (18H, s, 6CH3), 
7.34 (2H, s, Ph), 7.73 (1H, s, olefinic II), 12.48 (1H, br s, Nil) ppm (lit.,174); 
(63MHz; [2H6] DMSO) 30.09 (CH3), 34.72 (qC), 119.17 (qC), 124.45 (qC), 127.59 
(CH), 133.54 (CH), 139.47 (qC), 156.67 (qC), 167.51 (qC), 168.15 (qC) ppm; m/z 
(El) 333 (M, 36 %) and 262 (M-C(0)NHC(0), 100); (Found M (El), 333.14034. 
C18H23NO3S requires 333.13987). 
6.5 Knoevenagel Condensation Between Thiazolidine-2,4-dione and 4-
Substituted Benzophenones. 
2 
0 	 0 
+ 	
Toluene, AcOH (cat.), 
	






6.5.1 General Procedure. 
Thiazolidine-2,4-dione (15.0 mmol) and the appropriate phenone (15.0 mmol) were 
heated at reflux in toluene (30 cm'), containing piperidine (0.45 mmol) and acetic 
acid (0.45 mmol), under Dean and Stark conditions,. 
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Experimental: Synthesis. 
6.5.2 (Z)-5-( 1-methyl-i -phenylmethylidene)thiazoljdjne-2,4-djone 201. 
CT NH 
After 50 h the reaction mixture was allowed to cool and the crude product recovered 
by filtration and recrystallised from toluene. The mother liquors were reduced and 
recrystallised from toluene. Both sets of crystals • were combined to afford the title 
compound as a light brown solid (1.65 g, 7.53 mmol, 52 %); mp 124-126 °C (From 
toluene); RF  (EtOAc-petroleum ether (bp 40-65 °C), 1:1) 0.60; (Found: C, 60.06; H, 
4.23; N, 6.40. C11H9NO2S requires C, 60.27; H, 4.11; N, 6.39 %); Umax (KBr)/cm 1 
1737 (C=O), 1678 (C=O), 1582 (Ph), 1567 (Ph), 1489 (CH,), 1377 (CH3) and 767 
(Ph-H); 6H  (250 MHz; [2H6] DMSO) 2.64 (3H, s, CH3), 7.43 (5H, in, Ph) ppm; S 
(63MHz; [2H5] DMSO) 21.62 (CH3)1  122.06 (qC), 126.76 (CH), 129.03 (CH), 129.41 
(qC), 142.19 (qC), 149.61 (qC), 166.67 (qC), 167.72 (qC) ppm; m/z (El) 219 (M, 52 
%) and 148 (M-C(0)NHC(0), 100); (Found M(EI), 219.03576. C11H9NO2S requires 
219.03540). 
6.5.3 (Z)-5-( 1-methyl-i -(4-methoxyphenyl)methylidene))thjazoljdjne-2,4-djone 202. 
MeO jo 	NH 
After 47 h the reaction mixture was allowed to cool and the crude product recovered 
by filtration and recrystallised from toluene. Purification by column chromatography 
on silica gel, with ethyl acetate-petroleum ether (bp 40-65 °C) (1:3) as eluent, 
afforded the title compound as a light green/yellow powder (1.04 g, 4.20 mmol, 29 
%); mp 155-156 °C; RF (EtOAc-petroleum ether (bp 40-65 °C), 1:3) 0.22; (Found 
C, 57.87; H, 4.42; N, 5.62. C12H11NO3S requires C, 57.83; H, 4.42; N, 5.62 %); Um 
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(KBr)/cm 1 2842 (CH3), 2783 (CH3)1  1720 (C0), 1675 (CO), 1586 (Ph), 1560 (Ph), 
1511 (Ph), 1463 (CH3), 1367 (CH3) and 837 (Ph-H); 8H  (250 MHz; [2H6] DMSO) 
2.62 (3H, s, CH3), 3.78 (3H, s, OCH3), 6.99 (2H, d, J9.O, Ph), 7.37 (2H, d, J9.0, Ph), 
12.22 (1H, hr s, NH) ppm; 8c (63MHz; [2H6] DMSO) 21.56 (CH3), 55.38 (CH3), 
114.27 (CH), 120.95 (qC), 128.60 (CH), 134.16 (qC), 149.50 (qC), 160.02 (qC), 
166.67 (qC), 167.87 (qC) ppm; m/z (El) 249 (M, 88 %) and 178 (M-C(0)NHC(0), 
100); (Found M(EI), 249.04574. C12H11NO3S requires 249.04597). 
6.5.4 (Z)-5-0-ethyl-i -(4-methoxyphenyl)methylidene))thiazolidine-2,4-dione 203. 
jcp NH  S 
MeO 
After 10 d the reaction mixture was concentrated under reduced pressure. Purification 
by column chromatography on silica gel, with ethyl acetate-petroleum ether (bp 40-
65 °C) (2:7) as eluent, afforded the title compound as a light yellow powder (1.89 g, 
7.20 mmol, 50%); mp 109-110 °C; R. (EtOAc-petroleum ether (bp 40-65 °C), 1:1) 
0.52; (Found: C, 59.25; H, 5.05; N, 5.30. C13H13NO3S requires C, 59.32; H, 4.94; N, 
5.32 %); Umax  (KBr)/cm' 2972 (CH2/CH3), 1724 (C0), 1683 (C0), 1578 (Ph), 
1560 (Ph), 1510 (Ph), 1456 (CH2/CH3), 1372 (CH3) and 840 (Ph-H); 8H (250 MHz; 
[2H6] DMSO) 0.93 (3H, t, J7.5, CH7CH3), 3.14 (2H, q, J7.5, CH2CH3), 3.78 (3H, s, 
OCH3), 7.00 (2H, d, J9.0, Ph), 7.32 (2H, d, J9.0, Ph), 12.24 (1H, br s, NH) ppm; & 
(63MHz; [2H6] DMSO) 12.89 (CH3), 27.25 (CH2), 55.33 (CH3), 113.28 (CH), 121.31 
(qC), 128.78 (CH), 132.62 (qC), 155.90 (qC), 159.98 (qC), 166.21 (qC), 167.89 (qC) 
ppm; m/z (El) 263 (M, 63 %) and 192 (M-C(0)NT4C(0), 100); (Found W (El), 
263.06089. C13H13NO3S requires 263.06162). 
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6.6.1 General Procedure. 
Sodium hydride, as a 60 % dispersion in mineral oil, (0.25 g, 6.2 mmol) was washed, 
under nitrogen, with hexane (2 x 10 cm') and the resultant powder resuspended in 
THF (40 cm') and DMF (10 cm'). 172 (1.30 g, 5.53 mmol) was added and the 
suspension heated to 40 °C. lodomethane or benzylbromide (6.00 mmol) was added 
and the suspended material instantly dissolved, at which point the solution was 
coolied to ambient temperature. Water (50 cm') was added, followed by sat. aqueous 
sodium chloride (300 cm'), and the mixture was extracted with ethyl acetate (3 x 150 
cm3). The combined organics were washed with water (4 x 200 cm'), dried over 
sodium sulfate and evaporated under reduced pressure to afford the title compound. 




Using iodomethane in the general procedure afforded the title compound as a light 
green powder (1.38 g, 5.54 mmol, 100 %); mp 140-142 °C; RF  (EtOAc-petroleum 
ether (bp 40-65 °C), 1:1) 0.58; (Found : C, 58.04; H, 4.67; N, 5.63. C12H11NO3S 
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requires C, 57.83; H, 4.42; N, 5.62 %) Umax (KBr)/cm' 2941 (CH3), 1731 (C=O), 
1679 (C0), 1592 (Ph), 1511 (Ph), 1434 (CH3), 1365 (CH3) and 830 (Ph-H); 6H(250 
MHz; [2H6] DMSO) 3.09 (3H, s, CH3), 3.83 (3H, s, OCH3), 7.10 (2H, d, J9.0, Ph), 
7.58 (2H, d, J9.0, Ph), 7.86 (1H, s, olefinic H) ppm; 6(63MHz; [2H6] DMSO) 27.87 
(CH3), 55.61 (CH3), 115.05 (CH), 118.34 (qC), 125.54 (qC), 132.31 (CH), 132.71 
(CH), 161.21 (qC), 166.02 (qC), 167.54 (qC) ppm; m/z (El) 249 (M, 52 %), 234 (M-
Cl3, 29) and 164 (M-C(0)N(CH3)C(0), 100); (Found M (El), 249.04605. 
C12H11NO3S requires 249.04597). 
6.6.3 (Z)-3-benzyl-5-(4-methoxybenzylidene)thiazolidine-2..4-dione 205. 
0 
MeO jo~ 
Using benzylbromide in the general procedure afforded the title compound as a 
yellow powder (1.78 g, 5.48 mmol, 100 %); mp 145-147 °C; RF (EtOAc-petroleum 
ether (bp 40-65 °C), 1:1) 0.69; Umax (KBr)/cm1 3012 (olefinic C-H/Ph-H), 2965 
(CH2/CH3), 2930 (CH2/CH3), 1736 (C=O), 1673 (C=O), 1589 (Ph), 1565 (Ph), 1512 
(Ph), 1454 (CH2/CH3), 1379 (CH3), 829 (Ph-H), 746 (Ph-H), 726 (CH2) and 690 (Ph-
H); H (250 MHz; [2H6] DMSO) 3.78 (3H, s, OCH3), 4.83 (2H, s, CH2Ph), 7.11 (2H, 
d, J 9.0, Ph), 7.32 (5H, m, Ph). 7.60 (2H, d, J 9.0, Ph), 7.92 (1H, s, olefinic H) ppm; 
6 (63MHz; [2H6] DMSO) 44.68 (CH2), 55.63 (Cl3), 115.12 (CH), 117.89 (qC), 
125.49 (qC), 127.71 (CH), 127.90 (CH), 128.78 (CH), 132.46 (CH), 133.64 (CH), 
135.67 (qC), 161.39 (qC), 165.75 (qC), 167.50 (qC) ppm; m/z (El) 325 (M, 18 %) 




6.7 Synthesis of (Z)-5-(4-iodobenzylidene)thiazolidine-2,4-dione. 
6.7.1 2-lodoxy benzoic acid 210.145  
	
I 	 Ho" //0 
C OH 
KBr03, H2SO4- 
C I  0 	 0 
Potassium bromate (22.3 g, 133 mmol) was added over 30 min to a vigorously stirred 
mixture of 2-iodobenzoic acid (25.1 g, 101 mmol) in 0.73 M sulfuric acid (215 cm) 
at 55 °C. The heterogeneous mixture was heated to 68 °C and stirred for 3.5 h before 
being cooled on ice. The resultant solid was recovered by filtration and washed 
successively with water (2 x 250 cm3), acetone (250 cm3) and diethyl ether (250 cm3) 
before being dried under vacuum to afford the title compound as a yellow powder 
(24.6 g, 88 mmol, 88 %); 8H  (250 MHz; [2I 6] DMSO) 7.84 (1H, t, J 7.0, Ph), 8.01 
(2H, m, Ph), 8.14 (1H, d, J8.0, Ph) ppm (lit.,  178); 6(63MHz; [2H6] DMSO) 125.13 
(CH), 130.23 (CH), 131.54 (qC), 133.10 (CH), 133.55 (CH), 146.67 (qC), 167.65 
(qC) ppm; m/z (El) 280 (M, 3 %), 248 (M-02, 100), 231 (M-H031  99), 203 (M-CH041  
41) and 76 (M-CH04I, 37). 
6.7.2 4-Iodobenzoic acid methyl ester 207. 
0 	 0 
JLOH MeOH, H2SO4-eOMe 
4-Iodobenzoic acid 206 (12.5 g, 50.0 mmol) was heated at reflux in methanol (150 
cm'), containing 98 % sulfuric acid (1.2 cm'), for 15.5 h. After cooling the solvent 
was removed under reduced pressure and the crude product dissolved in ethyl acetate 
Experimental. Synthesis. 
(500 cm'). This was washed successively with sat. aqueous sodium hydrogen 
carbonate (2 x 100 cm'), sat. aqueous sodium chloride (100 cm') and water (100 
cm'). The organics were dried over magnesium sulfate, 'filtered, and the solvent 
removed under reduced pressure. Recrystallisation from methanol afforded the title 
compound as white crystals. (5.54 g, 33.8 mmol, 94 %); mp 113-115 °C (From 
MeOH) (lit.,179 115.4-115.7 °C); RF (EtOAc-petroleum ether (bp 40-65 °C), 1:1) 
0.79; Umax (Film)/cm" 2979 (CH3), 1719 (C=O), 1586 (Ph), 1452 (CH3), 1392 (CH3) 
and 844 (Ph-H); oH (250 MHz; CDCI3) 3.89 (3H, s, OCH3), 7.98 (4H, s, Ph) ppm 
(lit.,  179); O (63MHz; CDC13) 52.14 (CH3), 100.58 (qC), 129.43 (qC), 130.86 (CH), 
137.55 (CH), 166.41 (qC) ppm; m/z (El) 262 (M, 100 %), 231 (M-OCH31  94) and 
203 (M-0O2CH3, 24); (Found M(EI), 261.94916. C8H7021 requires 261.94908). 





Lithium aluminium hydride (1.91 g, 50.3 mmol) in anhydrous diethyl ether (75 cm3) 
was cooled, under argon, in an ice bath. Ester 207 (11.9 g, 45.2 mmol) was added in 
portions as a solid over 20 mm. Care: Effervescence! After the final addition the 
suspension was allowed to warm to ambient temperature and stirred for a further 1 h. 
Ethyl acetate (100 cm3) was added followed by 1 M hydrochloric acid (100 cm3) 
before filtration through CeliteTM.  The aqueous layer was separated and the organics 
washed successively with sat. aqueous sodium hydrogen carbonate (100 cm3) and sat. 
aqueous sodium chloride (100 cm3). The aqueous layer was washed with ethyl 
acetate (2 x 100 cm3). The organics were combined, washed with water (2 x 100 cm') 
dried over magnesium sulfate and the solvent removed under reduced pressure. 
Purification by column chromatography on silica gel, with ethyl acetate-petroleum 
ether (bp 40-65 °C) (1:4) as eluent afforded the title compound as a white powder 
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(9.25 g, 39.5 mmol, 88 %); mp 73-74 °C (lit.,180 71.8-73.4 °C); RF (EtOAc-
petroleum ether (bp 40-65 °C), 1:1) 0.49; Umax (Film)/cm' 3307 (0-H), 2922 (CH2), 
2868 (CH2), 1587 (Ph), 1484 (CH2), 1410 (0-H), 841 (Ph-H) and 748 (CH2); 5H (250 
MHz; CDC13) 2.55 (1H, br s, 011), 4.54 (2H, s, CH20H), 7.04 (2H, d, J8.5, Ph), 7.64 
(2H, d, J 8.5, Ph) ppm (lit.,180,181); 3c (63MHz; CDCI3) 64.29 (CH2), 92.76 (qC), 
128.60 (CH), 137.38 (CH), 140.25 (qC) ppm; m/z (El) 234 (M, 100 %), 217 (M-OH, 
7) and 203 (M-CH20H, 6); (Found M (El), 233.95467. C7H701 requires 233.95417). 





Alcohol 208 (6.09 g, 26.0 mmol) was added to a solution of IBX (7.90 g, 28.2 mmol) 
in DMSO (30 cm'). The mixture turned yellow and was stirred at ambient 
temperature for 15 mm, during which time a precipitate had formed. The reaction 
was then quenched with water (100 cm') and the suspension filtered through 
CeliteTM. The filtrate was extracted with ethyl acetate (2 x 200 cm'). The organics 
were then combined and washed with water (200 cm'), dried over magnesium 
sulfate, filtered, and the solvent removed under reduced pressure. Purification by 
column chromatography on silica gel, with ethyl acetate-petroleum ether (bp 40-65 
°C) (1:1) as eluent to afford the title compound as an orange powder (4.53g, 19.5 
mmol, 75 %); mp 76-77 °C (lit., 182 65-68 °C); RF (EtOAc-petroleum ether (bp 40-65 
°C), 1:1) 0.79; Umax (Film)/cm' 2827 (CH2), 1688 (C=0), 1584 (Ph) and 804 (Ph-H) 
(lit., 183); oH (250 MHz; CDC13) 7.55 (2H, d, J 8.5, Ph), 7.87 (2H, d, J 8.5, Ph) 9.92 
(1H, s, C(0)11) ppm (lit.,182); 6c (63MHz; CDC13) 102.67 (qC), 130.60 (CH), 135.32 
(qC), 138.18 (CH), 191.22 (CH) ppm; m/z (El) 232 (M, 100 %) and 203 (M-C(0)H, 
42); (Found M(EI), 231.93863. C7H501 requires 23 1.93852). 
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6.7.5 (Z)-5-(4-iodobenzylidene)thiazolidine-2,4-djone 188. 
0 	 0 
+ 	
Toluene, AcOH (cat.), 	
NH 
Piperidine (cat.). 
Thiazolidine-2,4-dione (1.76 g, 15.0 mmol) and aldehyde 209 (3.48 g, 15.0 mmol) 
were heated at reflux in toluene (100 cm3), containing piperidine (36 mg, 0.42 mmol) 
and acetic acid (30 mg, 0.50 mmol), under Dean and Stark conditions for 30 h.. The 
solution was allowed to cool and the precipitate recovered by filtration and 
recrystallised from ethanol. The mother liquors were reduced and recrystallised to 
obtain a second crop of crystals. This afforded the title compound as a yellow powder 
(1.68 g, 5.08 mmol, 34 %); mp 232-234 °C (From EtOH); RF (EtOAc-hexane, 1:1) 
0.57; Umax (KBr)/cm' 3052 (olefinic C-H/Ph-H), 1749 (C=O), 1717 (0=0), 1610 
(Ph), 1578 (Ph), 807 (Ph-H) and 516 (C-I); 6H (200 MHz; [2H6] DMSO) 7.37 (2H, d, 
J8.5, Ph), 7.87 (1H, s, olefinic H) 7.90 (2H, d, J8.5, Ph), 12.66 (111, br s, NI]) ppm; 
(50MHz; [2H6] DMSO) 97.87 (qC), 124.43 (qC), 130.86 (CH), 131.71 (CH), 
132.58 (qC), 138.25 (CH), 167.29 (qC), 167.68 (qC) ppm; m/z (El) 331 (M, 68 %) 




6.8 Synthesis Of (Z)-5-(4-methoxybenzylidene-d)thiazolidine-2,4-dione. 
6.8.1 4-Methoxy benzoic acid methyl ester 212. 
0 	 0 e OH MeOH, H2SO4. 1j'('OMe MeO No MeOL 
4-Methoxybenzoic acid 211 (5.20 g, 34.2 mmol) was heated at reflux in methanol 
(100 cm'), containing 98 % sulfuric acid (1.5 cm'), for 22 h. After cooling the solvent 
was removed under reduced pressure and the crude product dissolved in ethyl acetate 
(150 cm'). This was washed successively with sat. aqueous sodium hydrogen 
carbonate (2 x 50 cm'), sat. aqueous sodium chloride (50 cm') and water (50 cm'). 
The organics were dried over magnesium sulfate, filtered, and the solvent removed 
under reduced pressure to afford the title compound as white crystals (5.54 g, 33.8 
mmol, 99 %); mp 51-53 °C; RF (EtOAc-petroleum ether (bp 40-65 °C), 2:1) 0.89; 
Umax (Film)/cm' 3002 (Ph-H), 2967 (CH3), 2844 (CH,), 1711 (C=O), 1610 (Ph), 1513 
(Ph), 1446 (CH3), 1432 (Cl3) and 848 (Ph-H); oH (250 MHz; CDC13) 3.84 (3H, s, 
OCH3), 3.87 (3H, s, 0CH3), 6.90 (2H, d, J9.0, Ph), 7.98 (2H, d, J9.0, Ph) ppm; O 
(63MHz; CDC13) 51.75 (CH3), 55.29 (CH3), 113.46 (CH), 122.45 (qC), 131.45 (CH), 
163.18 (qC), 166.75 (qC) ppm; m/z (El) 166 (M, 59 %),135 (M-OCH3, 100) and 107 
(M-0O2CH3, 42); (Found M(EI), 166.06303. C9H1003 requires 166.06300). 
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MeO 	 MeO 
Lithium aluminium deuteride (1.40 g, 33.3 mmol) in anhydrous diethyl ether (10 
cm') was cooled, under argon, in an ice bath. A solution of ester 212 (5.00 g, 30.5 
mmol) in anhydrous diethyl ether (50 cm') was added dropwise over 10 mm. The 
solution was allowed to stir on ice for 2 h before warming to ambient temperature 
and stirring for a further 2 h. Ethyl acetate (100 cm') was added followed by 1 M 
hydrochloric acid (75 cm') before filtration through CeliteTM.  The aqueous layer was 
separated and the organics washed successively with sat. aqueous sodium hydrogen 
carbonate (75 cm'), sat. aqueous sodium chloride (75 cm') and water (75 cm'). The 
organics were dried over magnesium sulfate and the solvent removed under reduced 
pressure. Purification by column chromatography on silica gel, with ethyl acetate-
petroleum ether (bp 40-65 °C) (3:1), increasing to ethyl acetate, as eluent, afforded 
the title compound as a light yellow oil (3.01 g, 21.5 mmol, 68 %); mp 23-24 °C 
(lit.,184 25 °C); RF (EtOAc-petroleum ether (bp 40-65 °C), 1:1) 0.56; Umax (Film)/cm' 
3356 (0-11), 3002 (Ph-H), 2956 (CH3), 2908 (CH3), 2835 (CH3), 2177 (CD2), 2138 
(CD2), 2084 (CD2), 1464 (CH3), 1371 (CH3) and 845 (Ph-H) (lit.,185) ; H (250 MHz; 
CDC13) 1.86 (1H, br s, OH), 3.79 (3H, s, OCH3), 6.88 (211, d, J9.0, Ph), 7.27 (211, d, 
J9.0, Ph) ppm (lit., 185,186); 6c (63MHz; CDC13) 55.14 (CH3), 64.13 (tt, J22, CD2), 
113.77 (CH), 128.53 (CH), 132.85 (qC), 159.02 (qC) ppm (lit.,186);  m/z (El) 140 (M, 
100 %), 123 (M-OH, 89) and 107 (M-CD20H, 21); (Found M (El), 140.08109. 
C8H8D202 requires 140.08063). 
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6.8.3 4-Methoxy benzaldehyde-d 214.178  
MeO Q> 
 
OH IBX, DMSO MeO e D 
A solution of alcohol 213 (2.50 g, 17.9 mmol) in DMSO (10 cm') was added to a 
solution of IBX (5.50 g, 19.6 mmol) in DMSO (20 CM)  . The mixture turned yellow 
and was stirred at ambient temperature for 45 min,during which time a precipitate 
had formed. The reaction was then quenched with water. (100 cm') and the 
suspension filtered through CeliteTM.  The filtrate was extracted with ethyl acetate (3 x 
100 cm'). The organics were dried over magnesium sulfate, filtered, and the solvent 
removed under reduced pressure. Purification by column chromatography on silica 
gel, with ethyl acetate-petroleum ether (bp 40-65 °C) (1:1) as eluent, afforded the 
title compound as a light yellow oil (2.17 g, 15.8 mmol, 88 %); RF (EtOAc-petroleum 
ether (bp 40-65 °C), 1:1) 0.73; Umax (Film)/cm' 3002 (Ph-H), 2967 (CH3), 2844 
(CH3), 1711 (C=O), 1446 (CH3) and 848 (Ph-H) (lit.,184187188); 5H (250 MHz; 
CDC13) 3.87 (311, s, OCH3), 6.99 (2H, d, J 9.0, Ph), 7.83 (2H, d, J 9.0, Ph) ppm 
(lit.,189'190); ö (63MHz; CDC13) 55.44 (CH3), 114.17 (CH), 129.65 (qC), 131.85 
(CH), 164.47 (qC), 190.42 (t, J 27, C(0)D) ppm; m/z (El) 137 (M, 82 %) and 107 
(M-C(0)D, 52); (Found M(EI), 137.05898. C8H7D02 requires 137.05871). 
6.8.4 (Z)-5-(4-methoxybenzylidene-d)thiazolidjne-2,4-dione 215. 
o 	o 	 D o 
+ 	
Toluene, AcOH (cat 




S-_.. 	Piperidine (cat.). 
MeO 
0 	 0 
Thiazolidine-2,4-dione (1.19 g, 10.2 mmol) and aldehyde 214 (1.90 g, 13.9 mmol) 
were heated at reflux in toluene (100 CM),  containing piperidine (50 pi)  and acetic 
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acid (50 .il), under Dean and Stark conditions for 12 h. The solution was cooled and 
the precipitate recovered by filtration and recrystallised from ethanol. The mother 
liquors were reduced and recrystallised to obtain a second crop of crystals. This 
afforded the title compound as a yellow powder (1.95 g, 8.3 mmol, 81 %); mp 218-
219 °C (From EtOH); RF (EtOAc-petroleum ether (bp 40-65 °C), 1:1) 0.50; Om 
(KBr)/cm' 3002 (Ph-H), 2778 (CH3), 1731 (C=O), 1696 (C=O), 1584 (Ph), 1509 
(Ph), 1470 (CH3) and 830 (Ph-H); (250 MHz; [2H6] DMSO) 3.82 (3H, s, OCH3), 
7.09(2H, d, J 9.0, Ph), 7.55 (2H, d, J 9.0, Ph), 12.52 (1H, br s, NH) ppm; E 
(63MHz; [2H6] DMSO) 55.60 (Cl3), 115.03 (CH), 120.28 (qC), 125.53 (qC), 132.21 
(CH), 161.10 (qC), 167.57 (qC), 168.09 (qC) ppm; m/z (El) 236 (M, 91 %) and 165 
(M-C(0)NIHC(0), 100); (Found M (El), 236.03692. C11H8DNO3S requires 
236.03660). 
6.9 Synthesis of (Z)-5-(4-propylbenzylidene)thiazolidine-2,4-dione. 
6.9.1 4-Propylbenzaldehyde 216. 
DO OEt 	 0 
H 	
2 M HCI 	
H 
4-Propylbenzaldehyde diethylacetate (2.33 g, 10.5 mmol) was stirred at ambient 
temperature for 1 h in 2 M hydrochloric acid (21.5 cm'). The reaction was quenched 
by neutralisation with sat. aqueous sodium hydrogen carbonate before ethyl acetate 
(100 cm') was added. The layers were separated and the aqueous layer washed with 
ethyl acetate (100 cm'). The organics were combined and washed successively with 
sat. aqueous sodium hydrogen carbonate (100 cm') and water (2 x 100 cm3) before 
being dried with magnesium sulfate. The solvent was removed under reduced 
pressure to afford the title compound as a clear oil (1.30 g, 8.78 mmol, 84 %); RF 
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(EtOAc-petroleum ether (bp 40-65 °C, 1:4) 0.50; Umax (Film)/cm' 3055 (Ph-H), 2963 
(CH2/CH3), 2934 (CH2/CH3), 2872 (CH2/CH3), 1693 (C=O), 1608 (Ph), 1575 (Ph), 
1515 (Ph), 1465 (CH2/CH3), 824 (Ph-H) and 740 (CH2); 6H  (250 MHz; CDCI3) 0.91 
(3H, t, J 7.5, CH2CH2CH3), 1.64 (2H, tq, J 7.5, CH2CH2CH3), 2.63 (2H, t, J 7.5, 
CH2CH2CH3), 7.30 (2H, d, J 8.5, Ph), 7.76 (2H, d, J 8.5, Ph), 9.93 (1H, s, C(0)II) 
ppm; 6c (63MHz; CDCI3) 13.52 (CH3), 23.97 (CH2), 37.98 (CH2), 128.91 (CH), 
129.64 (CH), 134.20 (qC), 149.98 (qC), 191.82 (qC) ppm (lit.,191); m/z (El) 148 (M, 
10 %) and 119 (M-C(0)H, 10); (Found W (El), 148.08904. C10H120 requires 
148.08882). 
6.9.2 (Z)-5-(4-propylbenzylidene)thiazolidine-2,4-dione 182. 
0 	 0 
NH 	
Toluene, AcOH (cat), 	
NH 
Pipendine (cat.). 
Thiazolidine-2,4-dione (817 mg, 6.99 mmol) and aldehyde 216 (1.03 g, 6.96 mmol) 
were heated at reflux in toluene (60 cm'), containing piperidine (16 mg, 0.19 mmol) 
and acetic acid (19 mg, 0.32 mmol), under Dean and Stark conditions for 22 h. The 
solution was allowed to cool to ambient temperature before the solvent was removed 
under reduced pressure. The resultant solid Was recrystallised from ethanol. The 
mother liquors were reduced and recrystallised to obtain a second crop of crystals. 
This afforded the title compound as a yellow powder (1.57 g, 6.4 mmol, 90 %); mp 
163-164 °C (From EtOH); RF  (EtOAc-hexane, 1:1) 0.47; Umax  (KBr)/cm' 3024 
(olefinic C-H/Ph-H), 2928 (CH2ICH3), 2856 (CH2/CH3), 1739 (C0), 1690 (CO), 
1600 (Ph), 1510 (Ph), 1463 (CH2ICH3), 1390 (CH3), 824 (Ph-H) and 735 (CH2); oH 
(250 MHz; [2H6] DMSO) 0.85 (3H, t, J 7.5, CH2CH2CH3), 1.56 (211, tq, J 7.5, 
CH2CH2CH3), 2.55 (2H, t, J 7.5, CH2CH2CH3), 7.29 (2H, d, J 8. 0, Ph), 7.45 (2H, d, J 
8.0, Ph), 7.71 (1H, s, olefinic II) ppm; 8, (63MHz; [2H6] DMSO) 13.78 (CH3), 23.95 
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(CH2), 37.30 (Cl2), 122.48 (qC), 129.48 (CH), 130.29 (CH), 130.70 (qC), 132.10 
(CH), 145.43 (qC), 167.59 (qC), 168.14 (qC) ppm; m/z (El) 247 (M, 67 %) and 176 
(M-C(0)NHC(0), 91); (Found M(EI), 247.06746. C13H13NO2S requires 247.06670). 
6.10 Synthesis of (Z)-5-(4-butylbenzylidene)thiazolidine-2,4-dione. 
6.10.1 4-Butylbenzaldehyde 217. 
EtO OEt 	 0 
H 	
2 M HCI 	
H 
4-Butylbenzaldehyde diethylacetate (3.54 g, 15.0 mmol) was stirred at ambient 
temperature for 1 h in 2 M hydrochloric acid (31 cm3). The reaction was quenched by 
neutralisation with sat. aqueous sodium hydrogen carbonate before ethyl acetate (100 
cm 3)  was added. The layers were separated and the aqueous layer washed with ethyl 
acetate (100 cm'). The organics were combined and washed successively with sat. 
aqueous sodium hydrogen carbonate (100 cm3) and water (2 x 100 cm') before being 
dried with magnesium sulfate. The solvent was removed under reduced pressure to 
afford the title compound as a clear oil (2.32 g, 14.3 mmol, 95 %); RF  (EtOAc-
petroleum ether (bp 40-65 °C, 1:7) 0.59; Umax  (Film)/cm-' 2954 (CH2/CH3), 2933 
(CH2/CH3), 2860 (CH2/CH3), 1694 (C=O), 1606 (Ph), 1576 (Ph), 1516 (Ph), 1466 
(CH2/CH3), 1380 (CH3), 826 (Ph-H) and 740 (CH2) (lit.,192); 6H (250 MHz; CDC13) 
0.90 (3H, t, J7.5, CH2CH2CH2CH3), 1.33 (2H, tq, J7.5, CH2CH2CH2CH3), 1.59 (2H, 
tt, J 7.5, CH2CH2CH2CH3), 2.65 (2H, t, J 7.5, CH2CH2CH2CH3), 7.29 (2H, d, J 8.5, 
Ph), 7.76 (2H, d, J 8.5, Ph), 9.93 (1H, s, C(0)H) ppm (lit.,192);  6c (63M}lz; CDC13) 
13.66 (Cl3), 22.09 (CH2), 32.97 (CH2), 35.66 (CH2), 128.85 (CH), 129.65 (CH), 
134.16 (qC), 150.22 (qC), 191.79 (qC) ppm; m/z (El) 162 (M, 56 %) and 133 (M-
C(0)H, 6); (Found M(EI), 162.10458. C11H140 requires 162.10447). 
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6.10.2 (Z)-5-(4-butylbenzylidene)thiazolidine-2,4-djone 183. 







S 	Pipedine(cat.).  
Thiazolidine-2,4-dione (1.45 g, 12.4 mmol) and aldehyde 217 (2.01 g, 12.4 mmol) 
were heated at reflux in toluene (60 CM),  containing piperidine (30 mg, 0.35 mmol) 
and acetic acid (25 mg, 0.42 mmol), under Dean and Stark conditions for 22 h. The 
solution was allowed to cool before the solvent was removed under reduced pressure. 
The resultant solid was recrystallised from ethanol. The mother liquors were reduced 
and recrystallised to obtain a second crop of crystals. This afforded the title 
compound as a yellow powder (2.85 g, 10.9 mmol, 88 %); mp 159-160 °C (From 
EtOH); RF (EtOAc-hexane, 1:1) 0.52; (Found : C, 64.16; H, 5.94; N, 5.47. 
C14H15NO2S requires C, 64.35; H, 5.79; N, 5.36 %); Umax (KBr)/cm' 3024 (olefinic C-
H/Ph-H), 2926 (CH2/CH3), 2858 (CH2/CH3), 1739 (C=O), 1693 (C=O), 1598 (Ph), 
1508 (Ph), 1468 (CH2/CH3), 1384 (CH3), 823 (Ph-H) and 749 (CH,); 6H  (250 MHz; 
[2H6] DMSO) 0.84 (3H, t, J 7.5, CH2CH2CH2CH3), 1.24 (2H, tq, J 7.5, 
CH2CH2CH2CH3), 1.49 (2H, tt, J 7.5, CH2CH2CH2CH3), 2.54 (2H, t, J 7.5, 
CH2CH2CH2CH3), 7.25 (2H, d, J 8.0, Ph), 7.41 (2H, d, J 8.0, Ph), 7.69 (1H, s, 
olefinic H) ppm; & (63MHz; [2H6] DMSO) 13.92 (CH3), 22.01 (CH2), 32.95 (CH2), 
34.98 (CH2), 122.45 (qC), 129.37 (CH), 130.29 (CH), 130.66 (qC), 132.09 (CH), 
145.60 (qC), 167.58 (qC), 168.11 (qC) ppm; m/z (El) 261 (M, 41 %) and 190 (M-
C(0)NHC(0), 67); (Found M(EI), 261.08335. C14H15NO2S requires 261.08235). 
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6.11 Synthesis of (Z)-5-(4-i-propoxybenzylidene)thiazolidine-2,4-dione. 
6.11.1 4-i-Propoxybenzaldehyde 218. 





4-Hydroxybenzaldehyde (653 mg, 5.35 mmol), 2-iodopropane (1.00 g, 5.89 mmol) 
and potassium carbonate (813 mg, 5.89 mmol) were heated at 55 °C in DMF (40 
cm 3)  for 96 h. The reaction mixture was allowed to cool before the solvent was 
removed under reduced pressure. The crude product was partitioned between water 
(50 cm') and ethyl acetate (100 cm3). The layers were separated and the aqueous 
fraction washed with ethyl acetate (2 x 100 cm3). The organics were combined and 
washed successively with sat. aqueous sodium hydrogen carbonate (100 cm3), sat. 
aqueous sodium chloride (100 cm') and water (100 cm3) before being dried over 
magnesium sulfate. The solvent was removed under reduced pressure and 
purification by column chromatography on silica gel, with ethyl acetate-hexane (1:3) 
as eluent, afforded the title compound as a light yellow oil (598 mg, 3.65 mmol, 68 
%); RF  (EtOAc-hexane, 1:2) 0.58; 0max  (Film)/cm' 3073 (Ph-H), 2979 (CH3), 2936 
(CH3), 2827 (CH3), 1692 (C=O), 1601 (Ph), 1575 (Ph), 1505 (Ph), 1467 (CH3), 1386 
(CH3) and 833 (Ph-H); SH (200 MHz; CDC13) 1.31 (6H, d, J 6.0, OCH(CH3)2), 4.61 
(1H, spt, J 6.0, OCH(CH3)2), 6.91 (2H, d, J 9.0, Ph), 7.53 (2H, d, J 9.0, Ph), 9.80 
(1H, s, C(0)II) ppm; & (63MHz; CDC13) 21.60 (CH3), 70.06 (CH), 115.35 (CH), 
129.29 (qC), 131.74 (CH), 162.93 (qC), 190.44 (qC) ppm;m/z (El) 164 (M, 14 %) 
and 121 (M-CA,  100); (Found M(EI), 164.08373. C10H1202 requires 164.08373). 
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6.11.2 (Z)-5-(4-i-propoxybenzyljdenethjazo1jdjne-2,4-djone 176. 
0 
+ 	1NH 
Toluene, AcOH (cat 
"~Oe 	
S.._.. 	Piperidine (cat.). 
0 
)O 1 NH 
Thiazolidine-2,4-dione (339 mg, 2.90 mmol) and aldehyde 218 (476 mg, 2.90 mmol) 
were heated at reflux in toluene (20 cm'), containing piperidine (1 drop) and acetic 
acid (1 drop), under Dean and Stark conditions for 18 h. The solution was allowed to 
cool and the precipitate recovered by filtration. Recrystallised from ethanol afforded 
the title compound as a yellow powder (336 mg, 1.28 mmol, 44 %); mp 201-203 °C 
(From EtOH); RF (EtOAc-hexane, 1:1) 0.59; (Found : C, 59.22; H, 5.03; N, 5.28. 
C13H13NO3S requires C, 59.30; H, 4.98; N, 5.32 %); Umax (KBr)/cm' 2973 (CH3), 
2930 (CH3), 1736 (C=O), 1688 (C=O), 1592 (Ph), 1567 (Ph), 1511 (Ph), 1435 (CH3), 
1385 (CH3) and 830 (Ph-H); 6H (200 MHz; [2H6] DMSO) 1.28 (6H, d, J 6.0, 
OCH(CH3)2), 4.72 (1H, spt, J6.0, OCH(CH3)2), 7.06 (2H, d, J9.0, Ph), 7.53 (2H, d, J 
9.0, Ph), 7.74 (1H, s, olefinic CH), 10.73 (1H, br s, NI]) ppm; 8c (50MHz; [2H6] 
DMSO) 21.78 (CH3), 69.75 (CH), 116.24 (CH), 120.12 (qC), 125.18 (qC), 132.00 
(CH), 132.27 (CH), 159.44 (qC), 167.56 (qC), 168.06 (qC) ppm; ; m/z (El) 263 (M, 
24 %), 221 (M-CA, 25), 192 (M-C(0)NHC(0), 2) and 150 (M-C3H7-C(0)NRC(0), 
100); (Found M(EI), 263.06095. C13H13NO3S requires 263.06162). 
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6.12 Synthesis of (Z)-5-(4-i-butoxybenzylidene)thiazolidine-2,4-dione. 









4-Hydroxybenzaldehyde (2.44 g, 20.0 mmol), 1-iodo-2-methylpropane (4.05 g, 22.0 
mmol) and potassium carbonate (3.04 g, 22.0 mmol) were heated at 55 °C in DMF 
(148 cm) for 120 h. The reaction mixture was allowed to cool before the solvent was 
removed under reduced pressure. The crude product was partitioned between water 
(50 cm') and, ethyl acetate (150 cm'). The layers were separated and the aqueous 
fraction washed with ethyl acetate (3 x 150 cm). The organics were combined and 
washed successively with sat. aqueous sodium hydrogen carbonate (100 cm3), sat. 
aqueous sodium chloride (100 cm3) and water (100 cm3) before being dried over 
magnesium sulfate. The solvent was removed under reduced pressure and 
purification by column chromatography on silica gel, with ethyl acetate-hexane (1:9) 
as eluent, afforded the title compound as a light yellow oil (849 mg, 4.77 mmol, 22 
%); RF  (EtOAc-hexane, 1:1) 0.44; Umax (Film)/cm' 3075 (Ph-H), 2961 (CH2/CH3), 
2933 (CH2/CH3), 2874 (CH2ICH3), 1694 (C=O), 1601 (Ph), 1578 (Ph), 1511 (Ph), 
1471 (CH2/CH3), 1396 (CH3) and 832 (Ph-H); 6,1 (250 MHz; CDC13) 0.99 (6H, d, J 
6.5, OCH2CH(CH3)2), 2.05 (1H, tspt, J 6.5, OCH2CH(CH3)2), 3.74 (2H, d, J 6.5, 
OCH2CH(CH3)2), 6.93 (2H, d, J9.0, Ph), 7.76 (2H, d, J9.0, Ph), 9.81 (1H, s, C(0)R) 
ppm; 6 (63MHz; CDC13) 18.87 (CH3), 27.92 (CH), 74.40 (CH2), 114.51 (CH), 
129:51 (qC), 131.67 (CH), 164.10 (qC), 190.45 (qC) ppm; m/z (El) 178 (M, 21 %) 
and 122 (M-C4H8, 58); (Found M(EI), 178.09899. C, H1402 requires 178.09938). 
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6.12.2 (Z)-5-(4-i-butoxybenzylidenethiazolidine-2.4-dione 177. 
0 	 o 	 0 
Toluene, 
H 
+ 	ç_J( N 	
AcOH (cat.), 	
1'NH oe S Pipedine(cat.). 	 IOJ'  r 0 
Thiazolidine-2,4-dione (475 mg, 4.06 mmol) and aldehyde 219 (724 mg, 4.06 mmol) 
were heated at reflux in toluene (27 cm'), containing piperidine (10 mg, 0.12 mmol) 
and acetic acid (12 mg, 0.20 mmol), under Dean and Stark conditions for 18 h. The 
solution was allowed to cool and the precipitate recovered by filtration. 
Recrystallisation from ethanol afforded the title compound as a yellow powder (723 
mg, 2.61 mmol, 64 %); mp 176-178 °C (From EtOH); RF  (EtOAc-hexane, 1:1) 0.48; 
(Found : C, 60.70; H, 5.53; N, 5.00. C14H15NO3S requires C, 60.63; H, 5.46; N, 5.05 
%); Umax  (KBr)/cm' 3024 (olefinic C-H/Ph-H), 2953 (CH2/CH3), 1737 (C=O), 1687 
(C0), 1591 (Ph), 1568 (Ph), 1511 (Ph), 1467 (CH2/CH3), 1400 (CH3) and 808 (Ph-
H); 6H (250 MHz; [2H6] DM SO) 0.95 (6H, d, J6.5, OCH2CH(CH3)2), 2.00 (1H, tspt, J 
6.5, OCH2CH(CH3)2), 3.77 (2H, d, J 6.5, OCH2CH(CH3)2), 7.03 (2H, d, J 9.0, Ph), 
7.48 (2H, d, J 9.0, Ph), 7.69 (1H, s, olefinic Cl]) ppm; 6 (63MHz; [2H6] DMSO) 
19.00 (CH3), 27.72 (CH), 74.05 (CH2), 115.36 (CH), 120.19 (qC), 125.42 (qC), 
131.95 (CH), 132.14 (CH), 160.61 (qC), 167.47 (qC), 167.97 (qC) ppm; m/z (El) 277 
(M, 36 %), 221 (M-CA,  26), 206 (M-C(0)NHC(0), 10) and 150 (M-C4H8-
C(0)NHC(0), 100); (Found M(EI), 277.078 19. C14H15NO3S requires 277.07727). 
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6.13 Synthesis Of (Z)-5-(4-benzylbenzylidene)thiazolidine-2,4-dione. 





Sodium borohydride (2.28 g, 60.0 mmol) was added slowly to anhydrous TFA (50 
cm') which was cooled on ice under argon. This was warmed to ambient temperature 
and 4-bromobenzophenone 220 (2.61 g, 10.0 mmol) was added in anhydrous DCM 
(30 cm'). The resultant mixture was stirred at ambient temperature for a further 2 h 
before being cooled on ice and diluted with water (50 cm'). After neutralisation with 
sodium hydroxide pellets the mixture was extracted with diethyl ether (3 x 100 cm'). 
The organics were combined and washed successively with water (75 CM 3), sat. 
aqueous sodium chloride (75 cm') and water (75 cm') before being dried over 
magnesium sulfate. The solvent was removed under reduced pressure and 
purification by column chromatography on silica gel, with ethyl acetate-hexane' 
(1:10) as eluent, afforded the title compound as a clear oil (1.88 g, 7.59 mmol, 76 %); 
RF  (EtOAc-hexane, 1:10) 0.62; Umax  (Film)/cm' 3027 (Ph-H), 2910 (CH2), 2844 
(CH2), 1603 (Ph), 1585 (Ph), 1486 (CH2), 844 (Ph-H), 742 (Ph-H), 710 (C-Br) and 
697 (Ph-H) (lit.,193); 8H (250 MHz; CDC13) 3.97 (2H, s, CH2), 7.10 (2H, d, J8.5, Ph), 
7.22 (3H, m, Ph), 7.36 (2H, d, J 8.5, Ph), 7.45 (2H, d, J 8.5, Ph) ppm (lit.,194); ö 
(63MHz; CDC13) 41.13 (CH2), 119.78 (qC), 126.16 (CH), 128.43 (CH), 128.71 (CH), 
130.51 (CH), 131.36 (CH), 139.94 (qC), 140.28 (qC) ppm (lit.,195); m/z (El) 246 








N-formylpiperidine, Et 20. 
To a solution of 4-benzylbromobenzene 221 (1.50 g, 6.01 mmol) in anhydrous 
diethyl ether (6 cm'), under nitrogen, was added butyl lithium (4.3 cm3 of a 1.4 M 
solution in hexanes, 6.02 mmol). To this a solution of N-formylpiperidine (680 mg, 
6.02 mmol) in anhydrous diethyl ether (15 cm) was added over 2 mm. The resultant 
solution was stirred for 15 min at ambient temperature, during which time a white 
precipitate had formed. The mixture was acidified to pH 2 with 3 M hydrochloric 
acid then extracted with diethyl ether (3 x 25 CM) . The organics were combined and 
washed successively with sat. aqueous sodium hydrogen carbonate (40 cm3), sat. 
aqueous sodium chloride (40 cm') and water (40 cm3). The organics were dried over 
magnesium sulfate, filtered, and the solvent removed under reduced pressure to 
afford the title compound as a clear oil (1.18 g, 6.02 mmol, 100 %); RF (EtOAc-
hexane, 1:1) 0.70; Ufliax (Film)/cm' 3026 (Ph-H), 2967 (CH,), 2848 (CH2), 2717 
(C(0)-H), 1694 (C=O), 1602 (Ph), 1574 (Ph), 1494 (CH2), 734 (Ph-H), 722 (CH2) 
and 698 (Ph-H); 8H (250 MHz; CDC13) 4.07 (2H, s, CH2), 7.29 (7H, in, Ph), 7.82 (2H, 
d, J 8.0, Ph), 9.97 (1H, s, C(0)H) ppm; & (63MHz; CDC13) 41.84 (CH2), 126.30 
(CH), 128.47 (CH), 128.75 (CH), 129.33 (CH), 129.81 (CH), 134.42 (qC), 139.54 
(qC) 148.20 (qC), 191.74 (qC) ppm; m/z (El) 196 (M, 31 %) and 167 (M-C(0)H, 
100); (Found M(EI), 196.08854. C14H120 requires 196.08882). 
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6.13.3 (Z)-5-(4-benzylbenzylidene)thiazolidine-2,4-dione 184. 
	
0 	 0 0 	('/ Toluene, 
AcOH (cat.), 
NH 
+ 	 Piperidine (cat.). 
Thiazolidine-2,4-dione (537 mg, 4.59 mmol) and aldehyde 222 (900 mg, 4.59 mmol) 
were heated at reflux in toluene (52 cm'), containing piperidine (12 mg, 0.14 mmol) 
and acetic acid (8 mg, 0.14 mmol), under Dean and Stark conditions for 22 h.. The 
solution was allowed to cool before the solvent was removed under reduced pressure. 
Recrystallisation of the resultant solid from ethanol afforded the title compound as a 
yellow powder (2.85 g, 10.9 mmol, 88 %); mp 209-211 °C (From EtOH); RF 
(EtOAc-hexane, 1:1) 0.50; (Found: C, 68.85; H, 4.44; N, 4.85. C17H13NO2S requires 
C, 69.14; H, 4.44; N, 4.75 %); Umax (KBr)/cm' 3020 (olefinic C-H/Ph-H), 2777 
(CH2), 1742 (C=O), 1690 (C=O), 1594 (Ph), 1508 (Ph), 1493 (CH2), 837 (Ph-H), 746 
(Ph-H), 723 (CH2) and 685 (Ph-H); 8H (250 MHz; [2H6] DMSO) 3.98 (2H, s, CH2), 
7.24 (5H, m, Ph), 7.43 (2H, d, J8.5, Ph), 7.51 (2H, d, J8.5, Ph), 7.74 (1H, s, olefinic 
H) ppm; O (63MHz; [2H6] DMSO) 41.01 (CH2), 122.83 (qC), 126.31 (CH), 128.68 
(CH), 128.90 (CH), 129.76 (CH), 130.42 (CH), 130.97 (qC), 131.81 (CH), 145.67 
(qC), 144.32 (qC), 167.50 (qC), 168.07 (qC) ppm; m/z (El) 295 (M, 11 %) and 167 
(M-C(0)NHC(0), 33); (Found M(EI), 295.06794. C17H13NO2S requires 295.06670). 
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6.14 Synthesis Of (Z)-5-[(2R- and 2S-benzyl-3,4-dihydro-2H-1-benzopyran-6-
yl)methylidene] thiazolidine-2,4-dione. 
6.14.1 Chromone-2-carboxylic acid 225.153 
0 0 
+ EtO_ j(0Et 
OH 	 0 
0 
(i) NaOEt, EtOH 
(ii) HCI 	 OH 
0 
A mixture of 2-hydroxyacetophenone 223 (66.4 g, 488 mmol) and diethyl oxalate 
224 (107 g, 734 mmol) was added rapidly, with stirring, to a solution of sodium 
ethoxide (33.0 g, 486 mmol) in ethanol (230 cm') and the mixture heated to 65 °C. 
After 30 min a yellow precipitate had formed and hydrochloric acid (300 cm', s.g. 
1.18) in water (350 cm') was added and the solution heated under reflux for 4 h. 
After cooling overnight the pale brown precipitate was recovered by filtration and 
recrystallised from 70 % ethanol in water, and a second crop of crystals was obtained 
from the mother liquors, to afford the title compound as white crystals which were 
pure enough for use in the next stage (58.8 g, 309 mmol, 64 %); mp 250-251 °C dec. 
(From EtOH/H20) (lit.,153 250-251 °C dec.); RF  (EtOAc-hexane, 1:1) 0.16; Umax 
(Film)/cm' 3083 (olefinic C-H/Ph-H), 1733 (C=O), 1635 (C=O), 1588 (Ph), 1228 
(C-O) and 749 (Ph-H); 6H  (250 MHz; [2H6] DMSO) 6.88 (1H, s, olefinic II), 7.50 
(1H, dd, J 8.0, Ph), 7.69 (1H, d, J 8.5, Ph), 7.85 (1H, dd, J 8.5, Ph), 8.02 (1H, d, J 
8.0, Ph) ppm; 8 (63MHz; [2H6] DMSO) 113.62 (CH), 118.97 (CH), 123.84 (qC), 
125.03 (CH), 126.14 (CH), 135.26 (CH), 153.32 (qC), 155.55 (qC), 161.51 (qC), 
177.69 (qC) ppm; m/z (El) 190 (M, 25 %) and 149 (M-C(0)CH, 100); (Found W 
(El), 190.02671. C10H604 requires 190.02661). 
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6.14.2 2,3-Dihydrobenzopyran-2-carboxylic acid 226.154 
0 
H2, 5 % Pd/C, AcOH, 
OH 	 2 
a%O 	
3.5 kgcm, 70 °C. 
0 
C 01Y OH 
0 
Acid 225 (69.0 g, 363 mmol) in acetic acid (400 cm3), containing 5 % PdJC (7.50 g), 
was shaken at 70 °C under hydrogen at 3.5 kgcm 2 . The pressure was reapplied every 
time it dropped below 2.5 kgcm 2. After the uptake of hydrogen had ceased the 
catalyst was removed by filtration through CeliteTM  which was washed with acetic 
acid (100 cm'). The filtrates were combined and the acetic acid removed under 
reduced pressure. The crude product was taken up in diethyl ether (500 cm3) and 
washed with sat. aqueous sodium hydrogen carbonate (2 x 125 cm'). The aqueous 
washings were combined and acidified to pH 1 with 2 M hydrochloric acid and 
extracted with diethyl ether (3 x 250 CM)  . The organics were combined and dried 
over magnesium sulfate before the solvent was removed under reduced pressure to 
afford the title compound as white crystals, which were pure enough to be used in the 
next stage (36.2 g, 203 mmol, 56 %); mp 91-92 °C (lit.,154 93-96 °C); RF (EtOAc-
hexane, 1:1) 0.00; Umax (Film)/cm' 3041 (Ph-H), 2935 (CH2), 1728 (C0), 1612 
(Ph), 1584 (Ph), 1488 (Ph), 1458 (CH2), 1227 (C-O) and 753 (Ph-H); 8H  (250 MHz; 
[2H6] DMSO) 2.11 (2H, m, CH2), 2.66 (2H, m, CH2), 4.76 (1H, dd, J 4.0 6.5, 
CHC(0)OH), 6.81 (1H, dd, J7.0, Ph), 6.83 (1H, d, J8.5, Ph), 7.05 (1H, d, J7.0, Ph), 
7.06 (1H, dd, J 8.5, Ph) ppm; ö (63MHz; [2  H6]DMSO) 22.63 (CH2), 24.03 (CH2), 
72.94 (CH), 116.46 (CH), 120.40 (CH), 121.72 (qC), 127.44 (CH), 129.70 (CH), 
153.55 (qC), 172.24 (qC) ppm; m/z (El) 178 (M, 65 %),133 (M-0O2H, 100) and 105 
(M-C00O2H, 45); (Found M(EI), 178.06289. C10H1003 requires 178.06299). 
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6.14.3 2,3 -Dihydrobenzopyran-2-carboxylic acid ethyl ester 227.155 
o y0H 






Acid 226 (71.0 g, 399 mmol), ethanol (50.0 g, 1.23 mol) and 98 % sulfuric acid (1.5 
cm 3)  were heated under reflux in DCM (175 cm') for 23 h. The mixture was cooled 
to ambient temperature and diluted with water (300 cm3). The organic layer was 
separated and washed successively with sat. aqueous sodium hydrogen carbonate 
(250 cm3) and water (300 cm') before being dried over magnesium sulfate and the 
solvent removed under reduced pressure. The crude product was purified by 
fractional distillation to afford the title compound as a colourless oil (74.2 g, 360 
mmol, 90 %); bp 110-111 °C at 0.3 mmHg (lit.,154 116-117 °C at 0.5 mmHg); RF 
(EtOAc-petroleum ether (bp 40-65 °C), 3:1) 0.89; Ufliax  (Film)/cm' 2979 (CH2/CH3), 
2937 (CH2/CH3), 2850 (CH2/CH3), 1754 (C=O), 1601 (Ph), 1584 (Ph), 1458 
(CH2/CH3), 1372 (CH3), 1194 (C-O) and 755 (Ph-H); 8H (250 MHz; CDC13) 1.28 (3H, 
t, J 7.0, OCH2CH3), 2.22 (2H, in, CH2), 2.77 (2H, in, CH2), 4.24 (2H, q, J 7.0, 
OCH2CH3), 4.70 (1H, dd, J4.0 7.5, CHC(0)OEt), 6.85 (1H, dd, J7.5, Ph), 6.89 (1H, 
d, J 8.0, Ph), 7.02 (1H, dd, J 7.5, Ph), 7.10 (1H, d, J 7.5, Ph) ppm (lit.,155); 
(63MHz; CDCI3) 14.03 (CH3), 23.16 (CH2), 24.47 (CH2), 61.20 (CH2), 73.59 (CH), 
116.78 (CH), 120.61 (CH), 121.07 (qC), 127.37 (CH), 129.24 (CH), 153.34 (qC), 
170.74 (qC) ppm; m/z (El) 206 (M, 10 %), 133 (M-0O2Et, 31) and 105 (M-
C00O2Et, 12); (Found M (El), 206.09431. C32H1403 requires 206.09429). 
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6.14.4 2,3-Dihydrobenzopyran-(2R) and (2S)-carboxylic acid ethyl ester, R- and 5- 
227155 










H20, pH 7, 35 °C, 
1.0 M NaOH. 




Lipase PS was added to a mixture of racemic ester 227 (70.7 g, 343 mmol) in water 
(350 cm') at 35 °C and pH 7.0. The reaction was allowed to proceed at this 
temperature with the pH being adjusted to 7.0 by addition of 1.0 M sodium 
hydroxide by means of a pH autotitrator. The reaction was stopped after the addition 
of 190.4 cm' of the sodium hydroxide solution and the mixture allowed to cool to 
ambient temperature before being extracted with ethyl acetate (6 x 200 cm'). The 
combined organics were filtered through CeliteTM then washed with water (3 x 200 
cm'). The solvent was reduced to approximately one quarter of its volume and 
washed successively with 0.2 M sodium hydroxide (2 x 150 cm'), sat. aqueous 
sodium hydrogen carbonate (150 cm') and water (150 cm'). The organics were dried 
over magnesium sulfate and the solvent removed under reduced pressure to afford the 
title compound as a clear oil (30.1 g, 146 mmol, 43 %, 97 % e.e.). Data coincided 
with that for the racemic ester except: [a] -8.8 (c = 1.26, MeOH) (lit., 155 [aID -9.3 
(c = 1.24, MeOH)); RT (chiral gc) 52.29 mm. 
2,3-Dihydrobenzopyran-(25)-carboxylic acid ethyl ester, S-227: 





The aqueous fraction from the initial extraction was acidified to pH 1 with 2 M 
hydrochloric acid before extraction with ethyl acetate (6 x 200 cm'). The combined 
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organics were filtered through CeliteTM  and the solvent removed under reduced 
pressure to afford the residual acid as a white solid (22.4 g, 126 mmol, 37 %). 
The acid (18.0 g, 101 mmol), ethanol (12.5 cm') and 98 % sulfuric acid (0.5 cm') 
were heated under reflux in DCM (150 cm') for 22 h. The mixture was cooled to 
ambient temperature, dried over magnesium sulfate and the solvent removed under 
reduced pressure. Purification on silica gel, with ethyl acetate-petroleum ether (bp 
40-65°) (3:1) as the eluent, afforded the product as a pale yellow oil (16.9 g, 82.0 
mmol, 82 %, 76 % e.e.). Data coincided with that for the racemic ester except: [a] 21 
+6.3 (c = 1.20, MeOH); RT  (chiral gc) 51.96 mm. 
6.14.5 Increasing the Enantiomeric Excess of 2,3-Dihydrobenzopyran-(2S) 
carboxylic acid ethyl ester, S-227. 
1J,,LOEt 
76% ex. 	0 
Lipase PS 
IN 
H20, pH 7, 35 °C, 
1.0 M NaOH. 
MO -.1" Ir OEt 
a'O OEt 
0 
EtOH, DCM, H2SO4 
4 
Lipase PS was added to a mixture of S-227 (15.5 g, 75.2 mmol) in water (160 cm') at 
35 °C and pH 7.0. The reaction was allowed to proceed at this temperature with the 
pH being adjusted to 7.0 by addition of 1.0 M sodium hydroxide by means of a pH 
autotitrator. The reaction was monitored by chiral gc and stopped after 20 h, at which 
point both ester enantiomers were present in equal amounts. The mixture was 
allowed to cool to ambient temperature before being filtered through a membrane 
and extracted with ethyl acetate (2 x 100 cm'). The aqueous layer was acidified to pH 
1.0 with 2 M hydrochloric acid and extracted with ethyl acetate (3 x 100 cm'). The 
combined organics were dried over magnesium sulfate and the solvent removed 
under reduced pressure to afford the (5)-acid (5.63 g, 31.6 mmol, 41 %). 
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The acid (5.28 g, 29.7 mmol), ethanol (3.5 cm') and 98 % sulfuric acid (0.3 cm') 
were heated under reflux in DCM (45 cm') for 21 h. The mixture was cooled to 
ambient temperature and washed successively with sat. aqueous sodium hydrogen 
carbonate (2 x 50 cm'), sat. aqueous sodium chloride (50 cm') and water (50 cm'). 
The organics were dried over magnesium sulfate and the solvent removed under 
reduced pressure to afford the product as a pale yellow oil. (5.47 g, 26.6 mmol, 89 %, 
84 % e.e.) Data coincided with that for the racemic ester except: [a] +7.1 (c = 
1.23, MeOH). 
6.14.6 (2R)- and (25)-(Hydroxymethyl)-2,3-dihydrobenzopyran, R- and S228.155  
(2R)-(Hydroxymethyl)-2,3-dihydrobenzopyran, R-228: 
MO -.1" Ir 
OEt NaBH4, THF, H20. 
MO 	OH 
A solution of ester R-227 (29.0 g, 141 mmol) in THF (300 cm3) and water (30 cm3) 
was cooled on ice before sodium borohydride (12.5 g, 330 mmol) was added in 
portions, with stirring, over a 45 min period. This mixture was stirred for a further 13 
h during which period it was allowed to slowly warm to ambient temperature. The 
mixture was again cooled on ice prior to the addition of acetone (28 cm') which was 
followed by water (520 cm') and DCM (21 cm'). The layers were separated and the 
aqueous layer was washed with DCM (3 x 200 cm') and the combined organics were 
dried over magnesium sulfate before the solvent was removed under reduced 
22 pressure to afford the title compound as a clear oil (23.2 g, 141 mmol, 100 %); [a] 
-102.9 (c = 1.10, MeOH) (lit.,155  [aID  -113.4 (c = 1.12, MeOH)); RF  (EtOAc-
petroleum ether (bp 40-65 °C), 1:1) 0.26; Umax  (Film)/cm' 3388 (0-H), 3040 (Ph-H), 
2930 (CH2), 2856 (CH2), 1609 (Ph), 1583 (Ph), 1488 (CH2), 1235 (C-U), 1046 (C-U) 
and 753 (Ph-H); 8H  (200 MHz; CDC13) 1.86 (2H, in, CH2), 2.79 (3H, in, CH2 and 
CH20II), 3.80 (2H, in, CH20H), 4.09 (1H, in, CHCH20H), 6.89 (2H, in, Ph), 7.08 
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(2H, m, Ph) ppm (lit.,155); ö (50MHz; CDC13) 23.45 (CH2), 24.21 (CH2), 65.14 
(CH2), 76.20 (CH), 116.41 (CH), 120.10 (CH), 121.67 (qC), 127.00 (CH), 129.28 
(CH), 154.21 (qC) ppm; m/z (El) 164 (M, 36 %), 133 (M-CH20H, 79) and 105 (M-





NaBH4, THF, H20. 
a'O L OH 
0 
The (S)-alcohol was prepared in a similar manner, on a 24 mmol scale from S-227, in 
94 %. Data coincided with that for the (R)-isomer except: [a] +84.7 (c = 1.02, 
MeOH). 
6.14.7 (2R)- and (25)-Benzyl-2,3-dihydrobenzopyran. R- and S-229.155 
(2R)-Benzyl-2,3-dihydrobenzopyran, R-229: 
(i) (CF3SO2)20, Pyridine, DCM. 
.., 	OH (ii) PhMgBr, CuBr.Me2S, THF, Et20.M
O coo 
Alcohol R-228 (4.00 g, 24.4 mmol) and pyridine (6.1 cm') in anhydrous DCM (69 
cm') were cooled to -15 °C under argon. A solution of trifluoromethanesulfonic 
anhydride (10.4 g, 30.1 mmol) in anhydrous DCM (29 cm) was slowly added 
dropwise and the mixture stirred at -10 °C for 45 mm. The reaction was quenched by 
the addition of DCM (100 cm3) and 1 M hydrochloric acid (150 CM) . The layers 
were separated and the organics were washed successively with water (150 cm3), sat. 
aqueous sodium hydrogen carbonate (150 cm') and water (150cm3) before being 
dried over magnesium sulfate. The solvent was removed under reduced pressure, 
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ensuring that the temperature did not exceed 25 °C, to afford the triflate as a light 
orange oil which was used immediately in the following procedure. 
Copper bromide dimethylsulfide (1.18 g, 5.70 mmol) was added to anhydrous THF 
(68 cm') at -10 °C. Phenylmagnesium bromide (12.5 cm' of a 3.0 M solution in 
diethyl ether, 37.5 mmol) was slowly added dropwise followed by a solution of the 
triflate in anhydrous THF (50 cm'). This mixture was stirred for a further 16 h, whilst 
being allowed to slowly warm to ambient temperature, before quenching with ethyl 
acetate (100 cm') and sat. aqueous ammonium chloride (100 cm'). The layers were 
separated and the aqueous fraction was washed with ethyl acetate (100 cm'). The 
combined organics were washed successively with sat. aqueous ammonium chloride 
(100 cm'), water (100 cm'), sat. aqueous sodium hydrogen carbonate (100 cm') and 
water (100 cm') before being dried over magnesium sulfate. The solvent was 
removed under reduced pressure and the product purified by column chromatography 
on silica gel, with ethyl acetate-petroleum ether (bp 40-65 °C) (1:6) as eluent, to 
leave the title compound as a clear oil (4.79 g, 21.4 mmol, 87 %); [a] -98.7 (c 
1.02, MeOH) (lit.,155 [(XID  -110 (c = 1, MeOH)); R (EtOAc-petroleum ether (bp 40-
65 °C), 1:2) 0.69; Umax  (Film)/cm' 3063 (Ph-H), 3028 (Ph-H), 2928 (CH2), 2862 
(CH2), 1608 (Ph), 1582 (Ph), 1488 (CH2), 1236 (C-O), 1052 (C-O), 752 (Ph-H), 740 
(Ph-H) and 699 (Ph-H); 6H  (200 MHz; CDC13) 1.84 (1H, in, CHH), 2.12 (1H, in, 
CHI]), 2.87 (2H, in, CH2), 3.02 (1H, dd, J 7.0 13.5, OCHCHHPh), 3.31 (1H, dd, J 
6.0 13.5, OCHCHHPh), 4.37 (1H, in, OCHCH2Ph), 7.02 (1H, d, J8.0, Ph), 7.21 (2H, 
dd, J 8.0, Ph), 7.57 (5H, in, Ph) ppm (lit.,155); ö (50MHz; CDC13) 24.36 (CH2), 
26.34 (CH2), 41.60 (CH2), 76.29 (CH), 116.61 (CH), 119.86 (CH), 121.72 (qC), 
126.20 (CH), 127.00 (CH), 128.14 (CH), 129.29 (CH), 129.37 (CH), 137.66 (qC), 
154.68 (qC) ppm; m/z (El) 224 (M, 56 %), 133 (M-CH2Ph, 100) and 105 (M-




(i) (CF3SO2)20, py, DCM. 
OH 	(ii) PhMgBr, CuBr.Me2S, THF, Et20. 
C 011"~O 
The (5)-compound was prepared in a similar manner, on an 19 mmol scale from S- 
228, in 89 %. Data coincided with that for the (R)-isomer except: [a] +83.7 (c = 
1.05, MeOH). 
6.14.8 (2R)- and (28)-Benzyl-6-(formyl)-2,3-dihydro-4H-benzopyran, R- and S-
230.155 
(2R)-Benzyl-6-(formyl)-2,3-dihydro-4H-benzopyran, R-230: 
Pod3 	 0 
HCON(CH3)C6H5, 
DCM 	 H 
coo 	
14 0 ""'10 
Phophorous oxychloride (4.13 g, 27.1 mmol) and N-methylformanilide (3.68 g, 27.1 
mmol) were stirred at ambient temperature for 5 min during which time the mixture 
solidified. R-229 (3.50 g, 15.6 mmol) in DCM (4 cm') was added and the mixture 
heated to 65 °C, with distillation of the DCM, before being heated at reflux for 16 h. 
The reaction was quenched by addition of DCM (100 cm3) and 15 % wlv aqueous 
sodium acetate (100 cm'). The layers were separated and the organics were washed 
successively with 15 % w/v aqueous sodium acetate (2 x 75 CM), 1 M hydrochloric 
acid (75 cm3) and water (75 cm'). The organics were dried over magnesium sulfate 
and the solvent was removed under reduced pressure. Purified by column 
chromatography on silica gel, with ethyl acetate-petroleum ether (bp 40-65 °C) (1:3) 
as eluent, to leave the title compound as a low melting yellow solid (2.1 g, 8.3 mmol, 
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53 %); mp 65-66 °C (ljt.,155  68-70 °C); [a] -152.3 (c = 1.03, MeOH) (lit.,155  [aiD 
-164.4 (c = 1, MeOH)); RF (EtOAc-petroleum ether (bp 40-65 °C), 1:3) 0.59; Um 
(Film)/cm' 3058 (Ph-H), 3032 (Ph-H), 2930 (CH2), 2850 (CH2), 2734 (C(0)-H), 
1688 (C=O), 1604 (Ph), 1577 (Ph), 1493 (CH2)1  1266 (C-O), 740 (Ph-H), 716 (CH2) 
and 704 (Ph-H); 8H (250 MHz; CDC13) 1.71 (1H, m, CHH), 2.04 (1H, m, CHH), 2.81 
(2H, m, CH2), 2.91 (1H, dd, J 7.0 14.0, OCHCHHPh), 3.15 (1H, dd, J 6.0 14.0, 
OCHCHHPh), 4.30 (1H, m, OCHCH2Ph), 6.90 (1H, d, J 8.5, Ph), 7.30 (5H, m, Ph); 
7.61 (2H, m, Ph), 9.81 (1H, s, PhC(0)I]) ppm (lit.,155); & (63MHz; CDCI3) 24.16 
(CH2), 25.85 (CH2), 41.37 (CH2), 77.30 (CH), 117.27 (CH), 122.26 (qC), 126.42 
(CH), 128.24 (CH), 129.14 (qC), 129.32 (CH), 131.71 (CH), 137.01 (qC), 160.16 
(qC), 190.75 (CH) ppm; m/z (El) 252 (M, 37 %), 161 (M-CH2Ph, 100), 133 (M-
COCH2Ph, 8) and 105 (M-COCH2Ph-CO, 49); (Found M(EI), 252.11528. C17H1602 
requires 252.11503). 
(25)-Benzyl-6-(formyl)-2,3-dihydro-4H-benzopyran. S-230: 
pod3 	 0 CO 
DCM H 
HCON(CH3)C6H5, 
The (S)-aldehyde was prepared in a similar manner, on a 12 mmol scale from S-229, 




6.14.9 5-1(2R- and 2S-benzyl-3,4-dihydro-2H- 1 -benzopyran-6-yl)methylidene] 
thiazolidine-2,4-dione, R- and S-231. 
5-[(2R-benzyl-3 ,4-dihydro-2H- 1 -benzopyran-6-yl)methylidene]thiazolidine-2,4-
dione, R-231 
0 	 0 Thiazolidine-2,4-dione 
Toluene, 
H 'Tr))jj FfN 
AcOH (cat.), 	 S 	 0 "14"0 
Piperidine (cat.). 
Thiazolidine-2,4-dione (761 mg, 6.50 mmol) and aldehyde R-230 (1.64 g, 6.51 
mmol) in toluene (50 cm'), containing pipendine (20 mg, 0.24 mmol) and acetic acid 
(20 mg, 0.33 mmol), were heated at reflux under Dean and Stark conditions for 24 h. 
The solvent was removed under reduced pressure and the product purified by column 
chromatography on silica gel, with ethyl acetate-petroleum ether (bp 40-65 °C) (1:1) 
as eluent, to leave the title compound as a yellow powder (2.14 g, 6.10 mmol, 94 %); 
mp 178-180 °C (lit.,5 183-184 °C); [a] -135.6 (c = 1.02, DMSO); RF  (EtOAc- 
hexane, 1:1) 0.29; Un,ax  (KBr)/cm' 3026 (olefinic C-H/Ph-H), 2930 (CH2), 2775 
(CH2), 1731 (C=O), 1688 (C=O), 1595 (Ph), 1570 (Ph), 1499 (Ph), 1255 (C-O), 812 
(Ph-H), 751 (Ph-H) and 701 (Ph-H); 8(250 MHz; [2H6] DMSO) 1.61 (1H, in, CIIH), 
1.96 (1H, in, CR11), 2.77 (2H, in, CH2), 2.90 (1H, dd, J6.5 14.0, OCHCHHPh), 3.03 
(1H, dd, J6.5 14.0, OCHCITRPh), 4.31 (1H, in, OCHCH2Ph), 6.85 (1H, d, J9.0, Ph), 
7.27 (7H, in, Ph); 7.66 (1H, s, olefinic 11) ppm; 6 (63MHz; [2H6] DMSO) 23.86 
(CH2), 25.81 (CH2), 40.80 (CH), 76.99 (CH), 117.53 (CH), 119.92 (qC), 123.31 (qC), 
125.05 (qC), 126.50 (CH), 128.41 (CH), 129.63 (CH), 132.19 (CH), 132.35 (CH), 
137.68 (qC), 156.71 (qC), 167.61 (qC), 168.17 (qC) ppm; m/z (El) 351 (M, 100 %), 
280 (M-C(0)NIHC(0), 32), 260 (M-CH2Ph, 85) and 189 (M-C(0)NHC(0)-CH2Ph, 
33); (Found M(EI), 35 1.09277. C20H17NO3S requires 35 1.09292). 
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P. HQ I )L Th 
Pi14 peridine (cat.), 
AcOH (cat.). 
The (5)-isomer was prepared in a similar manner, on a 6 mmol scale from S-230, in 
86 %. Data coincided with that for the (R)-isomer except: [a] 12  +100.8 (c = 0.96, 
DMSO). 
6.15 Synthesis of 5-[ [5-benzoylj methylidene] thiazolidine-2,4-dione. 
6.15.1 2-Bromoacetophenone 232.157 
0 
0 	AId 3, 1,2-DCE 
U + Br)..Br 	 Br  
Benzene (1.58 g, 20.3 mmol) was added to a solution of aluminium chloride (2.57 g, 
19.2 mmol) in 1,2-DCE (10 cm') at 0 °C in one portion. Bromoacetyl bromide (3.41 
g, 16.9 mmol) was added over 10 mm, ensuring that the temperature did not exceed 
10 °C. The mixture was warmed to ambient temperature and stirred for a further 3.5 
h at which point water (17 cm') was added slowly, ensuring that the temperature did 
not exceed 45 °C. The layers were separated and the organics were washed 
successively with 1 M hydrochloric acid (20 cm') and water (20 cm3) before being 
dried over magnesium sulfate. The solvent was removed under reduced pressure to 
afford the title compound as a light brown powder (2.82 g, 14.2 mmol, 74 %); mp 
49-51 °C (lit.,196 49-51 °C); RF (EtOAc-hexane, 1:3) 0.52; Umax  (Film)/cm-' 3058 
(Ph-H), 3002 (CH2), 2954 (CH2), 1694 (C=O), 1595 (Ph), 1580 (Ph), 1448 (CH2) 746 
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(Ph-H), 704 (Ph-H) and 686 (C-Br) (lit.,197); 8H  (250 MHz; CDC13) 4.45 (2H, s, 
CH2Br), 7.48 (2H, t, J 7.5, Ph), 7.60 (1H, t, J 7.5, Ph), 7.97 (2H, d, J 7.5, Ph) ppm 
(lit.,  196) & (63MHz; CDC13) 30.91 (CH2)1  128.67 (CH), 133.71 (CH), 133.78 (CH), 
191.07 (qC) ppm; m/z (El) 198 (M(79Br), 21 %), 119 (M-Br, 5), 105 (M-CH2Br, 100) 
and 77 (M-C(0)CH2Br, 19); (Found M (El), 197.96871. C8H7079Br requires 
197.96803). 
6.15.2 5-Formylsalicylaldehyde 233.157 
H 	 H 	H 
0 
HMTA, TFA 
HO"'eO 	 HO 
HMTA (10.6 g, 76.0 mmol) was added, in one portion, to a solution of 4-
hydroxybenzaldehyde (9.27 g, 76.0 mmol) in TFA (70 cm'), under nitrogen. The 
resultant solution was heated at reflux for 24 h before being quenched with 3 M 
hydrochloric acid (120 cm3) and allowed to cool before being extracted with DCM (4 
x 145 cm'). The organics were dried over magnesium sulfate and the solvent was 
removed under reduced pressure to leave a yellow oily solid. This was stirred on ice 
in ethanol (10 cm3) and the solids were isolated by filtration and washed with cold 
ethanol (2 x 20 cm') to afford the title compound as a yellow solid (13.1 g, 65.7 
mmol, 76%); mp 110-111 °C (lit.,157 112-115 °C); RF  (EtOAc) 0.65; Umax  (Film)/cm 
3186 (0-H), 2837 (C(0)-H), 1689 (C=0), 1666 (C=0), 1571 (Ph) and 1156 (C-0) 
(lit.,157); oH  (250 MHz; [2H6] DMSO) 7.15 (1H, d, J8.5, Ph), 7.99 (1H, dd, J2.0 8.5, 
Ph), 8.18 (1H, d, J2.0, Ph), 9.86 (1H, s, C(0)II), 9.98 (111, s, C(0)H), 11.86 (1H br 
s, 011) ppm (lit.,157); 8  (63MHz, [2H6] DMSO) 118.34 (CH), 122.67 (qC), 128.48 
(qC), 135.82 (CH), 137.45 (CH), 166.14 (CH), 190.15 (CH), 191.85 (CH) ppm 
(lit.,157); m/z (El) 150 (M, 61 %), 149 (M-H, 100), 121 (M-C(0)H, 19) and 93 (M-
2C(0)H, 16); (Found M(EI), 150.03 193. C8H603 requires 150.03 169). 
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6.15.3 2-Benzoyl-5-benzothrancarboxaldehyde 234.157 
o 	 H 	H 	 0 
Br + 0 	
0 K2C031  MeCN 	Ph H 
	
HO 	 0 0 
A mixture of 2-bromoacetophenone 232 (398 mg, 2.0 mmol), 5-
formylsalicylaldehyde 233 (300 mg, 2.0 mmol) and potassium carbonate (276 mg, 
4.6 mmol) were heated at reflux in acetonitrile (7.2 cm3) for 22 h. Water (14 cm3) 
was added and the mixture allowed to cool to ambient temperature. The precipitate 
was recovered by filtration and washed successively with water-acetonitrile (2:1) (2 x 
2 cm3) and acetonitrile (2 x 2cm3) before being dried under vacuum to afford the title 
compound as a pale yellow powder (280 mg, 1.12 mmol, 56 %); mp 155-156 °C 
(lit.,157 156.5-157 °C); RF  (EtOAc-hexane, 1:1) 0.55; Umax  (Film)/cm 1695 (C=O), 
1645 (C=O), 1610 (Ph), 1549 (Ph) and 1108 (C-O) (lit.,157); 6, (250 MHz; [2H6] 
DMSO) 7.59 (4H, in, Ph), 7.73 (1H, d, J 8.5, Ph), 8.03 (3H, in, Ph), 8.25 (1H, d, J 
1.0, Ph), 10.07 (1H, s, C(0)H) ppm (lit.,157); 6c (63MHz; [2H6] DMSO) 113.24 (CH), 
116.18 (CH), 126.78 (CH), 127.27 (qC), 128.53 (CH), 128.66 (CH), 129.29 (CH), 
132.95 (qC), 133.18 (CH), 136.47 (qC), 153.51 (qC), 158.67 (qC), 183.74 (qC), 
190.93 (CH) ppm (lit.,157); m/z (El) 250 (M, 21 %), 221 (M-C(0)H, 5), 173 (M-
C6H5, 29) and 105 (M-C(0)C8H50, 100). 
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6.15.4 (Z)-5 - [15-benzoyllmethyljdene]thjazoljdjne-2,4-djone 235.157 
0 0 
Ph 	 H 
Thiazolidine-2,4-dione, Ph 	
NH 
Pyrrolidine, MeCN  
Aldehyde 234 (200 mg, 0.80 mmol) was heated at reflux in acetonitrile (4.7 cm') 
until dissolution had occurred. Pyrrolidine (6.8 p1, 0.08 mmol) and thiazolidine-2,4-
dione (112 mg, 0.96 mmol) were addded and the mixture heated at reflux for 20 h. 
The precipitate was removed by filtration, washed with acetonitrile (2 cm3) and dried 
under vacuum at 90 °C to afford the title compound as a blood red powder (173 mg, 
0.50 mmol, 63 %); mp 283-285 °C dec. (lit.,157 286-288 °C); RF (EtOAc-hexane, 
1:1) 0.50; Umax  (KBr)/cm' 3.030 (olefinic C-H/Ph-H), 1740 (C=O), 1696 (C=O) 1647 
(C=O), 1602 (Ph), 1551 (Ph) and 1126 (C-O) (lit.,157); 6H  (600 MHz; [2H6] DMSO) 
7.61 (2H, m, Ph), 7.72 (1H, m, Ph), 7.76 (1H, m, Ph), 7.80 (1H, s, olefinic H), 7.85 
(1H, s, olefinic H), 7.86 (1H, t, J 9.0, Ph), 8.00 (2H, m, Ph), 8.04 (1H, d, J 2.0, Ph) 
ppm (lit.,157); & (63MHz; [2H6] DMSO) 113.32 (CH), 117.32 (CH), 125.23 (CH), 
125.55 (qC), 127.81 (qC), 128.92 (CH), 129.35 (CH), 129.98 (CH), 130.89 (CH), 
133.40 (CH), 136.67 (qC), 152.45 (qC), 155.59 (qC), 169.42 (qC), 170.25 (qC), 
183.45 (qC) ppm (lit.,157); m/z (El) 349 (M). 
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6.16 Knoevenagel Condensation Between Cyclohexane Carboxaldehyde and 
Thiazolidine-2,4-dione. 
6.16.1 (Z)-5-cyclohexanemethylidene thiazolidine-2,4-di6ne 236. 
0 
+ 	
Toluene, AcOH (cat), 
NH 
S-..._, 	Piperidine (cat.). 	
S..i 
cill 	 0 S __~ 
0 
Thiazolidine-2,4-dione (1.76 g, 15.0 mmol) and cyclohexane carboxaldehyde (1.68 g, 
15.0 mmol) were heated at reflux in toluene (100 cm'), containing acetic acid (27 mg, 
0.45 mmol) and piperidine (38 mg, 0.45 mmol), under Dean and Stark conditions for 
24h. The reaction mixture was cooled to ambient temperature and the solvent 
removed under reduced pressure. Purification by column chromatography on silica 
gel, with ethyl acetate-petroleum ether (bp 40-65 °C) (1:1) as eluent, afforded the 
title compound as a light brown powder (2.85 g, 13.5 mmol, 90 %); m.p. 140-141 °C; 
RF (EtOAc-petroleum ether (bp 40-65 °C), 1:1) 0.58; Umax (KBr)/cm' 3020 (olefinic 
C-H), 2930 (CH2), 2850 (CH2), 1741 (C=O), 1698 (C=O), 1628 (C=C), 1450 (CH2) 
and 736 (CH2); 8H (600 MHz; [2H6] DMSO) 1.22 (5H, m, cyclic CH), 1.63 (5H, d, 
cyclic CH), 2.05 (1H, m, cyclic CH), 6.74 (1H, d, J9.5, olefinic I]) ppm; 8c (63MHz; 
[2H6] DMSO) 24.87 (CH2), 25.28 (CH2), 30.61 (CH2), 40.82 (CH), 125.17 (qC), 
141.35 (CH), 166.48 (qC), 167.81 (qC) ppm; m/z (El) 211 (M, 39 %), 168 (M-




6.17 Synthesis 	Of 	(Z)-2-sulfanyl-3-(4-methoxyphenyl)propenoic 	acid 
Derivatives. 
6.17.1 (Z)-2-sulfanyl-3-(4-methoxyphenyl)propenoic acid 237.161 
0 20 % w/v NaOH. 	 0 




196 (4.05 g, 16.1 mmol) in 20 % w/v aqueous sodium hydroxide (27 cm') was heated 
to 90 °C. The mixture was allowed to cool to ambient temperature before being 
acidified to pH 1 with 5 M hydrochloric acid. The precipitate was recovered by 
filtration and washed with methanol to afford the title compound as a yellow powder 
(3.17 g, 15.1 mmol, 94 %); mp 175-178 °C (lit., 98 177-178 °C); RF (EtOAc-
petroleum ether (bp 40-65 °C), 1:1) 0.67; 0max (KBr)/cm' 3063 (olefinic C-HiPh-H), 
3025 (olefinic C-H/Ph-H), 2926 (CH3), 2835 (CH3), 2567 (S-H), 1657 (C=O), 1607 
(Ph), 1,589 (Ph), 1508 (Ph), 1426 (CH,) and 828 (Ph-H); 6. (250 MHz; [2H6] DMSO) 
3.80 (3H, s, OCH3), 6.95 (2H, d, J 9.0, Ph), 7.80 (1H, s, olefinic H), 7.84 (2H, d, J 
9.0, Ph) ppm; & (63MHz; [2H6] DMSO) 55.48 (CH3), 114.04 (CH), 125.29 (qC), 
126.46 (qC), 133.29 (CH), 145.11 (CH), 160.98 (qC), 166.74 (qC); m/z (El) 210 (M, 
46 %), 209 (M-H, 58), 192 (M-H-OH, 12) and 164 (M-H-CO2H, 58); (Found W 
(El), 210.03591. C10H1003S requires 210.03507). 
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6.17.2 (Z)-2-methylsulfanyl-3-(4-methoxyphenyfl12ropenojc acid 238.160 
o 	(i) 20 % w/v NaOH. 	 o (ii) lodomethane. 







196 (1.50 g, 5.98 mmol) in 20 % w/v aqueous sodium hydroxide (10 cm') was heated 
to 90 °C. lodomethane (1.40 g, 9.86 mmol) was added and the mixture heated under 
reflux for 45 min at which point 4 M hydrochloric acid (5 cm') was added and the 
solution allowed to cool to ambient temperature. The precipitate was recovered by 
filtration, washed with water (2 x 10 cm') and recrystallised from methanol. A 
second crop of crystals was obtained from the mother liquors, to afford the title 
compound as a yellow powder (792 mg, 3.53 mmol, 59 %); mp 123-125 °C (From 
MeOH) (lit.,160 135 °C); RF (EtOAc-hexane, 1:1) 0.11; Umax (KBr)/cm' 3004 
(olefinic C-H/Ph-H), 2916 (CH3), 2841 (CH3), 1670 (C=O), 1602 (Ph), 1578 (Ph), 
1508 (Ph), 1419 (CH3), 1355 (CH3) and 826 (Ph-H); 5H (250 MHz; CDC13) 2.35 (3H, 
s, SCH3), 3.84 (3H, s, OCH3), 6.93 (2H, d, J 9.0, Ph), 7.92 (2H, d, J 9.0, Ph), 8.03 
(1H, s, olefinic H) ppm; 8c (63MHz CDC13) 17.50 (CH,), 55.18 (CH3), 113.66 (CH), 
123.66 (qC), 126.86 (qC), 133.23 (CH), 145.44 (CH), 160.96 (qC), 171.71 (qC); m/z 
(El) 224 (M, 100 %) and 164 (M-CH3-CO2H, 17); (Found M (El), 224.05035. 
C11H1203S requires 224.05072). 
6.17.3 (Z)- 2-methylsulfanyl-3-(4-methoxyphenyl)propenoic acid methyl ester 239. 
	
0 	 0 
MeOH, DCM, H2SO4- 




Acid 238 (1.03 g, 4.60 mmol), methanol (7.15 g, 223 mmol) and 98 % sulfuric acid 
(0.7 cm) were heated under reflux in DCM (10 cm) for 24 h. The solvent was 
removed under reduced pressure before ethyl acetate (100 cm) was added. This was 
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washed successively with sat. aqueous sodium hydrogen carbonate (2 x 75 cm'), sat. 
aqueous sodium chloride (50 cm') and water (50 cm') before drying over magnesium 
sulfate. The solvent was removed under reduced pressure to afford the title 
compound as a yellow oil (980 mg, 4.12 mmol, 90 %); RF (EtOAc-petroleum ether 
(bp 40-65 °C), 1:1) 0.67; Umax  (Film)/cm' 3002 (olefinic C-H/Ph-H), 2951 (CH3), 
2929 (CH3), 2838 (CH3)1  1712 (C=O), 1604 (Ph), 1566 (Ph), 1510 (Ph), 1434 (CH3), 
1352 (CH3), and 831 (Ph-H); 6H (250 MHz; CDC13) 2.27 (3H, s, SCH3), 3.80 (3H, s, 
OCH3), 3.83 (3H, s, OCH3), 6.89 (2H, d, J9.0, Ph), 7.81 (2H, d, J9.0, Ph), 7.81 (1H, 
s, olefinic II) ppm; 6 (63MHz; CDC13) 17.36 (CH3), 52.41 (CH3), 55.07 (CH3), 
113.45 (CH), 124.82 (qC), 127.01 (qC), 132.67 (CH), 142.58 (CH), 160.38 (qC), 
166.57 (qC); m/z (El) 238 (M, 84 %), 237 (M-H, 100), 207 (M-OMe, 4) and 179 (M-
0O2Me, 8); (Found M(EI), 238.06550. C12H1403S requires 238.06637). 
6.17.4 (Z)- 2-methylsulfanyl-3-(4-methoxyphenyl)propenoic acid ethyl ester 240. 
	
0 	 0 
OH 	
EtOH, DCM, H2SO4- 10 
	 OEt JD  MeO 	 SMe 	 MeO 	 SMe 
Acid 238 (990 mg, 4.42 mmol), ethanol (10.3 g, 223 mmol) and 98 % sulfuric acid 
(0.7 cm3) were heated under reflux in DCM (10 cm3) for 27 h. The solvent was 
removed under reduced pressure before ethyl acetate (100 cm3) was added. This was 
washed successively with sat. aqueous sodium hydrogen carbonate (2 x 75 cm'), sat. 
aqueous sodium chloride (50 cm') and water (50 cm3) before drying over magnesium 
sulfate. The solvent was removed under reduced pressure to afford the title 
compound as a yellow oil (920 mg, 3.68 mmol, 83 %); RF  (EtOAc-petroleum ether 
(bp 40-65 °C), 1:1) 0.74; Unax  (Film)/cm 1 3065 (olefinic C-H/Ph-H), 2979 
(CH2/CH3), 2929 (CH2/CH3), 2838 (CH2/CH3), 1708 (C=O), 1604 (Ph), 1567 (Ph), 
1510 (Ph), 1443 (CH2/CH3), 1365 (CH3), 832 (Ph-H) and 759 (CH2); 8H (250 MHz; 
CDC13) 1.36 (3H, t, J7.0, OCH2CH3), 2.29 (311, s, SCH3), 3.81 (3H, s, OCH3), 4.31 
(2H, q, J7.0, OCH2CH3), 6.91 (2H, d, J9.0, Ph), 7.80 (1H, s, olefinic II), 7.81 (2H, 
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d, J8.5, Ph) ppm; 8c  (63MHz; CDC13) 14.00 (CH3), 17.24 (CH2), 54.97 (CH), 61.31 
113.32 (CH), 125.22 (qC), 127.01 (qC), 132.49 (CH), 141.95 (CH), 160.18 
(qC), 165.94 (qC); m/z (El) 252 (M, 81 %), 251 (M-H, 100), 207 (M-OEt, 15) and 
179 (M-CO2Et, 11); (Found M(EI), 252.08206. C13H1603S requires 252.08202). 
6.17.5 (Z)-2-methylsulfanyl-3 -(4-methoxyphenyl)propenoic acid amide 241.162,163 
	
0 	 0 




(ii) Me3SiNHSiMe3, DCM. 	
MeO" 	
SMe 
Oxalyl chloride (685 mg, 5.39 mmol) was added to a solution of acid 238 (1.00 g, 
4.46 mmol) in anhydrous DCM (10 cm3) and DMF (1 drop) and the mixture heated 
to 25 °C. After 25 min the mixture was cooled to ambient temperature and the 
solvent was removed under reduced pressure to afford the crude acid chloride (1.33 
g). 1, 1, 1,3,3,3-hexamethyldisilazane (1.77 g, 11.0 mol) in anhydrous DCM (28 cm') 
was added rapidly to a solution of the crude acid chloride (750 mg) in anhydrous 
DCM (10 cm) at 0 °C. The solution was allowed to warm to ambient temperature 
and was stirred for 48 h before being quenched with methanol (2 cm'). This was 
washed successively with 5 % v/v sulfuric acid (2 x 10 cm3) and sat. aqueous 
ammonium sulfate (2 x 10 cm3) before drying over magnesium sulfate. The solvent 
was removed under reduced pressure to afford the title compound as a brown solid 
(537 mg, 2.41 mmol, 77 %); mp 209-211 °C; RF  (EtOAc-hexane, 1:1) 0.10; Umax 
(Film)/cm' 3357 (N-H), 3166 (N-H), 3002 (olefinic C-H/Ph-H), 2917 (CH3), 2848 
1644 (Ph), 1604 (Ph), 1567 (Ph), 1509 (Ph), 1462 (CH3), 1376 (CH3) and 830 
(Ph-H); 8H (250 MHz; CDC13) 2.23 (3H, s, SCH3), 3.82 (3H, s, OCH3), 6.59 (2H, d, J 
9.0, Ph), 7.89 (2H, d, J 9.0, Ph), 7.98 (1H, s, olefinic H) ppm; 6 (63MBz; CDC13) 
17.75 (CH3), 55.14 (CH3), 113.63 (CH), 124.83 (qC), 126.99 (qC), 132.62. (CH), 
142.61 (CH), 160.53 (qC), 168.81 (qC); m/z (El) 223 (M, 82 %), 222 (M-H, 91), 191 
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(M-OCH3, 4) and 175 (M-OCH3-NH2, 100); (Found M(EI), 223.06585. C11H13NO2S 
requires 223.06670). 
6.18 Hydrogenation Of 5-Benzylidene 5-Membered Heterocycles. 
R' __ 1'NH 
R2 
H21  10% Pd/C, 	RI NH 
I ,4-dioxane. - x'—I0 
6.18.1 General Procedures. 
General Procedure 1 
Unsaturated compound (0.44 mmol) in 1,4-dioxane (10 cm) was hydrogenated over 
10 % PdIC (200 mg) until hplc indicated that conversion was complete. The catalyst 
was removed by filtration through CeliteTM which was washed thoroughly with 1,4-
dioxane before the solvent was removed under reduced pressure to afford crude 
product. 
General Procedure 2: 
Unsaturated compound (0.44 mmol) in 1,4-dioxane (10 cm) was hydrogenated over 
10 % PdJC (23 mg) until hplc indicated that conversion was complete. The catalyst 
was removed by filtration through CeliteTM  which was washed thoroughly with 1,4-




General Procedure 3 
Unsaturated compound (0.91 mmol) in 1,4-dioxane (20 cm') was hydrogenated over 
10 % PdJC (400 mg) until hplc indicated that conversion was complete. The catalyst 
was removed by filtration through CeliteTM  which was washed thoroughly with 1,4-
dioxane before the solvent was removed under reduced pressure to afford crude 
product. 
General Procedure 4: 
Unsaturated compound (0.72 mmol) in 1,4-dioxane (15 cm3) was hydrogenated over 
10 % PIIC (44 mg) until hplc indicated that conversion was complete. The catalyst 
was removed by filtration through CeliteTM  which was washed thoroughly with 1,4-
dioxane before the solvent was removed under reduced pressure to afford crude 
product. 
6.18.2 5-(4- {2-{methyl(2-pyridyl)amino1ethoxy benzyl)thiazolidine-2,4-dione 2. 
0 
(Y1 N Me 	 H 
s 
0 
General procedure 3, for 48 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (2:1) as eluent, afforded the title compound as a white 
powder (210 mg, 0.59 mmol, 64 %); mp 149-151 °C (lit.,7 153-155 °C); RF  (EtOAc-
hexane, 2:1) 0.55; Umax  (Film)/cm' 2928 (CH2/CH3), 1752 (C=O), 1697 (CO), 1603 
(Ph), 1559 (Ph), 1510 (Ph), 1424 (CH2/CH3), 830 (Ph-H) and 735 (CH2) (lit., 7); 6H 
(250 MHz; [2H6] DMSO) 3.04 (1H, dd, J9.0 14.0, PhCHH), 3.06 (3H, s, NCH3), 3.29 
(1H, dd, J 4.5 14.0, PhCHH), 3.88 (2H, t, J 5.5, NCI-4), 4.10 (2H, t, J 5.5, OCH2), 
4.85 (1H, dd, J 4.5 9.0, PhCH2CII), 6.57 (1H, in, Py), 6.63 (1H, d, J 8.5, Py), 6.87 
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(2H, d, J 8.5, Ph), 7.13 (2H, d, J 8.5, Ph), 7.49 (1H, m, Py), 8.07 (1H, m, Ph), 12.01 
(1H, br s, NH) ppm (lit.,7); & (63MHz; [2 H6]DMSO) 36.35 (CH2), 37.15 (CH3), 
48.59 (CH2), 53.13 (CH), 65.41 (CH2), 105.84 (CH), 111.62 (CH), 114.39 (CH), 
128.74 (qC), 130.49 (CH), 137.43 (CH), 147.64 (CH), 157.59 (qC), 158.12 (qC), 
171.80 (qC), 175.81 (qC) ppm; m/z (El) 357 (M, 6 %) and 121 (M-
SC(0)NIHC(0)CHCH2-C6H4-OCH2, 100); (Found W (El), 357.1151. C38H19N303S 
requires 357.1147). 





General procedure 1, for 24 h. Purification by column chromatography on silica gel, 
with ethyl acetate-petroleum ether (bp 40-65 °C) (1:1) as eluent, afforded the title 
compound as a white powder (79 mg, 0.33 mmol, 75 %); mp 109-1 10'°C; RF (diethyl 
ether-hexane, 1:1) 0.42; Umax (Film)/cm' 3048 (Ph-H), 2905 (CH2/CH3), 1754 (C=O), 
1693 (C=O), 1612 (Ph), 1513 (Ph), 1451 (CH2/CH3) and 1378 (CH,); 8H (250MHz; 
CDC13) 3.08 (1H, dd, J 9.5 14.0, PhCHH), 3.45 (1H, dd, J 4.0 14.0, PhCHH), 3.79 
(3H, s, OCH3), 4.49 (1H, dd, J4.0 9.5, PhCH,CIJ), 6.84 (2H, d, J9.0, Ph), 7.14 (2H, 
d, J9.0, Ph), 8.78 (1H, br s, NH) ppm; E, (63MHz; CDCI3) 37.60 (CH2), 53.66 (CH), 
55.13 (CH3), 114.08 (CH), 127.50 (qC), 130.18 (CH), 158.88 (qC), 170.61 (qC), 
174.31 (qC) ppm; m/z (El) 237 (M, 45 %), 121 (M-SC(0)NHC(0)CH, 100); (Found 
M(EI), 237.04598. C11H11NO3S requires 237.04597). 
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6.18.4 5-(4-chlorobenzyl)thiazolidine-2,4-dione 244. 
General procedure 1, for 24 h. Purification by column chromatography on silica gel, 
with diethyl ether-hexane (1:1) as eluent, afforded the title compound as a white solid 
(55 mg, 0.23 mmol, 53 %); mp 110-111 °C (lit.,2 110-111 °C); RF (diethyl ether-
hexane, 1:1) 0.40; Ufliax (Film)/cm' 3064 (Ph-H), 1754 (C=O), 1694 (C=O), 1597 
(Ph), 1511 (Ph) and 1492 (CH2); 8H (250MHz; CDC13) 3.12 (1H, dd, J 9.5 14.0, 
PhCHH), 3.46 (111, dd, J4.0 14. 0, PhCHH), 4.51 (1H, dd, J4.0 9.5, PhCH2C1I), 7.15 
(2H, d, J 9.0, Ph), 7.29 (2H, d, J 9.0, Ph), 9.07 (1H, br s, NH) ppm; & (63MHz, 
CDC13) 37.64 (Cl2), 52.94 (CH), 128.90 (CH), 130.48 (CH), 133.54 (qC), 133.89 
(qC), 170.51 (qC), 174.28 (qC) ppm; m/z (El) 241 (M(35C1), 20 %), 125 (M-
SC(0)NIHC(0)CH, 100); (Found M (El), 240.99698. C10H8NO2S35C1 requires 
240.99643). 






General procedure 3, for 24 h. Purification by column chromatography on silica gel, 
with ethyl acetate-petroleum ether (40-65°C) (1:1) as eluent, afforded the title 
compound as a white solid (60 mg, 0.26 mmol, 29 %); mp 182-183 °C; RF (EtOAc-
petroleum ether (bp 40-65 °C), 1:1) 0.20; Umax (KBr)/cm' 3092 (Ph-H), 2846 (CH2), 
2239 (CN), 1755 (C=O), 1699 (C=O), 1605 (Ph), 1504 (Ph), 1448 (CH2) and 841 
(Ph-H); 6H (250MHz; CDC13) 3.25 (1H, dd, J 9.0 14.0, PhCHH), 3.46 (11, dd, J 5.0 
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14.0, PhCHH), 4.96 (1H, dd, J5.0 9.0, PhCH,CH), 7.45 (214, d, J9.0, Ph), 7.78 (2H, 
d,J9.0, Ph) ppm; 6(63MHz, CDC13) 37.16 (CH,), 51.96 (CH), 110.17 (qC), 118.91 
(qC), 130.58 (CH), 132.45 (CI), 142.93 (qC), 171.60 (qC), 175.65 (qC) ppm; m/z 
(El) 232 (M, 6 %), 116 (M-SC(0)NHC(0)CH, 100); (Found M (El), 232.03084. 
C11H8N202S requires 232.03065). 
6.18.6 5-cyclohexanemethylenethiazolidine-2,4-dione 247. 
rs 
NH 
H2, 10% Pd/C, 
1 ,4-dioxane. 
NH 
General procedure 3, for 27 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white solid 
(151 mg, 0.71 mmol, 78 %); m.p. 125-126 °C; RF  (EtOAc-hexane, 1:1) 0.63; Dm 
(Film)/cm' 2918 (Cl2), 2838 (CH2), 1749 (C=O) and 1688 (C=O); 6H  (600 MHz; 
CDC13) 0.91 (1H, in, cyclic CH)), 0.99 (1H, in, cyclic CH), 1.19 (3H, in, cyclic CH), 
1.38 (1H, in, cyclic Cl]), 1.68 (6H, in, SCHCHH and cyclic CH), 2.13 (114, in, 
SCHCHR), 4.28 (1H, dd, J 4.0 11.0, SCHCH2) ppm; 6c (63MHz, CDC13) 25.66 
(Cl2), 25.81 (CH2), 26.02 (CH2), 31.50 (CH2), 33.47 (CH2), 36.01 (CH), 40.53 
(CH2), 49.61 (CH), 171.45 (qC), 176.20 (qC) ppm; m/z (El) 213 (M, 27 %) and 97 




6.18.7 5-(4-methylbenzyl)thiazolidine-2,4-dione 249. 
General procedure 1, for 24 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white 
powder (98 mg, 0.44 mmol, 100 %); mp 73-75 °C; RF  (EtOAc-hexane, 1:1) 0.52; 
Umax  (Film)/cm' 2963 (CH2/CH3), 1754 (C0), 1694 (C0), 1516 (Ph), 1445 
(CH2/CH3), 799 (Ph-H) and 720 (CH,); 6H  (250MHz; CDC13) 2.32 (3H, s, CH3), 3.07 
(1H, dd, J 10.0 14.0, PhCHH), 3.50 (1H, dd, J4.0 14.0, PhCHH); 4.51 (1H, dd, J4.0 
10.0, PhCH2CH), 7.11 (4H, s, Ph), 9.20 (1H, br s, Nil) ppm; E (63MHz; CDC13) 
20.92 (CH3), 38.05 (CH2), 53.52 (CH), 128.83 (CH), 129.38 (CH), 132.58 (qC), 
137.18 (qC), 171.02 (qC), 174.70 (qC) ppm; m/z (El) 221 (M, 45 %), 105 (M-
SC(0)NHC(0)CH, 100); (Found M (El), 221.05190. C11H11NO2S requires 
221.05 105). 
6.18.8 5-(4-ethylbenzyl)thiazolidine-2,4-dione 250. 
General procedure 3, for 30 h afforded the title compound as a white solid (146 mg, 
0.62 mmol, 68 %); m.p. 102-104 °C; RF  (EtOAc-hexane, 1:1) 0.73; Umax  (Film)/cm' 
3054 (Ph-H), 2965 (CH2/CH3), 2930 (CH2ICH3), 2872 (CH2/CH3), 1754 (C=O), 1695 
(C=O), 1514 (Ph), 1438 (CH7/CH3), 825 (Ph-H), 737 (CH2) and 702 (CH2); ll 
(250MHz; CDC13) 1.22 (3H, t, J 7.5, CH7CH3), 2.63 (2H, q, J 7.5, CH2CH3), 3.08 
(1H, dd, J 10.0 14.0, PhCHH), 3.52 (1H, dd, J4.0 14.0, PhCHH), 4.52 (1H, dd, J4.0 
185 
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10.0, PhCHCH), 7.15 (411, s, Ph), 9.10 (1H, br s, NH) ppm; 5, (63MHz; CDC13) 
15.29 (CH3), 28.28 (CH2), 38.15 (CH2), 53.56 (CH), 128.18 (CH), 128.88 (CH), 
132.89 (qC), 143.49 (qC), 171.01 (qC), 174.68 (qC) ppm; m/z (El) 235 (M, 5%), 119 
(M-SC(0)NHC(0)CH, 100); (Found M (El), 235.06683. C12H13NO2S requires 
235.06670). 
6.18.9 5-(4-propylbenzyl)thiazolidine-2,4-dione 251. 
0 
NH 
General procedure 1, for 24 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white solid 
(87 mg, 0.35 mmol, 79 %); mp 73-75 °C; RF  (EtOAc-hexane, 1:1) 0.57; Umax 
(KBr)/cm' 3054 (Ph-H), 2958 (CH2ICH3), 2930 (CH2/CH3), 2870 (CH2/CH3), 1754 
(C0), 1695 (C0), 1514 (Ph), 1440 (CH2/CH3), 1328 (CH3) and 790 (Ph-H); oH 
200MHz; CDC13) 0.92 (3H, t, J 7.5, CH2CH2CH3), 1.62 (2H, tq, J 7.5, CH2CH2CH3), 
2.56 (211, t, J7.5, CH2CH2CH3), 3.08 (1H, dd, J 10.0 14.0, PhCHH), 3.52 (1H, dd, J 
4.0 14.0, PhCHH), 4.51 (1H, dd, J4.0 10.0, PhCH2CH), 7.13 (4H, s, Ph), 8.30 (1H, 
br s, NH) ppm; O (50MHz, CDC13) 13.69 (CH3), 24.31 (CH2), 37.50 (CH2), 38.22 
(CH2), 53.54 (CH), 128.83 (CH), 132.86 (qC), 142.06 (qC), 170.61 (qC), 174.34 
(qC) ppm; m/z (El) 249 (M, 15 %), 133 (M-SC(0)NHC(0)CH, 100); (Found M 
(El), 249.08228. C13H15NO2S requires 249.08235). 
186 
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6.18.10 5-(4-butylbenzyl)thiazolidine-2,4-djone 252. 
0 
NH 
General procedure 1, for 24 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white solid 
(88 mg, 0.33 mmol, 75 %); mp 75-77 °C; RF  (EtOAc-hexane, 1:1) 0.55; u 
(KBr)/cm' 3053 (Ph-H), 2956 (CH2/CH3), 2928 (CH2/CH3), 2858 (CH2/CH3), 1754 
(C=O), 1698 (C=O), 1514 (Ph), 1438 (CH2ICH3) and 1328 (CH3); H  (250MHz; 
CDC13) 0.91 (3H, t, J 7.5, CH2CH2CH2CH3), 1.35 (2H, tq, J 7.5, CH2CH2CH2CH3), 
1.58 (2H, tt, J7.5, CH2CH2CH2CH3), 2.58 (2H, t, J7.5, CH2CH2CH2CH3), 3.07 (1H, 
dd, J 10.0 14.0, PhCHH), 3.52 (1H, dd, J4.0 14.0, PhCHH), 4.51 (1H, dd, J4.0 10.0, 
PhCH2CII), 7.13 (4H, s, Ph), 9.00 (1H, br s, Nil) ppm; 6 (63MHz, CDC13) 13.82 
(CH3), 22.23 (CH2), 33.40 (CH2), 35.16 (CH2), 38.20 (CH2), 53.58 (CH), 128.77 
(CH) 128.83 (CH), 132.83 (qC), 142.27 (qC), 170.84 (qC), 174.53 (qC) ppm; m/z 
(El) 263 (M, 8 %), 147 (M-SC(0)NHC(0)CH, 100); (Found M (El), 263.09726. 
C14H17NO2S requires 263.09800). 
6.18.11 5-(4-benzylbenzyl)thiazolidine-2,4-dione 253. 
General procedure 1, for 24 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (2:3) as eluent, afforded the title compound as a white solid 
(75 mg, 0.25 mmol, 57 %); mp 114-116 °C; RF  (EtOAc-hexane, 2:3) 0.42; Umax 
187 
Eiperimental: Synthesis. 
(KBr)/cm' 3053 (Ph-H), 2908 (CH2), 2842 (CH2), 1754 (C0), 1694 (C0), 1513 
(Ph), 1452 (CH2), 734 (Ph-H) and 698 (Ph-H); 6H (250MHz; CDC13) 3.08 (1H, dd, J 
10.0 14.0, PhCHH), 3.52 (1H, dd, J4.0 14.0, PhCHH), 3.97 (2H, s, PhCH2Ph), 4.50 
(1H, dd, J 4.0 10.0, PhCH2CH), 7.24 (9H, m, Ph), 9.15 (111, br s, NH) ppm; 5 
(63MHz, CDC13) 38.10 (CH2), 41.33 (CH2), 53.42 (CH), 126.02 (CH), 128.35 (CH), 
128.76 (CH), 129.04 (CH), 129.21 (CH), 133.39 (qC), 140.47 (qC), 140.56 (qC), 
170.96 (qC), 174.64 (qC) ppm; m/z (El) 297 (M, 2 %), 181 (M-SC(0)NRC(0)CH, 
12); (Found W (El), 297.0930. C17H15NO2S requires 297.0824). 
6.18.12 5-(4-methoxybenzyl)imidazolidine-2,4-dione 254. 
MeO ., 	e__~ 
NH 
General procedure 2, for 18 h. Purification by column chromatography on silica gel, 
with ethyl acetate-petroleum ether (bp 40-65°C) (3:1) as eluent, afforded the title 
compound as a white powder (87 mg, 0.40 mmol, 90 %); mp 177-179 °C (lit.,199 
177-179 °C); RF (EtOAc-petroleum ether (bp 40-65 °C), 3:1) 0.23; Umax (Film)/cm' 
1714 (C=O), 1611 (Ph), 1512 (Ph), 1419 (CH2ICH3) and 830 (Ph-H); 8H (250MHz; 
[ 2H6 ] DMSO) 2.86 (2H, d, J 5.0, PhCH2), 3.71 (3H, s, OCH3), 4.27 (1H, t, J 5.0, 
PhCH,CH), 6.83 (2H, d, J 9.0, Ph), 7.09 (2H, d, J 9.0, Ph), 7.91 (1H, br s., NH), 
10.40 (1H, br s., NH) ppm; 6c (63MHz; [2H6] DMSO) 35.53 (CH2), 55.05 (CH3), 
58.67 (CH), 113.59 (CH), 127.37 (qC), 130.93 (CH), 157.27 (qC), 158.18 (qC), 
175.37 (qC) ppm; m/z (El) 220 (M, 75 %), 121 (M-NIHC(0)NHC(0)CH, 85); (Found 
M- (El), 220.08435. C11H12N2030 requires 220.08479). 
188 
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General procedure 4, for 24 h.. Purification by column chromatography on silica gel, 
with ethyl acetate-petroleum ether (40-65°C) (3:1) as eluent, afforded the title 
compound as a white solid (70 mg, 0.33 mmol, 45 %); mp 208-209 °C; RF (EtOAc-
petroleum ether (bp 40-65 °C), 3:1) 0.29; UmaX  (Film)/cm-' 2237 (CN), 1708 (C=O) 
and 1594 (Ph); 8H  (200MHz; (CD3)2C0) 3.11(1 H, dd, J 6.5 14.0, PhCHH), 3.27 (1 H, 
dd, J 4.5 14.0, PhCHH), 4.50 (1H, dd, J 4.5 6.5, PhCH2CIJ), 7.08 (1H, br s, NH), 
7.50 (2H, d, J 8.5, Ph), 7.72 (2H, d, J 8.5, Ph), 9.52 (1H, br s, NH) ppm; Ei (50MHz; 
(CD3)2C0) 36.32 (CH2), 57.91 (CH), 109.84 (qC), 115.19 (qC), 130.02 (CH), 131.16 
(CH), 141.17 (qC), 155.59 (qC), 173.12 (qC) ppm; m/z (El) 215 (M, 58 %), 116 (M-
NIETC(0)NHC(0)CH, 48); (Found M (El), 215.06953. C11H9N302 requires 
215.06948). 
6.18.14 5-(2-methoxybenzyl)thiazolidine-2,4-dione 256. 
OMe 	.0 
LJ NH  
General procedure 3, for 46 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white 
powder (178 mg, 0.75 mmol, 83 %); mp 105-107 °C; RF  (EtOAc-hexane, 1:1) 0.38; 
Umax (Film)/cm' 3066 (Ph-H), 2940 (CH2/CH3), 2840 (CH2/CH3), 1752 (C0), 1698 
(C=O), 1602 (Ph), 1588 (Ph), 1494 (Ph), 1464 (CH2/CH3), 754 (Ph-H) and 720 
(CH2); 8H (250MHz; CDC13) 2.92 (1H, dd, J 10.5 13.5, PhCHH), 3.76 (1H, dd, J4.0 
189 
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13.5, PhCHII), 3.84 (3H, s, OCH3), 4.74 (111, dd, J4.0 10.5, PhCH2CH), 6.89 (2H, 
m, Ph), 7.14 (1H, m, Ph), 7.27 (1H, m, Ph) ppm; 8 (63MHz; CDC13) 34.30 (CH2), 
51.56 (CH), 55.09 (CH3), 110.31 (CH), 120.49 (CH), 124.41 (qC), 128.97 (CH), 
130.73 (CH), 157.33 (qC), 171.30 (qC) and 174.96 (qC) ppm; m/z (El) 237 (M, 10 
%), 121 (M-SC(0)NHC(0)CH, 93); (Found M (El), 237.04555. C11H11NO3S 
requires 237.04560). 
6.18.15 5-(2,6-dimethoxybenzyl)thiazolidine-2,4-dione 257. 
OMe 
ác NH  
General procedure 3, for 46 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (3:2) as eluent, afforded the title compound as a white 
powder (191 mg, 0.72 mmol, 79 %); mp 150-152 °C (lit.,200 152-153 °C); RF 
(EtOAc-hexane, 3:2) 0.48; Ufliax  (Film)/cm' 3053 (Ph-H), 2938 (CH2/CH3), 2837 
(CH2/CH3), 1750 (C=O), 1699 (C=O), 1596 (Ph), 1588 (Ph), 1475 (CH2/CH3), 776 
(Ph-H) and 721 (CH2); 6H (250MHz;  CDC13) 3.33 (1H, dd, J 10.0 13.5, PhCHH), 3.50 
(1H, dd, J 5.5 13.5, PhCHR), 3.81 (6H, s, 20CH3), 4.75 (1H, dd, J 5.5 10.5, 
PhCH2CR), 6.54 (2H, d, J 8.5, Ph), 7.20 (1H, t, J 8.5, Ph), 8.68 (1H, br s, Nil) ppm; 
(63MHz; CDC13) 26.51 (CH2), 50.92 (CH), 55.53 (CH3), 103.52 (CH), 112.65 
(qC), 128.65 (CH), 158.36 (qC), 171.74 (qC) and 175.05 (qC) ppm; m/z (El) 267 (M, 




6.18.16 5 -(3,5 -di-.t-butyl-4-hydroxybenzyl)thiazolidine-2,4-dione 258. 
NH 
General procedure 3, for 48 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white 
powder (264 mg, 0.79 mmol, 87 %); mp 72-74 °C; RF (EtOAc-hexane, 1:1) 0.51; 
Umax  (Film)/cm-' 3206 (0-H), 3064 (Ph-H), 2959 (CH2ICH3), 2915 (CH2ICH3), 2874 
(CH2/CH3), 1754 (CO), 1697 (C=0), 1591 (Ph), 1436 (CH2/CH3), 1392 (CH3), 876 
(Ph-H) and 737 (CH2); 6H  (200MHz; CDC13) 1.42 (18H, s, 6CH3), 3.00 (1H, dd, J 
10.5 14.0, PhCHH), 3.50 (1H, dd, J 3.5 14.0, PhCHH), 4.47 (1H, dd, J 3.6 10.5, 
PhCH2CIJ), 7.02 (2H, s, Ph) ppm; 6c (50MHz; CDC13) 29.92 (CH3), 34.17 (qC), 
38.83 (CH2), 54.31 (CH), 125.46 (CH), 126.54 (qC), 136.24 (qC), 153.08 (qC), 
171.18 (qC), 174.90 (qC) ppm; m/z (El) 335 (M, 10 %), 333 (M-2H, 51), 219 (M-
SC(0)NHC(0)CH, 100). 
6.18.17 5 -[2R-benzyl-3 ,4-dihydro-2H- 1-benzopyran-6-yl)methyllthiazolidine-2,4-
dione 259. 
General procedure 1, for 21 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white 
powder (86 mg, 0.24 mmol, 56 %); mp 180-182 °C; RF  (EtOAc-hexane, 1:1) 0.43; 
Umax  (Film)/cm' 3062 (Ph-H), 3028 (Ph-H), 2923 (Cl2), 2850 (Cl2), 1753 (C0), 
191 
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1698 (C=O), 1614 (Ph), 1585 (Ph), 1498 (Ph), 1246 (C-O), 822 (Ph-H), 748 (Ph-H) 
and 701 (Ph-H); 8H (250 MHz; CDC13) 1.69 (1H, m, CHH), 1.97 (1H, s, CHH), 2.73 
(2H, m, CH2), 2.86 (1H, dd, J 7.0 13.5, OCHCHHPh), 2.99 (1H, dd, J 10.0 14.0, 
SCHCHHPh), 3.13 (1H, dd, J 6.0 13.5, OCHCHHPh), 3.42 (1H, J 4.0 14.0, 
SCHCHHPh), 4.20 (1H, m, OCHCH2Ph), 4.45 (1H, dd, J4.0 10.0, SCHCH2Ph), 6.75 
(1H, d, J 8.0, Ph), 6.94 (2H, m, Ph); 7.28 (5H, m, Ph), 8.78 (1H, br s, Nil) ppm; & 
(63MHz; CDC13) 24.42 (CH2), 26.22 (CH2), 37.78 (CH2), 41.59 (CH2), 53.79 (CH), 
76.56 (CH), 117.00 (CH), 122.18 (qC), 126.32 (CH), 127.05 (qC), 127.76 (CH), 
128.24 (CH), 129.42 (CH), 130.09 (CH), 137.54 (qC), 154.21 (qC), 170.75 (qC), 
174.36 (qC) ppm; m/z (El) 353 (M, 37 %), 262 (M-CH2Ph, 18) and 237 (M-
SC(0)NHC(0)CH, 82); (Found M (El), 353.10962. C20H19NO3S requires 
353.10857). 
6.18.18 5 -(1-methyl-i -phenylmethyl)thiazolidine-2,4-dione 260. 
General procedure 3, for 27 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a white solid 
(187 mg, 0.85 mmol, 93 %); mp 86-88 °C; RF  (EtOAc-hexane, 1:1) 0.58; Umax 
(Film)/cm' 3061 (Ph-H), 2973 (CH3), 1751 (C=O), 1694 (C0), 1603 (Ph), 1495 
(Ph), 1453 (CH3), 1382 (CH3), 764 (Ph-H) and 700 (Ph-H); 6H  (250MHz; CDC13) 
1.41 (1.8H, d, J 7.0, CH3), 1.48 (1.2H, d, J 7.0, CH3), 3.73 (0.4H, m, 
PhCH(CH3)CH), 3.81 (0.6H, m, PhCH(CH3)CH), 4.54 (0.4H, d, J 5.0, 
PhCH(CH3)CH), 4.60 (0.6H, d, J3.5, PhCH(CH3)CI-1), 7.25 (5H, m, Ph), 8.76 (0.4H, 
br s, NH), 9.20 (0.6H, br s, Nil) ppm; 5 (63MHz, CDC13) 13.36 (CH3), 19.60 (CH3), 
39.92 (CH), 41.43 (CH), 58.58 (CH), 59.56 (CH), 126.97 (CH), 127.50 (CH), 127.68 
(CH), 128.27 (CH), 128.80 (CH), 138.90 (qC), 141.32 (qC), 170.62 (qC), 171.26 
192 
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(qC), 174.15 (qC), 174.39 (qC) ppm; m/z (El) 221 (M, 4 %), 105 (M-
SC(0)NHC(0)CH, 100); (Found M (El), 221.05136. C1 H, 1NO2S requires 
221.05 105). 
6.18.19 5 -(1-methyl-i -(4-methoxyphenyl)methyl)thiazolidine-2,4-dione 261. 
General procedure 3, for 27 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a gummy 
solid (183 mg, 0.73 mmol, 80 %); RF  (EtOAc-hexane, 1:1) 0.46; Umax  (Film)/cm' 
3073 (Ph-H), 2956 (CH3), 2912 (CH3), 2824 (Cl3), 1752 (C=O), 1697 (C=O), 1610 
(Ph), 1514 (Ph), 1458 (CH3), 1380 (CH3) and 832 (Ph-H); H (250MHz; CDC13) 1.37 
(1.9H, d,J7.5, CH3), 1.43(1.111, d,J7.5, CH3), 3.76(1.211, s, OCH3), 3.77(111, m, 
PIICH(CH3)CH), 3.78 (1.8H, s, OCH3), 4.50 (0.351, d, J 5.0, PhCH(CH3)CI]), 4.57 
(0.65H, d, J3.5, PhCH(CH3)CII), 6.81 (0.7H, d, J9.0, Ph), 6.86 (1.3H, d, J9.0, Ph), 
7.17 (2H, d, J 8.5, Ph), 8.91 (0.35H, br s, NH), 9.33 (0.65H, br s, NH) ppm; 
(63MHz, CDC13) 13.51 (CR3), 19.71 (CH3), 39.13 (CH), 40.53 (CH), 54.99 (CR3), 
55.09 (CR3), 58.92 (CH), 59.86 (CH), 113.49 (CH), 114.04 (CH), 128.28 (CH), 
129.35 (CH), 130.73 (qC), 133.32 (qC), 158.68 (qC), 158.78 (qC), 170.89 (qC), 
171.46 (qC), 174.42 (qC), 174.53 (qC) ppm; m/z (El) 251 (M, 14 %), 135 (M-









General procedure 3, for 27 h. Purification by column chromatography on silica gel, 
with ethyl acetate-hexane (1:1) as eluent, afforded the title compound as a gummy 
solid (193 mg, 0.73 mmol, 80 %); RF  (EtOAc-hexane, 1:1) 0.51; Umax  (Film)/cm' 
3074 (Ph-H), 2965 (CH2/CH3), 2934 (CH2/CH3), 2882 (CHICH2ICH3), 2838 
(CH2ICH3), 1752 (CO), 1697 (CO), 1611 (Ph), 1513 (Ph), 1459 (CH2/CH3) and 
831 (Ph-H); 8H (250MHz; CDC13) 0.82 (1.8H, t, J7.5, CH2CH3), 0.87(1.211, t, J7.5, 
CH2CH3), 1.68 (1.2H, in, CH2CH3), 2.05 (0.8H, in, CH2CH3), 3.77 (1.2H, s, OCH3), 
3.79 (1.8H, s, OCH3), 4.50(0.611, d,J3.5, PhCH(CH2CH3)CII), 4.57 (0.4H, d,J5.0, 
PhCH(CH2CH3)CH), 6.81 (0.8H, d, J9.0, Ph), 6.86 (1.2H, d, J9.0, Ph), 7.15 (211, d, 
J 8.5, Ph), 8.40 (0.4H, br s, NH), 8.85 (0.611, br s, NH) ppm; 6 (63MHz, CDC13) 
11.63 (CH3), 11.84 (CH3), 22.19 (CH2), 26.80 (CH2), 47.54 (CH), 47.59 (CH), 55.03 
(CH3), 55.13 (CH3), 57.41 (CH), 59.20 (CH), 113.54 (CH), 114.18 (CH), 128.47 
(qC), 128.82 (CH), 130.10 (CH), 131.28 (qC), 158.86 (qC), 158.93 (qC), 170.41 
(qC), 170.78 (qC), 174.12 (qC) ppm; m/z (El) 265 (M, 6 %), 149 (M-
SC(0)NHC(0)CH, 100); (Found M(EI), 265.0765. C13H15NO3S requires 265.0773). 
194 
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6.18.21 5-(4-methoxybenzyl-d)thiazolidine-2,4-dione 263. 
NH 
MeO 01 \ 
General procedure 3, for 24 h. The product was dried at 40 °C under vacuum to 
afford the title compound as a white powder (169 mg, 0.71 mmol, 78 %); mp 104-
105 °C; RF  (EtOAc-hexane, 1:1) 0.38; Umax  (Film)/cm' 3064 (Ph-H), 2936 (CH3), 
2838 (CH3), 2788 (Cl3), 1754 (C=O), 1694 (C=O), 1610 (Ph), 1584 (Ph), 1514 (Ph), 
1462 (CH3) and 1383 (CH3); 8H  (250MHz; CDC13) 3.07 (0.311, d, J 9.5, PhCHD), 
3.43 (0.711, d, J 4.0, PhCDH), 3.79 (3H, s, OCH3), 4.49 (0.5H, d, J 4.0, 
PhCHDCR), 4.49 (0.5H, d, J9.5, PhCHDCR), 6.85 (2H, d, J9.0, Ph), 7.14 (211, d, 
J9.0, Ph), 8.78(111, br s, NH) ppm; 8c (63MHz; CDC13) 37.28 (t, J20, CHD), 53.59 
(CH), 55.12 (CH3), 114.08 (CH), 127.45 (qC), 130.17 (CH), 158.89 (qC), 170.58 
] 
(qC), 174.29 (qC) ppm; m/z (El) 238 (M, 15 %), 122 (M-SC(0)NHC(0)CH, 100); 
(Found M(EI), 238.05210. CJ1H10DN03S requires 238.05225). 
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7. Experimental : Biotransformations. 
7.1 General Experimental. 
Instrumentation and hplc conditions are shown in Sect. 6.1. 
The Rhodotorula rubra CBS 6469 described in this work was obtained from the 
Centraalbureau Voor Schimmelcultures, Baam, Netherlands. 
The growth medium for Rhodotorula rubra CBS 6469 was prepared as follows: 
Yeast extract (9 g) and mycological peptone (18 g) were dissolved in deionised water 
(900 cm') and the pH adjusted to 7.0-7.2 with 2.0 M NaOH solution before a 30% 
w/v D-glucose solution (99 cm') was added. This was autoclaved at 115 °C for 20 
mm. 
The cells were grown and prepared for use as follows 
A 10 tl ioopflui of Rhodotorula rubra CBS 6469 was used to inoculate 180 cm' of 
growth medium in a 500 cm3 baffled Erlenmeyer flask. This was shaken in an orbital 
shaker for 72 h at 30 °C and 220 rpm before a 2 cm' aliquot was used to inoculate a 
similar flask which was shaken for 48 h at 30 °C and 220 rpm. The cells were 
recovered by centrifugation at 3000 rpm/4 °C for 10 min before being washed twice 
with water. Each time the cells were recovered by centrifugation at 3000 rpm/4 °C 
for 10 mm. They were then washed with 0.1 M Tris-HC1 buffer (pH 8.0), containing 
5 % w/v sucrose, and recovered by centrifugation at 4500 rpm/4 °C for 15 min before 
being resuspended in the same buffer. 
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Low viscosity sodium alginate was purchased from Sigma (catalogue number A 
2158) and the syringe needle used was supplied Aldrich (18 guage SS, 6 inches long, 
deflecting tip, catalogue number Z10271-7). 
Mycological peptone and yeast extract were obtained from Oxoid. 
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7.2 Initial Optimisation Studies. 
7.2.1 General Procedure. 
Rhodotorula rubra CBS 6469 was grown in 180 cm' of growth medium before being 
resuspended in 0.1 M Tris-HCl buffer (pH 8.0), containing 5% w/v sucrose, to a total 
volume of 84 cm'. Two 2 cm' aliquots of the cell suspension were transferred to 
sample vials ensuring thorough vortexing between each transfer. 150 tl of a solution 
of 172 (0.33 mmol) in DMSO (6 cm3) was added to each aliquot and the mixture 
continuously shaken at 30 °C/ 220 rpm for 24 h. 
7.2.2 Biotransformation Using Part of the Cell Suspension and 18.75 % v/v 1,4-
Dioxane as Co-solvent. 
The remaining 80 cm' of cell suspension was diluted to 138 cm' with the same 
buffer. 80 cm3 of the resulting cell suspension was added to a 500 cm' Erlenmeyer 
flask. 172 (0.33 mmol) in 1,4-dioxane (15 cm') was added and the mixture 
continuously shaken at 30 °C and 220 rpm for 24 h. At this point a 200 il aliquot 
was removed and diluted with 809 pl of acetonitrile, filtered and subjected to hplc 
analysis. The extent of conversion was measured to be 25 %. Similar treatment of the 
2 cm3 aliquots indicated 62 % conversion. 
7.2.3 Biotransformation Using all of the Cell Suspension and 18.75 % v/v 1,4-
Dioxane as Co-solvent. 
The remaining 80 cm' of cell suspension was added to a 500 cm' Erlenmeyer flask. 
172 (0.33 mmol) in 1,4-dioxane (15 cm') was added and the mixture continuously 
shaken at 30 °C and 220 rpm for 24 h. At this point a 200 pd aliquot was removed 
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and diluted with 800 p.l of acetonitrile, filtered and subjected to hplc analysis. The 
extent of conversion was measured to be 49 %. Similar treatment of the 2 cm' 
aliquots indicated 59 % conversion. 
7.2.4 Biotransformation Using all of the Cell Suspension and 12 % v/v 1..4-Dioxane 
as Co-solvent. 
The remaining 80 cm' of cell suspension was added to a 500 cm' Erlenmeyer flask. 
172 (0.33 mmol) in 1,4-dioxane (9.6 cm') was added and the mixture continuously 
shaken at 30 °C and 220 rpm for 24 h. At this point a 200 p.1 aliquot was removed 
and diluted with 800 p.1 of acetonitrile, filtered and subjected to hplc analysis. The 
extent of conversion was measured to be 73 %. Similar treatment of the 2 cm' 
aliquots indicated 79 % conversion. 
7.2.5 Biotransformation Using all of the Cell Suspension and 7.5 % v/v DMSO as 
Co-solvent. 
The remaining 80 cm3 of cell suspension was added to a 500 cm' Erlenmeyer flask. 
172 (0.33 mmol) in DMSO (6 cm') was added and the mixture continuously shaken 
at 30 °C and 220 rpm for 24 h. At this point a 200 p.1 aliquot was removed and 
diluted with 800 p.1 of acetonitrile, filtered and subjected to hplc analysis. The extent 
of conversion was measured to be 58 %. Similar treatment of the 2 cm' aliquots 
indicated 57 % conversion. 
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7.3 Biotransformations Using Varying Amounts of Co-solvent. 
7.3.1 General Procedure. 
Rhodotorula rubra CBS 6469 was grown in 180 cm' of growth medium before being 
resuspended in 0.1 M Tris-HC1 buffer (pH 8.0), containing 5% w/v sucrose, to a total 
volume of 80 cm'. 2 cm' aliquots of the cell suspension were transferred to sample 
vials ensuring thorough vortexing between each transfer. A series of solutions 
containing equal amounts of 172 in varying volumes of solvent were prepared by 
diluting a stock solution of 172. An appropriate amount of each of these solutions, 
(equivalent to the addition of 1.6 x iO mol of substrate) were added to the aliquots 
of cell suspension. These suspensions were continuously shaken at 30 °C and 220 
rpm. At this point a 200 j.d aliquot was removed and diluted with 800 p.1 of 
acetonitrile, filtered and subjected to hplc analysis to determine the extent of 
conversion. 
7.3.2 Reduction of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione 172 with 
varying volumes of DMSO. 
2 cm' of a stock solution of 172 (531 mg, 2.26 mmol) in DMSO (14 cm') was diluted 
with various volumes of DMSO. An appropriate volume of each of these solutions 
was added to aliquots of cell suspension and each aliquot was shaken at 30 °C and 
220 rpm for 14 h. The results are shown in Table 7-1. 
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7.3.3 Reduction of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione 172 with 
varying volumes of 1 ,4-dioxane. 
1 cm' of a stock solution of 172 (388 mg, 1.65 mmol) in 1,4-dioxane (10 cm') was 
diluted with various volumes of 1 ,4-dioxane. An appropriate volume of each of these 
solutions was added to aliquots of cell suspension and each aliquot was shaken for 24 
h. The results are shown in table 7-2. 
Solution 	Volume of 	Volume of 	Ratio of DMSO to Conversion 
DMSO added solution added cell suspension 	(%) 
(cm') 	 (p.!) 	 (% v/v) 
1 	12 350 17.5 20 
2 10 300 15.0 20 
3 	8 250 12.5 22 
4 6 200 10.0 26 
5 	 4 150 7.5 33 
6 2 100 5.0 39 
7 	0 50 2.5 56 
Table 7-1 . Relationship between rate of conversion and % v/v of DMSO. 
Solution 	Volume of 	Volume of 	Ratio of 1,4- 	Conversion 
1 ,4-dioxane solution added dioxane to (%) 
added (cm') 	(p.1) 	cell suspension 
(% vlv) 
1 20 1050 52.5 0 
2 18 950 47.5 0 
3 16 850 42.5 0 
4 14 750 37.5 0 
5 12 650 32.5 0 
6 10 550 27.5 17 
7 8 450 22.5 47 
8 6 350 17.5 90 
Table 7-2 . Relationship between rate of conversion and % v/v of 1,4-dioxane. 
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Rhodotorula rubra CBS 6469. 
0.1 M Tris-HCI buffer (pH 8.0), 





7.4.1 General procedure.7  
Rhodotorula rubra CBS 6469 was grown in 180 cm' of growth medium before being 
resuspended in 0.1 M Tris-HC1 buffer (pH 8.0), containing 5% wlv sucrose, -to a total 
volume of 80 cm' in a 500 cm' Erlenmeyer flask. Substrate (0.31-0.33 mmol in 6 cm3 
DMSO) was added and the mixture continuously shaken at 30 °C and 220 rpm until 
hplc indicated complete conversion. The whole mixture, including cells, was 
continuously extracted into DCM (150 cm') for 18 h. The solvent was dried over 
magnesium sulfate and removed under reduced pressure. In each case column 
chromatography on silica gel was performed to remove traces of DMSO. 




On 0.33mmol scale hplc indicated complete conversion to product after 58 h. 
Purification by column chromatography on silica gel, with ethyl acetate-petroleum 
ether (bp 40-65 °C) (2:1) as eluent, afforded the title compound as a white solid (68 




7.4.3 5-(4-chlorobenzyl)thiazolidine-2,4-dione 244. 
0 
CI 
On 0.32 mmol scale hplc indicated complete conversion to product after 50h. 
Purification by column chromatography on silica gel, with ethyl acetate-petroleum 
ether (bp 40-65 °C) (2:1) as eluent, afforded the title compound as a white solid (32 
mg, 0.13 mmol, 41 %). Data coincided with that for the same compound prepared by 
catalytic hydrogenation. 
7.4.4 5-(4-nitroobenzyl)thiazolidine-2,4-dione 246. 
On 0.33 mmol scale hplc indicated complete conversion to product after 17 h. 
Purification by column chromatography on silica gel, with ethyl acetate-hexane (2:1) 
as eluent, afforded the title compound as a orange powder (68 mg, 0.27 mmol, 82 
mp 176-178 °C; RF  (EtOAc-hexane, 3:2) 0.50; U max  (KBr)/cm 1 2924 (CH2), 1758 
(C=O), 1700 (C=O), 1596 (Ph), 1512 (NO2), 1448 (CH2), 1347 (NO2), 841 (Ph-H) 
and 719 (CH2); 5H (250MHz; (CD3)2C0) 3.44 (1H, dd, J9.0 14.0, PhCHH), 3.67 (1H, 
dd, J 5.0 14.0, PhCHR), 4.96 (1H, dd, J 5.0 9.0, PhCH2CH), 7.64 (211, d, J 9.0, Ph), 
8.23 (2H, d, J 9.0, Ph), 10.76 (1H, br s, Nil) ppm; ö (63MHz, (CD3)2C0) 36.46 
(CH2), 51.02 (CH), 122.60 (CH), 129.91 (CH), 143.86 (qC), 146.48 (qC), 169.24 
(qC), 173.49 (qC) ppm; m/z (El) 252 (M, 37 %), 220 (M-02, 7), 136 (M-










On 0.33 mmol scale hplc indicated complete conversion to product after 17 h. 
Purification by column chromatography on silica gel, with ethyl acetate-petroleum 
ether (bp 40-65 °C) (2:1) as eluent, afforded the title compound as a white solid (64 
mg, 0.28 mmol, 84 %). Data coincided with that for the same compound prepared by 
catalytic hydrogenation. 
7.4.6 5-(cyclohexylmethyflthiazolidine-2.4-dione 247. 
0 	 0 




containing 5 % w/v sucrose, DMSO. 
0.1 M Tris-HCI buffer (pH 8.0), 	0 	S~ 
__~S 
On 0.33 mmol scale hplc indicated complete conversion to product after 24 h. 
Purification by column chromatography on silica gel, with ethyl acetate-hexane (3:2) 
as eluent, afforded the title compound as a white solid (58 mg, 0.27 mmol, 82 %). 









On 0.31 mmol scale hplc indicated complete conversion to product after 48 h. 
Purification by column chromatography on silica gel, with ethyl acetate-petroleum 
ether (bp 40-65 °C) (1:1) as eluent, afforded the title compound as a white solid (68 
mg, 0.28 mmol, 90 %). Data coincided with that for the same compound prepared by 
catalytic hydrogenation 263 except: 6H  (250MHz; CDC13) 3.09 (0.5H, d, J 9.5, 
PhCHD), 3.43 (0.5H, d, J 3.5, PhCDH), 3.79 (3H, s, OCH3), 4.49 (0.5H, d, J 3.5, 
PhCHDCH), 4.49 (0.5H, d, J9.5, PhCHDCH), 6.85 (2H, d, J9.0, Ph), 7.14 (2H, d, J 
9.0, Ph), 8.37 (1H, br s, NH) ppm. 
7.5 Screen of Compounds against Rhodotorula rubra CBS 6469. 
7.5.1 General Procedure. 
Rhodotorula rubra CBS 6469 was grown in 180 cm3 of growth medium before being 
resuspended in 0.1 M Tris-HC1 buffer (pH 8.0), containing 5% w/v sucrose, to a total 
volume of 80 cm'. 2 cm3 aliquots of the cell suspension were transferred to sample 
vials ensuring thorough vortexing between each transfer.To each aliquot 150 tl of a 
substrate solution (0.33 mmol in 6 cm' DMSO) was added and the resultant mixture 
was incubated at 30 °C and 220 rpm for either 6 or 24 h. At this point a 200 tl 
aliquot was removed and diluted with 800 tl of acetonitrile, filtered and subjected to 
hplc analysis to determine the extent of conversion. 
Every time a batch of compounds was screened two aliquots of cell suspension were 
used to biotransform 172 as a standard. 
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7.5.2 Screen Results : Reduction of (Z)-5-(4-susbtitutedbenzylidene)thiazolidine-
2,4-diones. 




170 H yes 24 36 46 
171 OH yes 24 16 46 
172 OMe yes 24 46 46 
173 OEt yes 24 51 36 
174 OPr yes 24 32 46 
175 OBu yes 24 21 46 
176 OP? yes 24 13 36 
177 OBu' yes 24 35 46 
178 OBn yes 24 6 46 
179 SMe yes 24 40 61 
180 Me yes 24 26 61 
181 Et no 24 
182 Pr no 24 
183 Bu no 24 
184 Bn no 24 
185 F yes 24 100 36 
186 Cl yes 24 88 36 
187 Br yes 24 84 74 
188 I yes 24 43 46 
189 CN yes 6 63 25 
190 NO2 yes 6 44 25 
191 OCF3 yes 6 38 25 
248 OTBDMS yes 24 93 46 
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R X' X2 Substrate Reaction Conversion Conversion 
Time (h) 	 of 172 
192 OMe NH 0 no 24 
193 Cl NH 0 no 24 
194 CN NH 0 no 24 
195 OMe S NH n.d. 24 
196 OMe S S n.d. 24 




R Substrate Reaction 	Conversion 	Conversion 
Time (h) of 172 
197 2-OMe n.d. 24 
198 3-OMe yes 24 	15 	43 
199 2,6-OMe n.d. 24 
200 3,5-But-4-OH no 24 
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7.5.5 Screen Results : Reduction of (Z)-5-(1-alkyl-1-(4-substitutedphenyl 
methylidene)thiazolidine-2,4-diones. 
R' R2 Substrate Reaction Conversion Conversion 
Time (h) 	 of 172 
201 H Me 	no 24 
202 OMe Me no 24 
203 OMe Et 	no 24 




R Substrate Reaction Conversion Conversion 
Time (h) 	 of 172 
204 Me yes 	24 	48 	44 
205 Bn yes 24 49 44 
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7.5.7 Screen Results: Reduction of Miscellaneous Thiazolidine-2,4-diones. 
Substrate Reaction Conversion Conversion 
Time (h) 	 of 172 
R-231 no 24 
S-231 no 24 
235 yes 24 	6 and 28 	74 
6 n.d. 24 
236 yes 24 	96 	44 
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7.6 Immobolisation of Rhodotorula rubra CBS 6469. 
7.6.1 Reduction of 172 by Rhodotorula rubra CBS 6469 Immobilised by Gel 





Rhodotorula rubra CBS 6469 
(entrapped in sodium alginate), 
0.1 M Tris-HCI buffer (pH 8.0), 





Rhodotorula rubra CBS 6469 was grown in 180 cm' of growth medium before being 
resuspended in 0.1 M Tris-HC1 buffer (pH 8.0), containing 5% w/v sucrose, to a total 
volume of 27 cm3. This suspension was mixed with a 2 % w/v solution of low 
viscosity sodium alginate solution in the same buffer (22 cm3)a.  This mixture was 
extruded from a syringe needle at a height of 8 cm into a 0.2 M aqueous solution of 
calcium chloride and allowed to harden for 30 min. The beads were recovered by 
filtration and and washed with water (400 cm3) before being suspended in 0.1 M 
Tris-HC1 buffer (pH 8.0), containing 5% w/v of sucrose, (80 cm'). 172 (75 mg, 0.32 
mmol) was added in DMSO (6 cm3) and the mixture shaken at 30 °C and 220 rpm for 
48 h at which point hplc had indicated complete conversion to product. The beads 
were removed by filtration and the filtrate was continuously extracted into DCM for 
18 h. The DCM was dried over magnesium sulfate and evaporated under reduced 
pressure. Purification by column chromatography over silica gel, with ethyl acetate-
hexane (3:2) as eluent, afforded the reduced compound as a white solid (75 mg, 0.19 
mmol, 58 %). Data coincided with that of the same compound prepared by catalytic 
hydrogenation. 
a  Low viscosity sodium alginate solution was shaken at 30 °C and 220 rpm for 24 h before use to 
ensure complete dissolution of the polymer. 
b  The mixture was extruded at such a rate to ensure that the beads formed were uniform in size and 
spherical in appearance. 
210 
Experimental: Biotransformations. 
7.7 Mechanistic Studies. 
7.7.1 Biotransformation of (Z)-5-(4-methoxybenzylidene)thiazolidine-2,4-dione 172 






Rhodotorula rubra CBS 6469 
0. 1M Tris-HCI, containing 5% wlv 




Rhodotorula rubra CBS 6469 was grown in 180 cm' of growth medium. After the 
initial wash with water the cells were resuspended in water, to a total volume of 100 
cm'. 30 cm' of this cell suspension was centrifuged at 3000 rpm/4 °C for 10 mm 
before being washed with 0.1 M Tris-HC1 buffer (pH 8.0), containing 5 % w/v 
sucrose, in D20 (4 x 15 cm'). After each wash the cells were recovered by 
centrifugation at 4500 rpm/4 °C for 15 mm. The cells were resuspended in the same 
buffer to a total volume of 20 cm' before 172 (19 mg, 80 j.tmol) was added in [2H6] 
DMSO (1.5 cm') and shaken at 30 °C and 220 rpm. After 7 d the reaction appeared 
to have ceased at 87 % conversion and the whole mixture was continuously extracted 
into DCM (50 cm') for 18 h. The DCM was dried over magnesium sulfate and 
evaporated under reduced pressure. Purification by column chromatography on silica 
gel, with ethyl acetate-hexane (3:2) as eluent, afforded a mixture of compounds 265 




8. Future Work. 
Given a longer time period to continue the research contained within this thesis there 
are certain points that would need to be addressed. 
The possible reduction mechanism outlined in Fig. 4-10 indicates that the sulfur may 
be required to help activate the double bond. Utaka has shown that 2-heptenoic acid 
and its methyl ester are not reduced whereas the 2-chloro compound is.90 Also, Das 
et al., have shown that the isolated 
styryl double bonds of 147 and 148 
are reduced but the enamide double 
bond is left untouched. 108 	 147 (n=8) 148 (n=6) 
It may be possible that as the carbonyl at position 4 in the 
thiazolidine-2,4-dione ring is 'amide-like' this may not be a 
powerful enough activating group on its own. Incubation of a 	
NH 
substrate from which the 4-carbonyl has been removed (eg. 266) 	266 	0 
would help identify whether or not this functionality is required. 
It would still be advantageous to develop a chiral hplc method to monitor the 
reduction of 172 and 215 at low pH, as one of the problems associated with these two 
reactions is the determination of when racemisation is occurring. Reduction of the 
deuterated substrate 215 to produce optically enriched product may help determine 
whether the hydrogen incorporated at the P position is in the pro-R or pro-S position, 
as well as the mode of addition across the double bond. 
The relative reduction rates shown by this Rhodotorula rubra CBS 6469 system are 
specific to the conditions used. Identification and isolation of the responsible enzyme 
may allow the calculation of relative reduction rates with less contributing factors, 
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such as diffusion through the cell wall. If the protein is soluble this may also be 
possible with a crude cell free extract. The use of purified or partially purified 
enzyme preparations would allow the determination of the nature of the cofactor 
involved and investigation of cofactor recycling. 
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9. Appendix 1: HPLC Data. 
This appendix outlines the hplc retention times of unsaturated and saturated 
compounds as utilised to monitor hydrogenation reactions, and the screening of 
compounds against Rhodotorula rubra CBS 6469. 
Eluent Compostion (%) Retention Time (mm) 
Unsaturated Saturated 
Bufferc Acetonitrile Compound Compound 
6 70 30 26.38 25.72 
170 80 20 13.87 11.57 
171 90 10 28.38 12.82 
172 80 20 35.12 23.77 
173 80 20 53.42 32.15 
174 70 30 15.38 12.89 
175 70 30 28.59 22.80 
176 70 30 13.63 12.11 
177 70 30 28.25 23.40 
178 70 30 27.11 24.23 
179 80 20 50.72 34.27 
180 80 20 56.93 46.38 
181 70 30 17.42 15.28 
182 60 40 8.40 11.43 
183 60 40 20.92 12.55 
184 60 40 6.50 4.00 
185 80 20 17.18 13.83 
186 80 20 46.35 31.57 
187 80 20 50.92 35.60 
188 80 20 65.98 42.35 
189 80 20 14.67 10.72 
190 80 20 23.27 14.07 
191 70 30 25.85 14.68 
192 80 20 23.52 10.38 
193 80 20 42.18 
194 80 20 17.55 7.90 
195 70 30 8.62 
196 80 20 39.70 
50 mM NaH2PO4 (pH 7) 
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Eluent Compostion (%) Retention Time (mm) 
Unsaturated Saturated 
Buffer Acetonitrile Compound Compound 
197 80 20 28.67 29.83 
198 80 20 33.70 24.85 
199 70 30 15.00 15.44 
200 60 40 24.50 27.95 
201 70 30 11.93 9.27 and 10.43 
202 70 30 20.04 9.42 and 10.93 
203 70 30 35.41 16.85 and 19.58 
204 60 40 29.02 15.20 
205 80 20 21.93 14.82 
231 80 20 65.29 34.99 
235 70 30 24.13 11.20 and 14.06 
236 70 30 17.21 15.40 
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10.1 X-Ray Crystal Structure of 172. 
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A. CRYSTAL DATA 
Empirical formula C13H15N04S2, [C1 I H9NO3S] .DMSO 
Formula weight 313.38 
Wavelength 1.54178 A 
Temperature 150(2) K 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 16.372(4) A 	alpha = 90 deg. 
b = 11.617(2) A beta = 101.346(18) deg. 
c = 7.6659(17) A gamma = 90 deg. 
Volume 1429.5(5) A3 
Number of reflections for cell 86 (20 <theta < 22 deg.) 
Z 4 
Density (calculated) 1.456 Mg/m' 
Absorption coefficient 3.500 mnt' 
F(000) 656 






0.54 x 0.42 x 0.27 mm 
Theta range for data collection 
	
2.75 to 69.97 deg. 













(Tmin= 0.183, Tm =0.506) 
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C. SOLUTION AND REFINEMENT. 
Solution direct methods (SHELXS-97) 
Refinement type Full-matrix least-squares on F2 
Program used for refinement SHELXL-97 
Hydrogen atom placement geometric 
Hydrogen atom treatment riding 
Data! restraints / parameters 2556/0/185 
Goodness-of-fit on F2 1.066 
Conventional R [F>4sigma(F)] Ri = 0.0435 [2405 data] 
Weighted R (F2 and all data) wR2 = 0.1277 
Extinction coefficient 0.0034(6) 
Final maximum delta/sigma 0.001 
Weighting scheme 
caic w[&(F02)+(0.0878P)2+0.6934P] where 3P=(Fo2+2Fc2) 
Largest diff. Peak and hole 0.413 and -0.561 e.A 3 
Table 10-1: Crystal data and structure refinement for 172. 
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X y z U(eq) 
S(1) 1516(1) 7862(1) 468(1) 33(1) 
0(2) 3001(1) 7604(2) -360(2) 46(1) 
C(2) 2586(1) 8155(2) 475(3) 34(1) 
N(3) 2850(1) 9077(2) 1545(2) 33(1) 
0(4) 2451(1) 10349(2) 3491(2) 45(1) 
 2284(1) 9573(2) 2435(3) 34(1) 
 1453(1) 9028(2) 1883(3) 30(1) 
 789(1) 9475(2) 2425(3) 33(1) 
 -83(1) 9149(2) 2013(3) 32(1) 
 -654(2) 9812(2) 2728(3) 36(1) 
 -1496(2) 9593(2) 2354(3) 38(1) 
 -409(1) 8239(2) 893(3) 37(1) 
 -1254(2) 8009(2) 489(3) 37(1) 
 -1803(1) 8697(2) 1202(3) 35(1) 
0(13) -2643(1) 8557(2) 861(2) 41(1) 
C(14) -2989(2) 7756(2) -499(3) 40(1) 
S(1S) 5012(1) 709(1) 2035(1) 35(1) 
0(1S) 4500(1) -279(2) 2493(3) 48(1) 
C(1 S) 6071(2) 286(2) 2715(4) 49(1) 
C(2S) 5005(2) 1778(2) 3701(4) 46(1) 
Table 10-2: Atomic coordinates (x104) and equivalent isotropic displacement parameters 
(A2x103) for 172. U(eq) is defined as one third of the trace of the 
orthogonalized UiJ tensor. 
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Table 10-3 Bond lengths [A] and angles [deg]for 172. 
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Ull U22 U33 U23 U13 U12 
S(1) 31(1) 26(1) 42(1) -6(1) 9(1) -1(1) 
0(2) 33(1) 46(1) 59(1) -12(1) 11(1) 2(1) 
C(2) 33(1) 30(1) 39(1) 3(1) 7(1) 1(1) 
N(3) 32(1) 29(1) 39(1) 2(1) 7(1) -4(1) 
0(4) 48(1) 34(1) 51(1) -11(1) 7(1) -7(1) 
 40(1) 24(1) 37(1) 3(1) 6(1) -3(1) 
 36(1) 22(1) 32(1) 0(1) 6(1) -1(1) 
 40(1) 24(1) 35(1) -1(1) 8(1) 1(1) 
 38(1) 25(1) 35(1) 2(1) 10(1) 3(1) 
 43(1) 29(1) 36(1) -1(1) 12(1) 4(1) 
 43(1) 33(1) 41(1) 0(1) 16(1) 10(1) 
 36(1) 31(1) 45(1) -6(1) 13(1) 2(1) 
C(1 l) 36(1) 31(1) 45(1) -4(1) 10(1) 1(1) 
C(12) 35(1) 31(1) 41(1) 9(1) 13(1) 5(1) 
0(13) 34(1) 41(1) 51(1) 3(1) 14(1) 5(1) 
C(14) 35(1) 36(1) 47(1) 7(1) 6(1) 0(1) 
S(1S) 29(1) 37(1) 39(1) -1(1) 8(1) -1(1) 
0(1S) 37(1) 50(1) 57(1) -1(1) 6(1) -17(1) 
C(1 S) 30(1) 49(1) 71(2) -7(1) 14(1) 4(1) 
C(2S) 40(1) 46(1) 51(1) -9(1) 9(1) 4(1) 
Table 10-4: Anisotropic displacement parameters (A2x1 03) for 172. The anisotropic 
displacement factor exponent takes the form: -2 ,2  [h2 a*2 U1  + ... + 2 h k 
a* b* U12] 
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Appendix 2. X-Ray Crystallography Data. 
X y z U(eq) 
H(3) 3360 9344 1662 40 
H(6) 910 10111 3211 39 
H(8) -451 10434 3497 43 
H(9) -1865 10049 2877 45 
H(10) -39 7766 396 44 
H(11) -1459 7384 -271 44 
H(14A) -2848 7995 -1630 59 
H(14B) -3596 7736 -619 59 
H(14C) -2759 6989 -179 59 
H(IS1) 6170 34 3959 74 
H(1 S2) 6435 940 2599 74 
H(1 S3) 6192 -349 1963 74 
H(2S1) 4437 2072 3613 68 
H(2S2) 5375 2412 3526 68 
H(2S3) 5198 1438 4880 68 
Table 10-5: Hydrogen coordinates (xl 04) and isotropic displacement parameters 
(A2x103) for 172. 
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10.2 X-Ray Crystal Structure of 179. 
I 
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Appendix 2: X-Ray Crystallography Data. 
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Appendix 2: X-Ray Crystallography Data. 
A. CRYSTAL DATA 
Empirical formula C1 1 H9NO2S2 
Formula weight 251.31 
Wavelength 1.54178 A 
Temperature 150(2) K 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 6.5676(6) A 	alpha = 90 deg. 
b = 9.8187(12) A beta = 100.089(10) deg. 
c = 17.6542(18) A gamma = 90 deg. 
Volume 1120.8(2) A3 
Number of reflections for cell 82 (20 <theta < 22 deg.) 
Z 4 
Density (calculated) 1.489 Mg/m3 
Absorption coefficient 4.181 mnt' 
F(000) 520 
B. DATA COLLECTION 
Crystal description 
	 Yellow needle 
Crystal size 
	 0.32 x 0. 16 x 0. 11 mm 
Theta range for data collection 
	 5.09 to 69.88 deg. 










	 Optimised Numerical 
(Tmin= 0.657, Tm==0.368) 
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Appendix 2: X-Ray Crystallography Data. 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints / parameters 
Goodness-of-fit on F2 
Conventional R [F>4sigma(F)] 
Weighted R (F2 and all data) 
Extinction coefficient 
Final maximum delta/sigma 
direct methods (SHELXS-97) 






Ri = 0.0288 [1787 data] 




calc w [&(Fo2)+(0.0362P)2+0.5453P] where 3P=(Fo2+2Fc2) 
Largest diff. peak and hole 	 0.229 and -0.222 e.A 3 
Table 10-6: Crystal data and structure refinement for 179. 
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Appendix 2: X-Ray Crystallography Data. 
X y z U(eq) 
S(1) 10572(1) 3253(1) 4812(1) 38(1) 
0(2) 14167(2) 3635(2) 5733(1) 61(1) 
C(2) 13108(3) 2863(2) 5307(1) 41(1) 
N(3) 13634(2) 1566(1) 5126(1) 31(1) 
0(4) 12532(2) -304(1) 4397(1) 31(1) 
 12222(3) 846(2) 4615(1) 26(1) 
 10306(3) 1643(2) 4379(1) 27(1) 
 8694(3) 1109(2) 3903(1) 27(1) 
 6686(3) 1679(2) 3591(1) 26(1) 
 5308(3) 868(2) 3090(1) 30(1) 
 3386(3) 1337(2) 2743(1) 31(1) 
 6032(3) 2999(2) 3741(1) 30(1) 
 4116(3) 3468(2) 3407(1) 31(1) 
 2763(3) 2647(2) 2901(1) 28(1) 
S(13) 376(1) 3377(1) 2505(1) 36(1) 
C(14) -933(3) 2081(2) 1889(1) 41(1) 
Table 10-7.• Atomic coordinates (xl 04) and equivalent isotropic displacement parameters 
(A2x103)for 179. U(eq) is defined as one third of the trace of the 
orthogonalized UiJ tensor. 
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C(10)-C(1 1) 1.373(2) 


























Table 10-8: Bond lengths [A] and angles [deg] for 179. 
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Appendix 2. X-Ray Crystallography Data. 
U!! U22 U33 U23 U13 U12 
S(1) 32(1) 33(1) 44(1) -13(1) -7(1) 9(1) 
0(2) 47(1) 49(1) 74(1) -28(1) -25(1) 11(1) 
C(2) 36(1) 38(1) 43(1) -9(1) -7(1) 8(1) 
N(3) 26(1) 31(1) 34(1) -2(1) -5(1) 5(1) 
0(4) 28(1) 27(1) 36(1) -1(1) -2(1) 5(1) 
 24(1) 29(1) 25(1) 3(1) 2(1) 2(1) 
 25(1) 28(1) 27(1) 1(1) 4(1) 5(1) 
 27(1) 26(1) 28(1) 1(1) 5(1) 2(1) 
 23(1) 27(1) 28(1) 1(1) 4(1) 2(1) 
 26(1) 27(1) 38(1) -3(1) 5(1) 0(1) 
 24(1) 31(1) 36(1) -2(1) 1(1) -3(1) 
 26(1) 28(1) 33(1) -3(1) -2(1) 0(1) 
 28(1) 25(1) 38(1) 2(1) 1(1) 3(1) 
 24(1) 28(1) 32(1) 7(1) 3(1) -2(1) 
S(13) 26(1) 27(1) 50(1) 9(1) -7(1) -1(1) 
C(14) 31(1) 43(1) 44(1) 5(1) -8(1) -6(1) 
Table 10-9. Anisotropic displacement parameters (A2x103) for 179. The anisotropic 
displacement factor exponent takes the form. -2 r2 [h2  a*2 U1  + ... + 2 h k 
a* b* U12] 
X y z U(e 
H(4) 14834 1209 5329 38 
H(6) 8901 204 3742 32 
H(8) 5704 -34 2986 36 
H(9) 2494 769 2397 37 
H(10) 6930 3576 4080 36 
H(11) 3703 4362 3520 37 
H(14A) -118 1851 1492 62 
H(14B) -2296 2415 1645 62 
H(14C) -1099 1268 2194 62 
Table 10-10. Hydrogen coordinates (x.104) and isotropic displacement parameters 
(A2x103) for 179 
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10.3 X-Ray Crystal Structure of 181. 









Appendix 2: X-Ray Crystallography Data. 
CRYSTAL DATA 
Empirical formula Cl2HIINO2S 
Formula weight 233.28 
Wavelength 1.54178 A 
Temperature 150(2) K 
Crystal system Monoclinic 
Space group P21/c 
Unit cell dimensions a = 11.7287(12) A 	alpha = 90 deg. 
b= 11.6561(11)A beta= 90.576(12) deg. 
c7.8628(ll)A gamma =9Odeg. 
Volume 1074.9(2) A3 
Number of reflections for cell 92 (20 <theta < 22 deg.) 
Z 4 
Density (calculated) 1.442 Mg/m3 
Absorption coefficient 2.544 mm' 
F(000) 488 
DATA COLLECTION 
Crystal description 	 Colourless plate developed in (100) 
Crystal size 	 0.54 x 0.39 x 0.12 mm 
Theta range for data collection 	 3.77 to 70.04 deg. 




Independent reflections 	 1950 [R(int) = 0.0281] 
Scan type 	 Omega-theta 
Absorption correction 	 Psi-scans (Tmin= 0.421, Tm =0.825) 
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Appendix 2. X-Ray Crystallography Data. 
C. SOLUTION AND REFINEMENT. 
Solution 
Refinement type 
Program used for refinement 
Hydrogen atom placement 
Hydrogen atom treatment 
Data / restraints I parameters 
Goodness-of-fit on F2 
Conventional R [F>4sigma(F)] 
Weighted R (F2 and all data) 
Extinction coefficient 
Final maximum delta/sigma  
direct methods (SHELXS-97) 
Full-matrix least-squares on F2 
SHELXL-97 
Geometric (after difference map) 
Riding or rotating group 
1950/0/147 
1.057 





caic w'=[&(Fo2)+(0.0485P)2+0.5297P] where 3P(Fo2+2Fc2) 
Largest diff. peak and hole 	 0.299 and -0.265 e.A 3 
Table 10-11 	Crystal data and structure refinement for 181. 
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Appendix 2: X-Ray Crystallography Data. 
X y z U(eq) 
S(1) 2113(1) 7790(1) 875(1) 21(1) 
0(2) 4018(1) 7358(1) 2606(2) 31(1) 
C(2) 3543(1) 7982(1) 1610(2) 21(1) 
N(3) 4005(1) 8945(1) 885(2) 20(1) 
0(4) 3675(1) 10378(1) -1044(1) 24(1) 
 3345(1) 9536(1) -263(2) 19(1) 
 2195(1) 9021(1) -411(2) 18(1) 
 1396(1) 9510(1) -1402(2) 19(1) 
 227(1) 9177(1) -1793(2) 18(1) 
 -399(1) 9869(1) -2903(2) 21(1) 
 -1515(1) 9606(1) -3366(2) 22(1) 
 -318(1) 8203(1) -1135(2) 21(1) 
 -1427(1) 7947(1) -1604(2) 22(1) 
 -2050(1) 8638(1) -2728(2) 19(1) 
 -3258(1) 8306(1) -3191(2) 26(1) 
 -3844(1) 9042(2) -4530(2) 31(1) 
Table 10-12: Atomic coordinates (x104) and equivalent isotropic displacement 
parameters (A2x103)for 181. U(eq) is defined as one third of the trace of 
the orthogonalized U/ tensor. 
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C( 1 2)-C(9)-C(8) 
C(1 1)-C(10)-C(7) 















































Bond lengths [A] and angles [deg]for 181. 
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Appendix 2: X-Ray Crystallography Data. 
Ull U22 U33 U23 U13 U12 
S(1) 16(1) 21(1) 26(1) 5(1) -2(1) -3(1) 
0(2) 21(1) 36(1) 35(1) 15(1) -4(1) -1(1) 
C(2) 18(1) 24(1) 21(1) 2(1) 1(1) 0(1) 
N(3) 16(1) 22(1) 21(1) 1(1) -2(1) -3(1) 
0(4) 21(1) 22(1) 29(1) 5(1) -3(1) -5(1) 
 18(1) 19(1) 19(1) -3(1) 0(1) -1(1) 
 17(1) 16(1) 20(1) -1(1) 1(1) -2(1) 
 20(1) 17(1) 19(1) 0(1) 1(1) -2(1) 
 18(1) 18(1) 18(1) -2(1) 0(1) 1(1) 
 23(1) 19(1) 22(1) 1(1) 0(1) -2(1) 
 22(1) 22(1) 22(1) 2(1) -4(1) 2(1) 
 19(1) 21(1) 24(1) 3(1) -4(1) 0(1) 
 21(1) 20(1) 27(1) 2(1) -1(1) -3(1) 
 17(1) 22(1) 19(1) -4(1) -2(1) 1(1) 
 18(1) 29(1) 29(1) 0(1) -5(1) -2(1) 
 23(1) 34(1) 35(1) -1(1) -10(1) 2(1) 
Table 10-14. Anisotropic displacement parameters (A2x103) for 181. The anisotropic 
displacement factor exponent takes the form: -2 ,r2 [h2 a *2  Ui 1 + ... + 2 
hk a*b* U12] 
X y z U(eq) 
H(3) 4700 9174 1148 24 
H(6) 1635 10196 -1945 22 
H(8) -54 10539 -3355 25 
H(9) -1917 10095 -4130 26 
 80 7716 -363 25 
 -1776 7281 -1148 27 
H(13A) -3721 8329 -2145 31 
H(13B) -3254 7503 -3599 31 
H(14A) -3905 9832 -4114 46 
H(14B) -4609 8738 -4765 46 
H(14C) -3397 9032 -5577 46 
Table 10-15.• Hydrogen coordinates (xl 04) and isotropic displacement parameters (A2  
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